Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3027238	s-tpoab	— (—)	18508	21394	100.00%	Distribution not available
3027238	s-tpoab	IU/ml (u/ml)	6065	7053	0.00%
3027238	s-tpoab	kU/l (u/ml)	4440	4990	0.00%
3027238	p-tpoab	— (—)	3605	4102	100.00%	Distribution not available
3027238	p-tpoab	kU/l (u/ml)	2633	3102	15.76%
3027238	tyroideaperoksidaasi,vasta-aineet	kU/l (u/ml)	390	443	0.00%
3027238	tyroideaperoksidaasi,vasta-aineet	— (—)	367	407	100.00%	Distribution not available
3027238	s-tyreoideaperoksidaasi,vasta-aineet	— (—)	283	289	100.00%	Distribution not available
3027238	s-tpo-ab	— (—)	201	213	100.00%	Distribution not available
3027238	s-tpoab	IU/ml_____ (u/ml)	102	114	0.00%
3027238	s-tpo-ab	IU/ml (u/ml)	69	76	0.00%
3027238	tyreoideaperoksidaasi,vasta-aineet,seerumi	— (—)	65	69	100.00%	Distribution not available
3027238	s-tpoab	U/ml (u/ml)	60	63	0.00%
3027238	tyroideaperoksidaasiva(tpoab)	kU/l (u/ml)	13	14	0.00%
3027238	s-tpo-ab	kU/l (u/ml)	10	11	0.00%	Distribution not available	Distribution not available
3027238	tpoab	kU/l (u/ml)	9	9	0.00%
3027238	p-tpoab	IU/ml (u/ml)	8	10	0.00%	Distribution not available
3027238	tpoab	— (—)	8	8	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Nontoxic multinodular goitre

1188

3728

3.52

310.00

1.3

1.1

101.54

70.35

u/ml

2.39

428

1185

Thyroiditis, ILD-related definition

1628

4214

5.10

307.65

1.5

1.2

270.54

139.01

u/ml

20.81

912

1576

Depression medications

2152

4039

2.88

307.65

1.3

1.2

133.40

97.89

u/ml

2.69

800

1485

Hypothyroidism and >3 levothyroxin purchases

5017

3937

9.79

307.65

1.3

1.2

217.78

98.12

u/ml

44.19

2332

1445

Hypothyreosis and Thyroxine purchase for inclusion criteria

11808

18874

4.90

307.65

1.3

1.2

209.29

80.16

u/ml

157.13

5414

6248

Hypothyroidism (congenital or acquired)

5063

3942

9.87

307.65

1.3

1.2

215.97

98.06

u/ml

43.31

2348

1446

Thyrotoxicosis, other and/or unspecified

3407

4794

10.22

307.65

1.4

1.2

194.17

69.62

u/ml

39.05

1557

1574

Hypothyroidism, drug reimbursement

1291

2433

4.21

307.65

1.3

1.2

225.78

102.88

u/ml

12.66

624

923

Hypothyroidism, strict autoimmune

9755

13658

5.66

307.65

1.3

1.2

213.56

76.38

u/ml

145.45

4467

4489

Carbimazole or st.post thyroidectomy, condition for graves disease

2834

7549

4.83

307.65

1.4

1.2

198.01

139.25

u/ml

7.54

1303

2900

Disorders of thyroid, IBD co-morbidities

3682

3977

9.00

307.65

1.4

1.2

198.12

156.88

u/ml

4.56

1743

1554

Thyrotoxicosis

3831

8404

6.11

307.65

1.4

1.2

190.82

135.70

u/ml

8.96

1731

3141

Disorders of the thyroid gland

13025

16530

6.26

307.65

1.3

1.2

193.69

69.89

u/ml

164.05

5821

5313

Autoimmune hyperthyroidism

826

1569

7.04

307.65

1.5

1.2

224.35

74.35

u/ml

16.85

463

509

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

3909

11603

4.05

307.65

1.4

1.2

161.22

142.13

u/ml

1.71

1597

4417

Thyroiditis

980

2286

5.83

307.65

1.5

1.2

223.13

149.51

u/ml

4.09

481

839

Benign thyroid growths and nodules

2521

6625

3.98

307.65

1.3

1.1

109.19

70.84

u/ml

5.21

876

2155

Hypothyroidism, other/unspecified

11513

15948

5.73

307.65

1.3

1.2

208.83

70.30

u/ml

176.14

5283

5140

Autoimmune diseases

9404

17644

2.95

307.65

1.3

1.2

187.36

82.67

u/ml

85.89

4036

5834

Hypothyroidism, levothyroxine purchases

5017

3937

9.79

307.65

1.3

1.2

217.78

98.12

u/ml

44.19

2332

1445

Thyrotoxicosis with diffuse goitre

2047

3473

8.02

307.65

1.4

1.2

220.39

73.23

u/ml

36.37

1120

1145

Subacute thyroiditis

498

741

9.52

307.65

1.5

1.2

165.96

71.74

u/ml

3.72

229

237

Used for control exclusion in common control thyroid runs

9708

13945

3.90

307.65

1.3

1.1

172.90

70.52

u/ml

91.41

4093

4477

Endocrine, nutritional and metabolic diseases

7063

10885

3.61

307.65

1.3

1.1

172.19

72.69

u/ml

61.43

2893

3660

Hypothyroidism, strict autoimmune, 3 medication purchases required

10294

18245

4.48

307.65

1.3

1.2

216.50

81.25

u/ml

146.00

4717

6078

Graves disease, strict definition

1628

3871

5.95

307.65

1.5

1.2

226.75

143.40

u/ml

8.51

894

1454

Thyrotoxicosis with toxic multinodular goitre

653

1408

5.95

300.19

1.3

1.2

94.82

123.85

u/ml

0.89

205

499

Depression

6286

25989

1.69

278.76

1.3

1.2

118.22

147.39

u/ml

6.26

2155

10166

Mood disorders

6576

26320

1.66

274.55

1.2

117.04

146.92

u/ml

6.73

2227

10272

Mood [affective] disorders

6565

26319

1.66

274.32

1.2

117.14

146.90

u/ml

6.66

2223

10270

Recurrent or chronic depression

2825

9791

2.13

256.09

1.3

1.2

117.68

160.45

u/ml

6.90

1016

3970

Anaemias

1547

3789

2.82

252.29

1.3

1.2

149.64

98.67

u/ml

3.32

571

1381

Anxiety (asthma-related co-morbidities)

4501

20204

1.79

246.47

1.3

1.2

121.91

150.68

u/ml

4.86

1525

8162

Neurotic, stress-related and somatoform disorders

5911

25661

1.65

244.54

1.3

1.2

124.89

144.86

u/ml

3.12

1990

10070

Anxiety disorders

5942

25718

1.65

244.40

1.3

1.2

124.92

144.72

u/ml

3.09

2003

10084

All anxiety disorders

4658

21725

1.75

240.07

1.3

1.2

120.81

147.54

u/ml

4.48

1574

8693

Headache

4571

21141

1.75

236.70

1.3

1.2

111.08

151.76

u/ml

11.39

1729

8246

Mood disorders, excluding more controls

5810

21408

1.66

236.51

1.2

116.87

148.00

u/ml

6.34

1966

8502

Autoimmune thyroiditis

309

415

11.76

235.30

1.6

1.2

307.60

72.65

u/ml

14.90

181

136

Anxiety disorders, excluding more controls

5290

20968

1.68

229.44

1.3

1.2

124.82

149.08

u/ml

3.89

1775

8373

Pain in joint

3668

12834

1.83

215.51

1.3

1.2

143.40

152.40

u/ml

0.52

1316

4914

Nontoxic goitre/thyroid nodule

1919

9281

2.24

206.59

1.3

1.2

108.92

144.00

u/ml

3.62

673

3560

Migraine

3989

18916

1.73

196.41

1.3

1.2

125.53

153.50

u/ml

4.55

1574

7344

Other antidepressants

5814

19333

1.58

193.73

1.2

114.31

153.35

u/ml

10.54

2049

7535

Autoimmune diseases related-to ILD

5162

28072

1.59

190.29

1.3

1.2

172.10

134.31

u/ml

7.55

2148

10462

Behavioural syndromes associated with physiological disturbances and physical factors

5820

26177

1.56

188.61

1.2

122.77

144.99

u/ml

4.29

2194

9920

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1118

4580

2.77

182.98

1.4

1.2

184.19

147.19

u/ml

1.79

515

1798

Sleep disorders

5640

25891

1.55

181.15

1.2

126.39

144.92

u/ml

3.05

2185

9851

Other metabolic disorders

1167

4895

2.69

180.91

1.4

1.2

186.08

145.01

u/ml

2.16

530

1919

Other anxiety disorders

3547

18387

1.73

177.13

1.3

1.2

121.51

146.90

u/ml

3.20

1187

7360

Sleep disorders (combined)

6404

22741

1.52

175.86

1.2

126.71

146.06

u/ml

3.24

2357

8642

Insomnia

5628

26308

1.54

174.57

1.2

125.30

144.46

u/ml

3.29

2205

9970

Episodal and paroxysmal disorders

6476

22631

1.49

165.18

1.3

1.2

121.95

149.38

u/ml

6.42

2421

8572

General symptoms and signs

6343

21816

1.50

164.27

1.3

1.2

119.05

150.68

u/ml

8.19

2336

8482

Depression or dysthymia

3509

11552

1.72

162.87

1.2

126.62

156.60

u/ml

3.40

1267

4530

Medical observation and evaluation for suspected diseases and conditions

3744

11768

1.68

158.85

1.3

1.2

129.88

148.97

u/ml

1.88

1264

4672

Abnormalities of breathing

5440

21050

1.52

156.41

1.3

1.2

120.22

150.69

u/ml

6.85

2047

8112

Malaise and fatigue

2988

14029

1.74

156.34

1.3

1.2

107.86

148.36

u/ml

7.09

1007

5319

Sleep apnoea, including avohilmo

5535

22806

1.51

154.93

1.2

130.43

142.84

u/ml

1.33

2074

8664

Symptoms and signs involving the circulatory and respiratory systems

6096

21080

1.49

154.06

1.3

1.2

126.66

150.64

u/ml

4.52

2286

8128

Other soft tissue disorders, not elsewhere classified

5591

21760

1.51

151.70

1.3

1.2

120.80

147.08

u/ml

4.82

1929

8353

Abnormalities of heart beat

2192

11945

1.87

147.69

1.3

1.2

115.96

148.78

u/ml

3.84

790

4566

Type 1 diabetes, wide definition, subgroup 1

1411

6885

2.20

147.67

1.3

1.2

174.84

137.56

u/ml

2.13

587

2611

Selective serotonin reuptake inhibitors

5471

19412

1.51

146.63

1.2

122.29

153.38

u/ml

5.68

1927

7551

Sleep apnoea

5046

21622

1.52

143.97

1.2

126.30

143.30

u/ml

2.25

1829

8271

Dermatitis and eczema

6418

27100

1.44

139.97

1.2

123.71

143.90

u/ml

3.36

2401

10254

Type 1 diabetes, wide definition

1428

7144

2.14

139.09

1.3

1.2

175.63

137.93

u/ml

2.20

595

2701

Other and/or unspecified nontoxic goitre

505

1558

3.62

136.69

1.2

120.25

68.79

u/ml

2.27

152

510

Neurological diseases, wide definition

1976

5297

1.96

136.29

1.3

1.2

128.14

151.66

u/ml

1.33

743

1997

Type 1 diabetes

1543

8004

2.04

134.73

1.3

1.2

170.58

137.90

u/ml

1.90

633

3035

Triptan medication for migraine, single purchase ok

4982

23460

1.49

130.42

1.3

1.2

134.19

144.68

u/ml

1.11

1989

8952

Migraine, single triptan purchase ok & required. ICD-code if available is included

4982

23460

1.49

130.42

1.3

1.2

134.19

144.68

u/ml

1.11

1989

8952

Examination and observation for other reasons

3302

11745

1.64

129.88

1.2

126.69

149.14

u/ml

2.27

1124

4661

Other nutritional deficiencies

4223

26271

1.52

128.57

1.3

1.2

135.83

142.83

u/ml

0.46

1530

10156

Lower back pain or/and sciatica

6198

27764

1.42

128.55

1.3

1.2

120.75

144.26

u/ml

4.91

2385

10482

Disorders of other endocrine glands

2707

16501

1.69

128.43

1.3

1.2

116.12

141.44

u/ml

2.92

977

6212

Female infertility

2348

8320

1.81

125.60

1.3

1.2

142.12

157.30

u/ml

0.96

859

3364

Other headache syndromes

2694

16740

1.68

124.83

1.3

1.2

118.88

152.09

u/ml

5.03

1037

6440

Low back pain

4610

21480

1.49

123.75

1.3

1.2

124.28

149.06

u/ml

3.99

1719

8135

Female infertility, cervical, vaginal, other or unspecified origin

2161

8079

1.83

122.03

1.3

1.2

150.15

157.51

u/ml

0.33

775

3255

Dorsalgia

5753

21866

1.43

118.94

1.3

1.2

119.18

148.55

u/ml

6.49

2177

8264

Urticaria

2100

12530

1.78

117.42

1.3

1.2

124.57

146.39

u/ml

1.56

775

4832

Neurological diseases

5062

17862

1.46

116.29

1.3

1.2

120.97

155.90

u/ml

8.08

1911

6763

Dentofacial anomalies [including malocclusion]

4586

25255

1.47

115.03

1.3

1.2

130.01

145.53

u/ml

1.69

1806

9671

Insulin, fast-acting

1864

10807

1.80

112.92

1.3

1.2

157.55

133.72

u/ml

1.41

738

3964

Amiodarone users

470

1578

3.23

109.30

1.2

72.32

125.59

u/ml

3.00

131

529

Urticaria and erythema

2402

15086

1.67

108.97

1.3

1.2

123.87

145.43

u/ml

1.74

893

5795

Other specific joint derangements/joint disorders

4606

20272

1.46

108.31

1.3

1.2

140.14

144.47

u/ml

0.25

1699

7742

Insulin, fast-acting or short human

1866

10947

1.78

108.22

1.3

1.2

157.15

134.34

u/ml

1.31

740

4007

Pain in throat and chest

4794

20156

1.44

107.17

1.3

1.2

123.22

149.90

u/ml

4.43

1806

7789

Antihypertensive medication - note that there are other indications

4304

15650

1.49

106.74

1.3

1.2

134.04

151.38

u/ml

1.72

1641

6017

Pain in limb

4731

21405

1.44

105.93

1.3

1.2

132.67

147.56

u/ml

1.30

1628

8231

Other dorsopathies, not elsewhere classified

5770

21921

1.40

105.71

1.2

123.80

148.61

u/ml

4.76

2212

8283

Sub-endpoint used in defining T1D endpoints

1551

8611

1.85

103.15

1.3

1.2

168.87

132.85

u/ml

2.27

638

3184

Asthma (mode)

4336

15941

1.47

102.85

1.2

113.40

151.08

u/ml

8.06

1600

6243

Nontoxic single thyroid nodule

433

1447

3.32

102.67

1.3

1.2

90.03

70.01

u/ml

0.59

145

454

Asthma (only as main-diagnosis), excluding more controls

4007

15376

1.48

100.62

1.2

114.94

152.20

u/ml

7.40

1505

6032

Asthma (only as main-diagnosis)

4069

15843

1.48

100.37

1.2

114.00

150.76

u/ml

7.40

1524

6197

Dysphagia

1250

6693

1.96

98.70

1.2

104.98

141.85

u/ml

2.64

441

2495

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

5609

26664

1.38

98.12

1.3

1.2

139.75

140.64

u/ml

0.05

2034

10178

Asthma, excluding more controls

4252

15376

1.46

97.04

1.2

114.18

152.20

u/ml

7.88

1559

6032

Asthma

4337

15843

1.45

95.97

1.2

113.49

150.76

u/ml

7.81

1584

6197

Autoimmune diseases excluding thyroid diseases

4427

17064

1.43

95.03

1.2

84.12

76.87

u/ml

0.81

1496

5531

Conjunctivitis (acute, non atopic), including avohilmo

5485

24585

1.38

94.17

1.2

140.36

138.94

u/ml

0.08

1986

9354

Irritable bowel syndrome

1804

10947

1.74

94.08

1.3

1.2

113.72

145.69

u/ml

2.87

656

4309

Asthma, including avohilmo

6513

27237

1.34

94.00

1.2

116.25

145.97

u/ml

7.64

2424

10305

Gastro-oesophageal reflux disease

3539

20783

1.48

93.87

1.3

1.2

110.28

142.20

u/ml

4.44

1211

7986

Soft tissue disorders

5724

21885

1.37

91.69

1.3

1.2

126.38

146.78

u/ml

3.32

2090

8397

Cystitis

4874

21237

1.40

91.32

1.3

1.2

135.22

144.45

u/ml

0.75

1817

8166

Symptoms and signs involving the skin and subcutaneous tissue

3968

26974

1.43

88.88

1.2

120.78

143.38

u/ml

3.27

1418

10283

Other and unspecified urticaria

1337

7620

1.87

88.70

1.3

1.2

114.72

144.29

u/ml

2.11

503

2958

Psychiatric diseases

5011

18443

1.39

88.22

1.2

127.03

149.75

u/ml

3.15

1819

7229

Obesity and other hyperalimentation

3829

25839

1.44

87.96

1.3

1.2

129.92

143.50

u/ml

1.27

1370

10028

Symptoms and signs involving the digestive system and abdomen

5145

19034

1.38

87.82

1.2

129.00

146.34

u/ml

2.04

1893

7248

Disorders of conjunctiva

4890

28182

1.38

86.92

1.3

1.2

138.80

141.52

u/ml

0.16

1795

10767

Obesity

3811

25789

1.44

86.90

1.3

1.2

129.75

143.62

u/ml

1.31

1366

10007

Acute upper respiratory infections

5664

25628

1.35

86.60

1.2

131.37

142.68

u/ml

1.15

2073

9784

General examination and investigation of persons without complaint and reported diagnosis

3301

11762

1.49

86.23

1.2

115.13

149.02

u/ml

4.17

1197

4670

Other systemic involvement of connective tissue (FG)

1467

8445

1.79

86.03

1.3

1.2

103.56

144.64

u/ml

3.95

529

3245

Benzodiazepine use

5489

27968

1.35

85.78

1.3

1.2

111.75

144.78

u/ml

7.88

1824

10840

Abdominal and pelvic pain

5117

19033

1.38

85.52

1.2

126.79

146.34

u/ml

2.55

1883

7248

Type 1 diabetes, strict definition, subgroup 1

614

2705

2.53

84.95

1.4

1.3

202.86

142.26

u/ml

1.77

269

1022

Exclusions for E4_PCOS_BROAD

1065

5720

1.99

84.93

1.3

1.2

117.10

144.21

u/ml

1.40

385

2132

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2125

6657

1.65

84.75

1.2

148.76

164.60

u/ml

0.71

795

2680

Oral corticosteroids

5740

25550

1.34

84.08

1.3

1.2

113.45

147.05

u/ml

8.70

2116

9804

Pain and other conditions associated with female genital organs and menstrual cycle

1691

8666

1.74

84.06

1.3

1.2

125.62

155.77

u/ml

1.56

590

3500

Autoimmune diseases excluding thyroid diseases, strict definition

4020

15631

1.42

83.70

1.2

73.43

71.39

u/ml

0.18

1314

5024

Metabolic disorders

4815

21432

1.38

82.64

1.3

1.2

147.83

138.99

u/ml

0.68

1762

8291

Personality disorders, excluding more controls

1702

10495

1.70

82.62

1.3

1.2

100.13

150.35

u/ml

7.06

525

4324

Type 1 diabetes, strict definition

628

2832

2.45

81.98

1.4

1.3

201.61

143.11

u/ml

1.73

275

1074

Atopic dermatitis

3832

22121

1.42

81.36

1.3

1.2

135.43

147.96

u/ml

0.86

1430

8576

Sciatica+with lumbago

2770

16818

1.50

80.57

1.2

122.31

151.35

u/ml

3.47

1114

6431

Thyroiditis, unspecified

154

298

6.61

80.24

1.6

1.1

262.91

72.64

u/ml

4.75

Persons encountering health services in other circumstances, wide

6018

23709

1.33

80.16

1.2

142.15

138.63

u/ml

0.20

1907

9503

Any mental disorder

5660

21533

1.34

80.01

1.2

123.61

147.97

u/ml

3.81

1945

8536

Type 1 diabetes, strict (exclude DM2)

702

3349

2.28

78.98

1.4

1.3

196.96

145.12

u/ml

1.67

310

1251

Disturbances of skin sensation

1767

11152

1.66

78.90

1.3

1.2

118.25

147.44

u/ml

2.54

661

4375

Habitual aborter

289

928

4.07

78.89

1.3

143.87

147.24

u/ml

0.04

382

Other disorders of lacrimal gland

2037

13247

1.60

78.88

1.3

1.2

113.16

143.13

u/ml

3.68

817

5119

Type 1 diabetes, definitions combined

705

3378

2.27

78.38

1.4

1.3

196.93

145.08

u/ml

1.68

311

1263

Dyspnoea

4655

25131

1.37

78.31

1.2

115.69

144.26

u/ml

5.68

1720

9532

Pain, not elsewhere classified

1624

10036

1.69

77.99

1.3

1.2

107.33

152.46

u/ml

5.27

596

3861

Triptan medication for migraine, min. 3 purchases

4021

22142

1.41

77.60

1.3

1.2

132.35

148.23

u/ml

1.71

1634

8666

Acute upper respiratory infections of multiple and unspecified sites

4355

23604

1.38

77.12

1.3

1.2

120.48

144.42

u/ml

3.20

1533

9128

Conjunctivitis

4541

27420

1.37

77.09

1.3

1.2

139.63

142.45

u/ml

0.16

1673

10525

Insulin, intermediate and long-acting

2390

15509

1.53

76.95

1.3

1.2

150.85

134.75

u/ml

0.79

907

5667

ILD medications: prednisolone, methylprednisolone, prednisone

5892

25241

1.32

76.68

1.3

1.2

117.45

147.14

u/ml

6.69

2146

9689

First line medication for Crohn's disease

6055

25186

1.32

76.45

1.3

1.2

118.82

147.58

u/ml

6.74

2196

9706

Disorders of lacrimal system

2388

15885

1.53

76.24

1.3

1.2

116.49

144.28

u/ml

3.55

949

6088

Dorsopathies

5674

22005

1.33

76.05

1.2

122.44

148.68

u/ml

5.22

2147

8306

Nonorganic sleeping disorders, excluding more controls

1350

8035

1.77

75.98

1.3

1.2

112.83

147.99

u/ml

2.94

492

3294

Any reimbursement code in KELA

3849

13959

1.42

75.81

1.3

1.2

152.80

148.92

u/ml

0.19

1452

5528

Migraine with aura

1856

12000

1.63

75.17

1.3

1.2

121.40

152.30

u/ml

3.07

726

4696

Other systemic involvement of connective tissue

1477

9006

1.72

75.14

1.3

1.2

103.18

142.03

u/ml

3.69

532

3422

Cough

2152

13334

1.56

74.06

1.2

130.87

148.64

u/ml

1.07

744

5093

Disorders of eyelid, lacrimal system and orbit

4514

24850

1.36

74.00

1.3

1.2

131.77

143.48

u/ml

1.20

1699

9395

Intestinal infectious diseases, including avohilmo, including avohilmo

6063

26264

1.31

73.47

1.2

135.61

140.37

u/ml

0.36

2179

10012

Persons encountering health services for other counselling and medical advice, not elsewhere classified

5772

23687

1.32

73.18

1.2

152.70

138.61

u/ml

1.15

1786

9495

Diseases of oesophagus, stomach and duodenum

5594

25496

1.32

72.69

1.3

1.2

121.34

143.84

u/ml

3.49

2026

9796

Other diseases of intestines

5913

25638

1.31

71.60

1.2

129.68

142.55

u/ml

1.53

2142

9867

Parasetamol

4081

15188

1.39

71.45

1.2

132.80

154.22

u/ml

2.23

1523

5752

Hyperkinetic disorders, excluding more controls

1087

5795

1.88

71.43

1.3

88.19

150.79

u/ml

8.01

373

2353

Chronic rhinitis, nasopharyngitis and pharyngitis

1848

12039

1.60

70.98

1.3

1.2

135.42

144.66

u/ml

0.35

665

4583

Bipolar affective disorders

1244

7417

1.78

70.02

1.2

93.99

146.25

u/ml

5.54

366

2991

Disorders of lacrimal system and orbit in diseases classified elsewhere

243

748

3.99

69.18

1.5

1.2

201.82

151.31

u/ml

1.10

116

301

Hypothyroidism due to medicaments and other exogenous substances

118

204

7.43

69.16

1.3

1.2

228.40

63.41

u/ml

0.95

Pain (limb, back, neck, head abdominally)

3568

12937

1.41

68.94

1.2

137.41

151.68

u/ml

1.01

1294

4951

Follow-up examination after treatment for conditions other than malignant neoplasms

2386

10816

1.51

68.86

1.2

142.10

150.21

u/ml

0.41

829

4299

Obesity related asthma

1813

11845

1.59

68.61

1.3

1.2

104.32

144.48

u/ml

4.45

634

4583

Other special examinations and investigations of persons without complaint or reported diagnosis

3251

11768

1.43

67.85

1.2

134.66

148.97

u/ml

1.01

1262

4672

Other diseases of urinary system

5226

22642

1.32

67.55

1.2

135.27

143.60

u/ml

0.67

1932

8659

Diseases of the skin and subcutaneous tissue

5191

20023

1.33

67.44

1.2

130.55

148.71

u/ml

2.16

1954

7632

Systemic connective tissue disorders

1778

11619

1.59

67.18

1.3

1.2

106.61

142.46

u/ml

3.73

637

4434

Myalgia

1478

9285

1.67

67.06

1.3

1.2

124.30

151.16

u/ml

1.78

480

3688

Opioids

5531

22201

1.31

66.84

1.2

131.70

145.85

u/ml

1.52

1995

8700

Other functional intestinal disorders

2317

14476

1.50

66.54

1.2

131.06

141.55

u/ml

0.43

794

5499

Type1 diabetes, definitions combined, early onset

534

2464

2.41

66.33

1.4

1.3

208.02

142.88

u/ml

1.63

224

895

Fibromyalgia

727

3777

2.11

65.91

1.3

1.2

111.26

155.51

u/ml

2.12

256

1596

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2575

17481

1.46

65.71

1.3

1.2

124.72

142.25

u/ml

1.48

948

6550

Inflammatory bowel disease treatment related agents

6096

26735

1.29

64.89

1.3

1.2

114.42

147.39

u/ml

8.68

2230

10216

Nontoxic diffuse goitre

197

540

4.14

64.49

1.3

1.2

116.45

69.91

u/ml

0.81

175

Other diseases of upper respiratory tract

5546

22562

1.30

64.39

1.2

134.45

140.59

u/ml

0.48

2129

8371

ILD medications

6067

25881

1.29

63.70

1.3

1.2

115.78

146.65

u/ml

8.02

2227

9918

Asthma (diagnoses ohter than nonallergic)

4674

29180

1.32

63.48

1.3

1.2

111.08

144.00

u/ml

7.84

1680

11103

Other joint disorders

5073

20497

1.32

63.09

1.3

1.2

139.51

144.41

u/ml

0.32

1923

7818

Graves ophthalmopathy

238

769

3.79

62.77

1.5

1.2

200.87

145.15

u/ml

1.30

115

313

Graves ophthalmopathy, strict

223

694

3.99

62.76

1.5

1.2

191.12

146.62

u/ml

0.89

108

285

Disorders of orbit

325

1231

3.00

62.69

1.4

1.2

198.37

146.64

u/ml

1.34

146

476

Diseases of the eye and adnexa

4586

17590

1.33

61.94

1.3

1.2

134.95

146.80

u/ml

1.05

1780

6771

Generalized anxiety disorder

1251

7733

1.72

61.49

1.3

1.2

94.59

146.50

u/ml

6.04

402

3098

Temporomandibular joint disorders, including avohilmo

3075

21971

1.40

61.19

1.3

1.2

130.75

145.03

u/ml

1.04

1206

8524

Obesity due to excess calories

2808

20413

1.42

60.91

1.3

1.2

126.68

143.27

u/ml

1.37

1006

7927

Visual disturbances and blindness

2615

18724

1.43

60.88

1.3

1.2

127.51

140.42

u/ml

0.99

972

6967

Insulin, fast-acting (human)

824

4543

1.92

60.58

1.3

1.2

174.94

139.94

u/ml

1.13

350

1698

Visual disturbances

2476

17609

1.45

60.52

1.3

1.2

129.24

139.80

u/ml

0.71

929

6572

Persons encountering health services in other circumstances

2278

15800

1.47

60.35

1.3

1.2

110.37

138.72

u/ml

3.38

802

6321

Provisional assignment of new diseases of uncertain etiology

2813

20271

1.41

60.27

1.3

1.2

141.90

137.55

u/ml

0.16

998

7645

Codes for special purposes

2815

20288

1.41

60.23

1.3

1.2

141.90

137.41

u/ml

0.16

998

7655

Asthma, unspecified (mode), excluding more controls

2789

14370

1.42

59.97

1.2

110.05

152.02

u/ml

7.37

998

5648

Special screening examination for infectious and parasitic diseases

1620

7686

1.60

59.76

1.3

1.2

151.07

150.83

u/ml

0.01

472

3127

Chronic diseases of tonsils and adenoids

4336

21017

1.33

59.53

1.3

1.2

137.32

142.63

u/ml

0.38

1760

7909

Excessive, frequent and irregular menstruation

2556

9648

1.47

59.45

1.3

1.2

117.60

155.37

u/ml

5.52

941

3834

Codeine

5153

21809

1.30

59.32

1.2

128.07

146.64

u/ml

2.24

1884

8553

Symptoms and signs involving the nervous and musculoskeletal systems

2837

20733

1.40

58.50

1.3

1.2

119.42

141.28

u/ml

2.29

1060

7751

Somatoform disorder

999

5894

1.79

58.48

1.3

1.2

116.29

145.82

u/ml

1.37

336

2390

Other intervertebral disc disorders

4105

18670

1.34

58.43

1.2

127.42

150.39

u/ml

3.11

1651

7106

Cardiac arrhythmias

3504

16825

1.37

58.09

1.3

1.2

124.56

150.25

u/ml

3.19

1380

6575

Hypopituitarism

412

1791

2.49

58.02

1.3

1.2

80.14

136.78

u/ml

3.41

159

650

Asthma, unspecified (mode)

2825

14814

1.41

57.55

1.2

110.46

150.56

u/ml

6.88

1003

5809

Other pulmonary diagnosis

4176

15981

1.34

57.13

1.2

136.95

150.90

u/ml

1.17

1565

6254

Oedema, not elsewhere classified

1500

9531

1.58

57.07

1.3

1.2

131.44

147.43

u/ml

0.54

518

3616

Noninflammatory disorders of female genital tract

2689

9675

1.44

57.03

1.2

141.01

155.55

u/ml

0.82

963

3838

Any gastric operation

4550

17653

1.32

56.88

1.3

1.2

137.53

147.73

u/ml

0.88

1640

7007

GASTRO-related operations

4550

17653

1.32

56.88

1.3

1.2

137.53

147.73

u/ml

0.88

1640

7007

Functional dyspepsia

1458

9474

1.60

56.86

1.3

1.2

124.96

144.93

u/ml

0.78

558

3659

Spondylosis

2326

12824

1.45

56.61

1.3

1.2

117.72

148.82

u/ml

3.92

921

4864

Irregular menses

3584

20476

1.36

56.59

1.3

1.2

127.23

151.51

u/ml

3.28

1349

8220

Migraine without aura

1531

10121

1.59

56.54

1.3

1.2

126.34

153.75

u/ml

1.90

577

3996

Excluding asthma or asthma-COPD overlap

4169

15981

1.33

56.36

1.2

137.76

150.90

u/ml

1.08

1575

6254

Cardiovascular diseases

4114

16747

1.34

56.26

1.3

1.2

135.57

149.09

u/ml

1.14

1585

6580

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2768

12774

1.43

55.91

1.3

148.37

145.65

u/ml

0.11

1121

5076

Codeine or tramadol medication

5951

25939

1.27

55.72

1.2

129.58

142.63

u/ml

1.44

2181

9958

Other obstetric conditions, not elsewhere classified

2803

13005

1.43

55.34

1.3

149.24

145.78

u/ml

0.15

1143

5173

ILD differential diagnosis

4149

15941

1.33

55.17

1.2

137.18

151.08

u/ml

1.16

1561

6243

COPD differential diagnosis

4149

15947

1.33

55.05

1.2

137.18

151.17

u/ml

1.17

1561

6244

Asthma, hospital admissions , main diagnosis only

4331

29422

1.31

54.93

1.2

114.49

143.89

u/ml

5.93

1613

11172

Dental pulpitis, including avohilmo

5163

26275

1.28

54.63

1.3

1.2

131.08

142.89

u/ml

1.30

1951

10100

Other reaction to severe stress, and adjustment disorders

2288

16377

1.44

54.44

1.3

1.2

134.95

148.67

u/ml

0.82

778

6595

Other and unspecified dermatitis

2698

19810

1.40

54.32

1.2

103.97

145.09

u/ml

8.23

1030

7496

Insulin, combination of fast acting with intermediate-acting or long-acting

2597

17118

1.40

54.24

1.3

1.2

145.97

133.67

u/ml

0.60

991

6265

Dermatitis

3154

23189

1.36

53.95

1.2

107.46

145.44

u/ml

7.85

1189

8781

Fever of other and unknown origin

2788

17772

1.39

53.79

1.2

104.69

147.18

u/ml

8.68

979

6820

Nerve, nerve root and plexus disorders

5345

25613

1.27

53.47

1.2

122.19

145.26

u/ml

4.41

2079

9688

Caries of enamel

5114

26628

1.28

53.36

1.2

136.97

140.70

u/ml

0.26

1749

10340

2450

17657

1.42

52.88

1.3

1.2

108.56

142.74

u/ml

4.74

878

6736

Inflammatory diseases of female pelvic organs

4255

22833

1.31

52.16

1.3

1.2

132.10

148.24

u/ml

1.53

1613

8986

Diseases of the musculoskeletal system and connective tissue

3137

11702

1.37

51.71

1.2

143.01

152.40

u/ml

0.50

1179

4519

Nonorganic sleeping disorders

1350

8841

1.60

51.57

1.3

1.2

112.83

143.65

u/ml

2.35

492

3431

Dermatographic urticaria

514

2588

2.19

51.36

1.3

1.2

148.73

152.16

u/ml

0.05

195

986

Personality disorders

1702

11705

1.52

51.22

1.3

1.2

100.13

143.54

u/ml

5.47

525

4590

Disorders of adult personality and behaviour

1809

12599

1.49

50.90

1.3

1.2

104.44

144.79

u/ml

4.96

562

4919

Endometriosis

2119

8695

1.47

50.68

1.3

1.2

124.87

155.52

u/ml

3.03

839

3468

Mycoses, including avohilmo

4852

29478

1.28

50.53

1.2

119.79

142.93

u/ml

4.02

1782

11202

Phobic anxiety disorders

959

5819

1.74

50.50

1.3

1.2

135.48

149.65

u/ml

0.46

334

2297

Asthma, hospital admission 2, infections

3021

22224

1.35

50.36

1.3

1.2

106.64

143.44

u/ml

6.78

1067

8388

Asthma-related infections

3021

22224

1.35

50.36

1.3

1.2

106.64

143.44

u/ml

6.78

1067

8388

Vocal cord dysfunction

753

3732

1.86

50.06

1.3

1.2

120.82

158.57

u/ml

1.96

281

1563

Chronic sinusitis

2194

15780

1.43

49.93

1.3

1.2

128.35

142.83

u/ml

0.83

854

5970

Care involving use of rehabilitation procedures

3134

21372

1.35

49.79

1.3

1.2

108.27

143.08

u/ml

6.41

1078

8339

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1678

10085

1.52

49.58

1.3

108.88

145.03

u/ml

3.35

580

3879

Female infertility, associated with anovulation

707

4007

1.93

49.45

1.3

113.44

155.54

u/ml

2.53

270

1649

Panic disorder

1052

6586

1.69

49.42

1.3

1.2

129.90

147.45

u/ml

0.62

352

2641

Intestinal infectious diseases

4903

29186

1.27

49.34

1.3

1.2

132.89

140.65

u/ml

0.59

1746

11098

Disorders of skin appendages

2858

21411

1.36

49.11

1.3

1.2

118.69

141.23

u/ml

2.47

1122

8131

Other/unspecified dorsalgia

1886

13096

1.46

49.03

1.3

1.2

127.39

150.92

u/ml

1.65

661

4965

Symptoms and signs involving speech and voice

1606

10978

1.51

48.93

1.3

1.2

109.84

139.74

u/ml

2.93

579

4192

Voice disturbances

1361

9045

1.56

48.00

1.3

1.2

112.43

145.30

u/ml

2.91

509

3456

Other disorders of adrenal gland

315

1337

2.63

47.91

1.4

1.2

164.27

148.45

u/ml

0.24

118

503

Other general symptoms and signs

383

1750

2.38

47.60

1.4

1.2

132.90

159.95

u/ml

0.64

119

671

Bronchitis

5717

27929

1.25

47.55

1.3

1.2

126.43

142.45

u/ml

2.02

2033

10721

Insulin medication

2596

15961

1.38

47.51

1.3

1.2

146.05

137.05

u/ml

0.40

990

5936

Genitourinary diseases

2518

9179

1.40

47.47

1.2

131.46

149.45

u/ml

1.14

921

3471

Adrenocortical insufficiency

258

1007

2.89

47.00

1.4

1.2

167.19

154.02

u/ml

0.17

102

381

Migraine with aura and triptan purchases

1225

8058

1.61

46.90

1.3

126.21

148.15

u/ml

1.18

473

3150

Symptoms and signs involving cognition, perception, emotional state and behaviour

4884

26241

1.26

46.57

1.3

1.2

116.05

143.95

u/ml

6.03

1770

10034

Constipation

4224

22638

1.29

46.43

1.2

118.53

143.69

u/ml

4.05

1480

8683

Other arrhythmias

3283

18834

1.33

46.42

1.3

1.2

110.79

146.75

u/ml

7.69

1265

7258

Other and unspecified effects of external causes

1612

11170

1.50

46.36

1.3

1.2

130.44

142.23

u/ml

0.43

560

4337

Other disorders of urethra and urinary system

3747

20357

1.31

46.35

1.2

126.65

144.48

u/ml

1.67

1402

7865

Dizziness and giddiness

3646

22107

1.31

46.17

1.3

1.2

121.86

142.54

u/ml

2.76

1340

8470

Nausea and vomiting

1322

8566

1.55

45.89

1.3

1.2

108.53

146.70

u/ml

2.88

447

3177

Diseases of salivary glands

1702

11936

1.47

45.54

1.2

132.32

140.70

u/ml

0.37

648

4594

Medical treatment for female infertility

1703

11936

1.49

45.54

1.3

150.28

149.09

u/ml

0.04

652

4868

Shoulder lesions

3406

15720

1.32

45.24

1.2

119.45

147.47

u/ml

3.68

1276

6133

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

4721

29644

1.26

44.91

1.2

125.48

142.14

u/ml

1.90

1766

11214

Lumbar disc prolapse

3081

17450

1.33

44.90

1.2

128.42

149.44

u/ml

2.22

1260

6663

Endometriosis of pelvic peritoneum

1068

6222

1.64

44.81

1.3

1.2

112.58

158.67

u/ml

4.01

427

2538

Disturbance of activity and attention

1063

6685

1.65

44.58

1.3

88.86

146.17

u/ml

6.79

368

2547

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

360

1667

2.37

44.43

1.3

1.2

184.02

138.48

u/ml

1.39

148

625

Gastrointestinal diseases

3468

13415

1.32

44.37

1.3

1.2

133.08

152.21

u/ml

1.65

1309

5200

Other symptoms and signs involving the nervous and musculoskeletal systems

2089

15239

1.41

44.08

1.3

1.2

108.91

142.12

u/ml

4.04

801

5769

Hyperkinetic disorders

1097

6971

1.63

43.70

1.3

91.08

145.51

u/ml

6.08

376

2629

Tramadol

3880

18388

1.29

43.20

1.2

119.43

147.14

u/ml

4.20

1325

7227

Disease of hard tissues of teeth, NOS

2311

8828

1.40

43.14

1.2

136.65

150.18

u/ml

0.78

829

3433

Fenamates

743

2932

1.80

42.67

1.3

1.2

119.73

151.65

u/ml

1.39

247

1136

5820

24272

1.23

42.61

1.2

129.41

143.96

u/ml

1.69

2111

9334

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1671

11683

1.46

42.53

1.3

1.2

114.10

152.89

u/ml

3.85

548

4807

Diabetes mellitus

5336

25212

1.24

42.38

1.2

138.88

142.59

u/ml

0.24

1960

9697

Specific personality disorders

1472

10224

1.50

42.25

1.3

1.2

99.45

144.99

u/ml

5.15

453

4015

Non-selective monoamine reuptake inhibitors

1575

10550

1.47

42.25

1.2

99.18

153.05

u/ml

6.97

551

4143

Arthropathies

5006

20520

1.25

42.23

1.3

1.2

133.73

144.31

u/ml

0.94

1932

7825

Drug-induced thyroiditis

18.37

42.18

1.2

41.59

44.97

u/ml

—

Migraine without aura and triptan purchases

1247

8445

1.56

41.53

1.3

122.73

150.17

u/ml

1.61

460

3331

Heartburn

601

3388

1.87

41.07

1.3

1.2

132.57

147.33

u/ml

0.38

202

1291

Menorrhagia

1974

7948

1.43

41.06

1.3

1.2

130.84

158.02

u/ml

1.62

756

3183

Ovarian cyst

2160

9066

1.41

41.06

1.3

1.2

124.43

155.59

u/ml

3.01

873

3607

Other maternal disorders predominantly related to pregnancy

3774

18779

1.29

40.95

1.3

1.2

149.09

147.67

u/ml

0.07

1530

7421

Unspecified mental disorder

2060

15179

1.39

40.89

1.2

100.27

142.05

u/ml

6.04

669

5871

Adverse effects, not elsewhere classified

1176

7868

1.56

40.81

1.3

1.2

142.76

144.37

u/ml

0.03

410

3025

Chronic lower respiratory diseases

6252

27420

1.22

40.69

1.2

119.59

145.20

u/ml

5.67

2334

10421

Persons encountering health services for examination and investigation

3059

11768

1.33

40.53

1.2

138.27

148.97

u/ml

0.59

1111

4672

Vasomotor and allergic rhinitis

2189

15939

1.38

40.51

1.3

1.2

137.35

143.94

u/ml

0.27

848

6068

Disorders of synovium and tendon

2716

17623

1.33

40.50

1.2

139.37

150.05

u/ml

0.70

1092

6841

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

3252

24489

1.30

40.40

1.2

141.30

143.71

u/ml

0.11

1226

9488

Polycystic ovarian syndrome, consortium definition

4759

22259

1.25

40.29

1.3

1.2

123.09

149.95

u/ml

4.86

1771

8802

Allergic conjunctivitis

3393

25814

1.29

40.23

1.2

141.46

143.15

u/ml

0.08

1282

9966

Candidiasis, including avohilmo

1739

12533

1.43

40.19

1.3

1.2

108.94

141.94

u/ml

3.53

652

4755

Subjective visual disturbances

1305

8920

1.51

40.15

1.3

1.2

129.32

140.28

u/ml

0.48

471

3402

Iron deficiency

314

1463

2.47

39.77

1.3

106.16

148.33

u/ml

1.23

124

579

Spondylopathies

3391

15690

1.30

39.76

1.2

116.76

148.86

u/ml

5.04

1300

5961

Sicca syndrome [Sjögren]

488

2623

2.00

39.65

1.3

1.2

95.15

140.82

u/ml

2.00

172

1009

867

5459

1.67

39.57

1.3

1.2

133.61

141.18

u/ml

0.21

280

2227

Ovarian dysfunction

710

4313

1.80

39.41

1.3

124.90

147.45

u/ml

0.70

261

1707

Other menopausal disorders

1482

5720

1.50

38.98

1.2

141.22

161.60

u/ml

1.05

605

2279

KRA_PSY_EATING, excluding more controls

715

4302

1.78

38.88

1.3

100.12

153.07

u/ml

3.11

215

1784

Enlarged lymph nodes

764

4690

1.69

37.95

1.2

109.89

149.11

u/ml

2.00

268

1785

Cervicalgia

997

6514

1.58

37.94

1.2

116.79

152.42

u/ml

2.24

374

2492

Diabetes, varying definitions

5259

25196

1.23

37.90

1.2

138.24

142.49

u/ml

0.29

1927

9692

Diseases of the ear and mastoid process

6022

25227

1.21

37.42

1.2

137.74

143.10

u/ml

0.43

2288

9599

Any death

1263

12744

0.68

37.07

1.2

130.65

133.69

u/ml

0.09

353

4632

Unspecified/other endometriosis

693

4129

1.76

36.97

1.3

133.97

155.34

u/ml

0.59

252

1710

Obesity, other/unspecified

1945

14463

1.39

36.93

1.2

133.44

147.19

u/ml

0.80

674

5741

Diabetes mellitus in pregnancy

2576

12614

1.35

36.90

1.3

153.32

148.79

u/ml

0.19

1025

5119

Use of hypnotics and sedatives

5127

24215

1.23

36.73

1.2

110.53

147.22

u/ml

9.72

1783

9395

Complications of procedures, not elsewhere classified

3957

25801

1.25

36.71

1.2

122.57

143.21

u/ml

2.84

1501

9793

Other extrapyramidal and movement disorders in other diseases

1085

7292

1.54

36.12

1.3

1.2

110.33

143.99

u/ml

2.06

404

2703

Postviral fatigue syndrome

113

331

4.57

36.04

1.7

1.3

82.72

149.11

u/ml

1.68

144

Diseases of oral cavity, salivary glands and jaws

2309

8923

1.35

35.92

1.2

129.66

149.90

u/ml

1.51

841

3470

Obsessive-compulsive disorder

516

2923

1.90

35.75

1.2

98.72

149.44

u/ml

2.19

168

1149

Diarrhoea and gastroenteritis of presumed infectious origin

3559

25574

1.26

35.30

1.3

1.2

140.51

138.83

u/ml

0.08

1280

9715

Other diseases of hard tissues of teeth

2286

8905

1.35

35.05

1.2

136.87

150.13

u/ml

0.76

799

3462

Kela-code for severe mental illness

1754

12925

1.39

34.93

1.2

84.65

142.39

u/ml

11.73

572

4987

Dental caries

1061

6724

1.53

34.76

1.2

120.35

150.44

u/ml

1.76

362

2625

Acute sinusitis

2889

20725

1.29

34.46

1.3

1.2

133.05

145.63

u/ml

0.80

1101

8088

Persons encountering health services for specific procedures and health care

5539

27416

1.21

34.18

1.2

125.70

142.17

u/ml

2.00

1858

10693

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2703

18380

1.30

34.11

1.2

123.82

138.37

u/ml

1.12

977

6898

Mouth breathing

1605

11677

1.40

34.03

1.3

1.2

123.77

140.28

u/ml

1.00

620

4352

Abnormal results of function studies

471

2628

1.90

33.67

1.3

1.2

105.90

143.65

u/ml

1.54

168

971

Diabetes medication

5278

25776

1.21

33.65

1.2

140.25

142.35

u/ml

0.13

1956

9866

Certain infectious and parasitic diseases

5100

21243

1.22

33.63

1.2

136.46

144.64

u/ml

0.62

1793

8362

Amenorrhoea

539

3167

1.84

33.19

1.3

131.47

154.84

u/ml

0.62

188

1293

Pain in thoracic spine

802

5156

1.62

33.16

1.3

1.2

109.34

152.63

u/ml

3.16

319

2028

Rotator cuff syndrome

2546

13591

1.31

33.10

1.2

113.46

145.85

u/ml

4.17

970

5297

Urinary track infection

4048

16561

1.25

33.07

1.3

1.2

147.39

150.71

u/ml

0.17

1558

6583

Schizophrenia or delusion, excluding more controls

1411

9993

1.43

32.98

1.2

84.34

149.02

u/ml

11.56

478

4046

Disorders of vestibular function (Vertigo)

1996

14708

1.35

32.90

1.2

114.91

142.07

u/ml

2.72

734

5522

Tonsillectomy and adenotomy

3494

19691

1.26

32.42

1.3

1.2

136.69

144.24

u/ml

0.55

1403

7608

Coxibs

1179

4220

1.50

32.11

1.3

1.2

122.86

146.71

u/ml

1.24

444

1574

Complications of surgical and medical care, not elsewhere classified

4844

26979

1.21

32.07

1.2

124.77

143.23

u/ml

2.69

1814

10231

Primary adrenocortical insufficiency

104

306

4.18

32.00

1.5

1.2

298.69

157.74

u/ml

1.45

126

Abnormal findings on examination of blood, without diagnosis

1686

11284

1.38

31.78

1.2

117.00

133.15

u/ml

0.98

603

4093

Post-traumatic stress disorder

671

4233

1.69

31.27

1.3

97.58

152.86

u/ml

3.88

255

1714

Infections, IBD-co-morbidities

639

2721

1.70

31.17

1.3

1.2

119.16

154.17

u/ml

1.27

206

1066

Procreative management

1757

10824

1.37

31.07

1.3

1.2

150.40

147.02

u/ml

0.12

652

4105

Covid-19 confirmed case

1564

11509

1.39

30.94

1.3

1.2

136.36

134.06

u/ml

0.05

562

4263

Certain infectious and parasitic diseases, including avohilmo

3597

14590

1.25

30.90

1.2

142.63

145.88

u/ml

0.15

1285

5778

Social phobias

584

3559

1.74

30.80

1.3

1.2

164.47

151.65

u/ml

0.25

195

1396

Covid-19 suspected case

1245

8884

1.45

30.78

1.3

1.2

144.86

139.12

u/ml

0.18

429

3463

Cervicobrachial syndrome

1088

7560

1.48

30.75

1.3

1.2

122.70

152.88

u/ml

1.96

460

2977

Other heart diseases, wide

4779

24197

1.21

30.60

1.3

1.2

125.01

147.11

u/ml

3.29

1828

9303

Asthma and allergy, excluding more controls

850

5579

1.57

30.47

1.3

1.2

110.66

151.47

u/ml

2.70

334

2205

Disorder of thyroid, unspecified

230

4.35

30.37

1.4

1.2

133.61

68.63

u/ml

0.82

Chronic gastritis

959

6497

1.51

30.36

1.2

168.00

134.83

u/ml

1.34

323

2343

Diseases of the respiratory system

3279

13201

1.26

30.34

1.2

141.27

148.69

u/ml

0.38

1199

5079

Factors influencing health status and contact with health services

1140

3910

1.49

30.32

1.2

128.90

148.46

u/ml

0.86

415

1627

Caries of dentine

916

5928

1.53

30.30

1.2

115.14

148.27

u/ml

1.91

312

2310

Cardiovascular diseases (excluding rheumatic etc)

3932

18503

1.24

30.26

1.3

1.2

137.42

147.32

u/ml

0.71

1515

7236

Other sleep disorders

531

3159

1.75

30.01

1.4

1.2

80.40

154.23

u/ml

5.79

197

1169

Disorders of vitreous body

2010

14659

1.33

29.99

1.2

133.97

142.20

u/ml

0.32

714

5472

Carpal tunnel syndrome

2830

19601

1.27

29.91

1.2

130.43

146.19

u/ml

1.35

1126

7492

Cerebral cysts

335

1748

2.06

29.87

1.4

1.2

82.62

146.40

u/ml

3.56

133

675

Diseases of inner ear

2260

16845

1.31

29.85

1.2

115.39

141.06

u/ml

2.72

834

6313

Other arthrosis

2177

11229

1.32

29.84

1.2

133.44

143.12

u/ml

0.49

769

4349

Other diseases of lip and oral mucosa

2001

15390

1.33

29.75

1.2

128.43

142.51

u/ml

0.88

714

5866

Exclusions for E4_PCOS_CONSORTIUM

4317

22442

1.22

29.75

1.2

119.50

148.55

u/ml

5.60

1570

8792

Asthma and allergy

850

5606

1.56

29.74

1.3

1.2

110.66

152.99

u/ml

2.86

334

2213

Rheumatism, unspecified

685

4365

1.64

29.69

1.3

1.2

111.20

147.74

u/ml

1.92

257

1752

Disorders of vitreous body and globe

2050

14924

1.32

29.62

1.2

132.53

141.52

u/ml

0.37

726

5566

Atopic dermatitis, strict definition with reimbursement

1910

14070

1.34

29.40

1.3

1.2

122.99

147.23

u/ml

1.83

701

5447

Implicit viral Sepsis, including avohilmo

1256

8989

1.43

29.33

1.3

1.2

101.10

139.32

u/ml

3.47

415

3319

Adenomyosis (Endometriosis of uterus)

697

4469

1.63

29.22

1.3

1.2

142.47

156.97

u/ml

0.36

282

1758

Acetic acid derivatives and related substances

1146

4094

1.48

29.17

1.2

128.51

145.33

u/ml

0.44

384

1532

Statin medication

3491

16010

1.25

29.14

1.2

148.67

144.18

u/ml

0.23

1348

6193

Polycystic ovarian syndrome, broad definition

953

6606

1.54

29.12

1.3

113.57

151.06

u/ml

2.38

368

2653

Excessive attrition of teeth

3256

26320

1.25

28.97

1.2

130.89

143.34

u/ml

1.10

1204

10096

Other and unspecified iron deficiency

1496

11050

1.38

28.89

1.2

140.79

137.47

u/ml

0.11

518

4141

Disorders of mineral metabolism

388

2140

1.90

28.63

1.2

177.17

130.79

u/ml

0.97

150

793

Restless leg syndrome

687

4417

1.62

28.57

1.3

1.2

111.56

141.06

u/ml

1.11

265

1655

Other inflammation of eyelid, including avohilmo

2541

20277

1.28

28.29

1.2

151.73

142.67

u/ml

0.40

917

7828

Cholecystectomy

3221

22306

1.24

28.23

1.2

125.48

142.77

u/ml

1.40

1197

8561

Injuries to the ankle and foot

3880

27544

1.22

28.23

1.2

134.01

142.33

u/ml

0.63

1379

10637

Chronic laryngitis and laryngotracheitis

631

3987

1.64

28.10

1.2

152.80

142.25

u/ml

0.22

212

1502

Nutritional anaemias

2074

15354

1.31

28.09

1.2

143.44

136.41

u/ml

0.32

734

5724

Cervical disc disorders

1419

10456

1.39

28.07

1.2

114.81

147.44

u/ml

2.90

585

3966

Diseases of the digestive system

1765

13320

1.34

28.03

1.3

1.2

116.33

133.39

u/ml

1.08

622

4890

Cervicocranial syndrome

545

3330

1.71

28.01

1.3

1.2

106.58

154.57

u/ml

2.51

218

1287

Hypermobility syndrome

423

2452

1.89

27.86

1.3

1.2

98.18

154.34

u/ml

2.26

167

967

Disorders of lipoprotein metabolism and other lipidaemias

3336

16526

1.24

27.78

1.2

143.56

136.91

u/ml

0.37

1149

6411

Benign paroxysmal vertigo

1235

8932

1.42

27.70

1.2

120.34

142.60

u/ml

1.27

439

3336

Other disorders of bladder

414

2346

1.83

27.53

1.3

1.2

152.91

137.45

u/ml

0.13

123

835

Allergic asthma (mode), excluding more controls

1326

9485

1.40

27.50

1.3

1.2

108.38

153.13

u/ml

5.06

544

3754

Symptoms and signs concerning food and fluid intake

475

2806

1.76

27.29

1.2

136.14

151.59

u/ml

0.30

162

1003

Extrapyramidal and movement disorders

1484

11062

1.37

27.25

1.3

1.2

102.04

137.57

u/ml

3.35

560

4051

Other noninflammatory disorders of vulva and perineum

593

3743

1.67

27.15

1.3

1.2

137.60

162.47

u/ml

0.79

228

1520

Complications of medical and surgical care

3418

25318

1.23

27.13

1.2

133.15

141.38

u/ml

0.60

1272

9586

Neoplasms

4249

18627

1.21

27.07

1.2

132.22

145.44

u/ml

1.32

1555

7307

Allergic asthma (mode)

1326

9522

1.40

26.87

1.3

1.2

108.38

152.18

u/ml

4.89

544

3767

Iron deficiency anaemia

1824

13762

1.32

26.78

1.2

139.41

136.47

u/ml

0.11

640

5135

Allergic rhinitis

1836

14009

1.33

26.76

1.3

1.2

135.92

145.06

u/ml

0.35

704

5424

Hypogonadotropic hypogonadism

137

513

2.87

26.54

1.2

55.77

117.17

u/ml

2.14

174

Pruritus

616

3939

1.63

26.41

1.3

1.2

112.67

143.76

u/ml

1.52

243

1488

Persistent mood disorders

918

6364

1.49

26.40

1.3

1.2

123.01

141.29

u/ml

0.59

277

2501

Benign neoplasms

4976

23003

1.19

26.29

1.2

125.35

145.09

u/ml

3.10

1877

8800

Tinnitus

1009

7118

1.46

26.25

1.3

1.2

127.50

141.20

u/ml

0.59

392

2670

Dental operations

2387

9663

1.29

26.19

1.2

129.09

149.60

u/ml

1.62

864

3709

COPD/asthma related infections

5186

22127

1.19

26.17

1.2

132.06

145.38

u/ml

1.33

1868

8597

COPD/asthma/ILD related infections

5186

22127

1.19

26.17

1.2

132.06

145.38

u/ml

1.33

1868

8597

Other disorders of skin and subcutaneous tissue

3201

22189

1.23

26.12

1.2

129.57

141.18

u/ml

0.96

1235

8321

Maternal care for other conditions predominantly related to pregnancy

1534

11376

1.37

25.88

1.3

1.2

142.67

152.05

u/ml

0.43

592

4613

Uterine polyps

1448

6278

1.39

25.82

1.3

1.2

131.40

160.16

u/ml

1.93

585

2493

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

4340

21674

1.20

25.79

1.2

142.79

142.91

u/ml

0.01

1593

8336

Polyuria

792

5346

1.52

25.72

1.3

1.2

128.56

131.46

u/ml

0.07

234

1920

Missing teeth due to accident, extraction or parodontitis

2440

17431

1.27

25.67

1.2

124.30

139.16

u/ml

1.10

813

6554

Propionic acid derivatives

1229

4431

1.42

25.60

1.2

129.45

147.71

u/ml

0.89

461

1640

Disorders of calcium metabolism

297

1562

2.01

25.57

1.2

177.46

131.83

u/ml

0.78

116

572

Other eating disorders

426

2533

1.83

25.56

1.4

1.3

100.35

147.20

u/ml

1.42

130

952

Diaphragmatic hernia

1354

10073

1.37

25.25

1.2

125.27

141.68

u/ml

0.76

482

3710

Undetermined asthma, excluding more controls

620

3997

1.60

25.22

1.2

113.91

147.40

u/ml

1.59

212

1565

Polyp of the female genital tract

1554

6625

1.36

25.02

1.3

1.2

127.94

158.97

u/ml

2.35

626

2644

Hypertensive diseases (excluding secondary)

2720

12780

1.26

24.99

1.2

147.81

149.13

u/ml

0.05

1042

5142

Other disorders of fluid, electrolyte and acid-base balance

1093

7401

1.42

24.85

1.2

102.56

131.81

u/ml

2.09

374

2683

Haemorrhoids and perianal venous thrombosis

1362

10092

1.37

24.79

1.2

112.25

139.44

u/ml

2.05

520

3832

Non-allergic asthma (mode), excluding more controls

837

5718

1.49

24.54

1.2

112.55

149.93

u/ml

1.92

285

2209

Other gastritis (incl. Duodenitis)

811

5554

1.50

24.52

1.2

111.21

137.55

u/ml

1.18

298

2007

Emotionally unstable personality disorder

837

5826

1.51

24.45

1.3

106.64

145.50

u/ml

2.13

249

2275

Idiopathic urticaria

179

807

2.51

24.44

1.3

1.2

133.67

146.87

u/ml

0.19

331

Undetermined asthma

620

4026

1.59

24.44

1.2

113.91

146.49

u/ml

1.52

212

1562

Pregnancy examination and test

1229

5610

1.42

24.36

1.3

137.24

151.98

u/ml

0.46

459

2245

Paracetamol or NSAID medication

792

2664

1.53

24.13

1.2

128.18

158.47

u/ml

1.28

292

983

Other diseases of liver

799

5491

1.50

24.08

1.2

121.49

142.59

u/ml

0.79

277

2120

Hyperlipidaemia, other/unspecified

1232

8150

1.38

24.01

1.2

114.49

127.98

u/ml

0.60

433

2926

Other diseases of anus and rectum

1185

8671

1.39

23.97

1.2

106.15

141.11

u/ml

3.01

431

3273

Dysplasia of cervi uteri

1454

7730

1.36

23.95

1.3

1.2

165.30

157.01

u/ml

0.26

564

3124

Gingivitis and periodontal diseases

4570

20059

1.19

23.77

1.2

135.40

141.45

u/ml

0.41

1659

7821

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1293

9718

1.38

23.77

1.3

120.96

149.18

u/ml

2.10

493

3835

Other and unspecified disorders of vitreous body

1645

12415

1.32

23.65

1.2

123.65

142.08

u/ml

1.19

593

4648

Endometriosis of ovary

925

6178

1.46

23.63

1.3

1.2

139.37

159.20

u/ml

0.87

376

2471

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

3442

26245

1.21

23.59

1.3

1.2

124.15

142.77

u/ml

1.78

1323

10045

Concussion

2495

15643

1.26

23.51

1.2

123.23

156.67

u/ml

2.92

910

5958

Eating disorder

718

4906

1.55

23.42

1.3

101.22

149.44

u/ml

2.66

217

1917

Continuous positive airway pressure

658

3609

1.55

23.41

1.2

127.09

162.78

u/ml

1.43

195

1354

Non-allergic asthma (mode)

837

5771

1.48

23.40

1.2

112.55

146.21

u/ml

1.67

285

2233

Finngen Rheumatological endpoints

4916

23934

1.18

23.30

1.2

127.42

144.72

u/ml

2.01

1809

9258

Dental caries, including avohilmo

3054

12829

1.23

23.23

1.2

133.57

147.94

u/ml

0.96

1090

4974

Other abnormal products of conception

2384

12650

1.27

23.18

1.3

142.00

149.02

u/ml

0.38

897

5242

Other enthesopathies

1370

10353

1.35

23.17

1.2

126.30

150.67

u/ml

1.45

531

4150

Any operation in hilmo

183

394

2.46

23.13

1.3

1.1

91.33

140.39

u/ml

1.49

178

Pure hypercholesterolaemia

2877

14962

1.24

23.04

1.2

144.47

135.49

u/ml

0.51

1003

5752

Emotional disorders starting during childhood or adolecense, excluding more controls

331

1818

1.90

23.03

1.3

122.32

142.53

u/ml

0.41

112

685

Other symptoms and signs involving cognitive functions and awareness

1706

11736

1.31

22.99

1.2

110.83

137.71

u/ml

1.41

596

4346

Polycystic ovarian syndrome

511

3282

1.69

22.90

1.3

120.89

148.94

u/ml

0.78

197

1297

Exposure to unspecified factor

5031

29501

1.17

22.89

1.2

147.84

138.63

u/ml

0.64

1630

11414

Alopecia areata

199

959

2.31

22.86

1.2

137.14

143.61

u/ml

0.10

377

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2671

21462

1.24

22.85

1.2

132.11

139.34

u/ml

0.45

1010

8076

Asthma/COPD (KELA code 203)

4773

27393

1.18

22.80

1.2

117.36

145.12

u/ml

5.47

1838

10413

Thyrotropin deficiency

100

356

3.36

22.59

1.2

1.3

31.13

157.52

u/ml

7.70

148

Other symptoms and signs involving the digestive system and abdomen

810

5656

1.48

22.50

1.2

92.96

150.52

u/ml

5.85

308

2207

Malignant neoplasm of head and neck

266

1400

1.97

22.48

1.1

1.2

105.69

127.49

u/ml

0.46

518

Secondary right heart disease

164

723

2.41

22.46

1.1

1.2

207.36

139.92

u/ml

0.51

265

Coeliac disease

611

4049

1.57

22.40

1.3

1.2

134.80

149.97

u/ml

0.40

244

1500

Diabetic maculopathy, excluding more controls

425

2591

1.70

21.91

1.2

133.29

134.89

u/ml

0.03

162

945

Hypothyroidism, autoimmune, DX-based

158

5.36

21.89

1.7

1.2

343.07

165.86

u/ml

1.79

Primary ovarian failure

177

839

2.43

21.85

1.4

1.2

135.55

148.17

u/ml

0.12

350

Viral Sepsis

807

5649

1.46

21.84

1.3

1.2

107.97

135.31

u/ml

1.28

271

2030

Persons with potential health hazards related to communicable diseases

2205

17703

1.26

21.72

1.3

123.43

143.49

u/ml

1.25

861

6793

Cardiodefibrillation

949

6807

1.41

21.65

1.2

106.70

123.15

u/ml

0.70

297

2290

Diseases of pulp and periapical tissues and dental caries

2729

11438

1.24

21.63

1.2

131.27

148.86

u/ml

1.45

977

4414

Eating disorders

770

5402

1.50

21.63

1.3

105.69

150.13

u/ml

2.48

237

2086

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4631

26856

1.17

21.62

1.2

135.07

141.67

u/ml

0.46

1636

10274

Other shoulder lesions

469

2952

1.66

21.52

1.3

1.2

125.37

139.61

u/ml

0.32

167

1144

Implicit viral Sepsis

803

5636

1.46

21.43

1.3

1.2

107.22

135.24

u/ml

1.32

270

2026

Spinal stenosis

1690

9710

1.30

21.38

1.2

125.97

148.04

u/ml

1.34

610

3544

Paroxysmal tachycardia

1066

6505

1.39

21.36

1.2

136.53

147.29

u/ml

0.26

385

2529

Deviated nasal septum

1149

8547

1.37

21.27

1.2

125.67

134.49

u/ml

0.34

426

3166

Other and unspecified polyneuropathies, also in other diseases

602

3997

1.54

21.26

1.2

132.02

122.69

u/ml

0.24

224

1402

Syncope and collapse

1796

11829

1.29

21.14

1.2

122.77

145.46

u/ml

1.59

604

4447

Gestational diabetes (for exclusion)

2746

15665

1.24

21.13

1.3

150.57

147.88

u/ml

0.12

1043

6379

Anti-inflammatory and antirheumatic products, non-steroids

1195

4432

1.38

21.08

1.2

134.87

147.71

u/ml

0.52

439

1640

Disorders of ocular muscles, binocular movement, accommodation and refraction

2507

20442

1.24

21.04

1.3

1.2

133.56

141.26

u/ml

0.48

989

7785

Localized swelling, mass and lump of skin and subcutaneous tissue

1384

10623

1.33

21.03

1.2

117.36

141.15

u/ml

1.54

454

4080

Adjustment and management of implanted device

526

3396

1.58

21.01

1.2

136.35

128.95

u/ml

0.14

133

1195

Mycoses

1223

9234

1.35

20.97

1.3

1.2

114.56

139.68

u/ml

1.66

466

3538

Elevated blood glucose level

364

2165

1.75

20.83

1.3

1.2

144.27

146.88

u/ml

0.03

118

790

Poisoning by drugs, medicaments and biological substances

1250

9504

1.35

20.69

1.2

105.60

143.73

u/ml

3.05

388

3721

Spontaneous abortion

2883

16083

1.23

20.65

1.2

140.17

146.07

u/ml

0.33

1071

6439

Hyperhidrosis

218

1123

2.11

20.60

1.4

1.2

78.45

154.20

u/ml

3.05

439

Inflammatory disease of uterus

933

6829

1.43

20.54

1.3

121.19

151.98

u/ml

0.92

355

2760

Haemorrhage from respiratory passages

1146

7566

1.36

20.53

1.2

123.50

142.45

u/ml

0.81

367

2782

Abnormal involuntary movements

577

3849

1.55

20.31

1.3

1.2

145.60

142.52

u/ml

0.06

216

1409

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2451

20119

1.23

20.28

1.2

129.11

139.69

u/ml

0.73

925

7578

Disorders of parathyroid gland

757

5257

1.46

20.10

1.2

122.53

143.10

u/ml

0.88

286

1934

Contraceptive management

2102

11872

1.26

20.09

1.2

144.03

145.98

u/ml

0.08

855

4694

Poisoning by medicine

1147

8656

1.36

20.08

1.2

109.42

143.90

u/ml

2.24

350

3375

Pollen allergy

1165

8702

1.36

20.03

1.3

125.33

142.85

u/ml

0.78

432

3326

Hypertension, essential

3559

17029

1.20

19.94

1.2

140.98

144.10

u/ml

0.15

1326

6758

Atrial fibrillation and flutter with reimbursement

937

4259

1.41

19.88

1.2

130.76

148.61

u/ml

0.65

345

1654

Recurrent aphthous stomatitis , including avohilmo

691

4805

1.49

19.85

1.3

1.2

116.78

140.39

u/ml

1.03

253

1754

Atopic dermatitis, strict definition

1814

14220

1.28

19.83

1.3

125.42

144.39

u/ml

1.18

669

5482

Soft tissue disorders related to use, overuse and pressure

1100

8246

1.36

19.70

1.3

1.2

133.68

145.64

u/ml

0.45

406

3181

Acute thyroiditis

6.86

19.68

1.3

1.2

225.69

76.81

u/ml

0.60

Caries of dentine, including avohilmo

3373

14517

1.20

19.65

1.2

137.05

146.28

u/ml

0.55

1219

5591

Non-invasive ventilation

1082

6967

1.37

19.61

1.2

114.82

160.22

u/ml

4.66

528

2776

Pain associated with micturition

549

3657

1.56

19.56

1.3

1.2

116.28

139.63

u/ml

0.78

207

1345

Nonalcoholic fatty liver disease

472

3047

1.61

19.53

1.2

124.63

141.48

u/ml

0.38

158

1164

Contact with and exposure to communicable diseases

1893

15211

1.27

19.52

1.3

123.29

143.70

u/ml

1.14

784

5881

Adhesive capsulitis of shoulder

661

4562

1.49

19.49

1.2

123.47

142.06

u/ml

0.63

232

1781

Diabetes, insulin treatment (Kela reimbursement)

4490

23087

1.17

19.47

1.2

140.89

141.16

u/ml

0.01

1642

8832

Viral and other specified intestinal infections, including avohilmo

1579

11991

1.29

19.45

1.3

1.2

124.87

138.98

u/ml

0.79

623

4572

Oxicams

805

3212

1.45

19.32

1.2

109.91

143.69

u/ml

1.56

293

1206

Atrial fibrillation and flutter

1243

6079

1.34

19.29

1.2

128.35

151.30

u/ml

1.27

452

2404

Diseases of pulp and periapical tissues, including avohilmo

5099

22996

1.16

19.11

1.2

136.04

140.87

u/ml

0.36

1890

8741

Stomatitis and related lesions

949

7009

1.39

19.10

1.3

1.2

120.20

137.85

u/ml

0.78

343

2622

Other neurological diseases

2793

18081

1.21

19.09

1.2

104.82

139.48

u/ml

5.79

1030

6710

Rosacea

657

4567

1.49

19.07

1.2

105.46

148.25

u/ml

2.43

281

1746

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1671

13334

1.28

19.06

1.3

1.2

114.10

144.82

u/ml

2.63

548

5199

Other symptoms and signs involving the urinary system

369

2252

1.69

18.96

1.2

137.21

126.83

u/ml

0.10

153

803

Type 2 diabetes

4692

23592

1.16

18.96

1.2

130.11

143.78

u/ml

1.46

1668

9124

Other and unspecified visual disturbances

491

3223

1.58

18.83

1.3

1.2

122.72

148.23

u/ml

1.00

202

1172

Diseases of liver

1314

10162

1.32

18.81

1.2

127.30

138.61

u/ml

0.48

441

3818

Other disorders of thyroid

336

3.06

18.80

1.4

1.2

129.53

128.24

u/ml

0.01

136

Acne, including avohilmo

1584

10169

1.30

18.76

1.3

115.29

145.96

u/ml

2.66

597

3825

Other retinal disorders

2316

14453

1.23

18.66

1.2

136.23

135.11

u/ml

0.04

802

5314

Other pulmonary heart/vessel disease

169

815

2.18

18.57

1.1

1.2

207.36

132.80

u/ml

0.58

299

Persons encountering health services in circumstances related to reproduction

2666

14890

1.22

18.51

1.2

143.16

143.96

u/ml

0.03

1015

5673

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1713

13602

1.28

18.50

1.3

128.59

145.89

u/ml

1.07

581

5333

Trochanteric bursitis

663

4633

1.48

18.49

1.3

1.2

131.76

145.21

u/ml

0.37

256

1826

Other disorders of eye and adnexa

712

5049

1.46

18.47

1.3

1.2

145.24

143.22

u/ml

0.04

230

1928

Other heart diseases

2417

12978

1.23

18.35

1.3

1.2

137.64

147.78

u/ml

0.51

937

5127

Lichen ruber planus, wide definition including periferal and oral lichen planus

919

6790

1.39

18.34

1.2

118.91

140.84

u/ml

1.23

343

2552

Polyneuropathies and other disorders of the peripheral nervous system

686

4817

1.45

18.27

1.2

133.73

125.06

u/ml

0.23

251

1714

Other and unspecified mood [affective] disorders

447

2908

1.62

18.22

1.3

1.2

131.70

146.77

u/ml

0.32

123

1146

Asthma-related pneumonia

1377

10718

1.30

18.17

1.3

1.2

99.21

139.10

u/ml

4.14

457

3980

Diplopia

536

3605

1.53

18.17

1.3

1.2

121.01

141.89

u/ml

0.66

193

1332

Hernia of abdominal wall, postoperative

721

5087

1.44

18.01

1.2

117.03

138.83

u/ml

0.88

241

2038

Other and unspecified rosacea

452

2949

1.60

17.99

1.2

98.46

148.42

u/ml

2.51

203

1124

Deforming dorsopathies

1235

9539

1.32

17.95

1.2

119.37

150.08

u/ml

2.09

458

3582

Other disorders of eyelid

1559

11666

1.28

17.95

1.2

128.47

139.28

u/ml

0.55

557

4311

Diverticular disease of intestine

2644

13711

1.21

17.91

1.2

131.94

140.54

u/ml

0.51

985

5251

Asthma, hospital admissions 3, pneumonia

1378

10750

1.30

17.87

1.3

1.2

99.21

139.17

u/ml

4.15

457

3994

Asthma-related pneumonia or sepsis

1378

10750

1.30

17.87

1.3

1.2

99.21

139.17

u/ml

4.15

457

3994

Schizophrenia, schizotypal and delusional disorders

1418

11161

1.30

17.86

1.2

85.14

141.29

u/ml

8.99

479

4322

Malignant neoplasm of tonsil and base of tongue

318

2.95

17.85

1.2

124.70

130.59

u/ml

0.04

129

Monoamine oxidase A inhibitors

457

2983

1.58

17.81

1.2

100.62

146.31

u/ml

1.93

133

1152

Polyarthrosis

789

5130

1.42

17.75

1.2

112.91

151.80

u/ml

2.36

309

1942

Enthesopathies of lower limb, excluding foot

1029

7776

1.35

17.66

1.2

134.79

155.20

u/ml

0.83

375

3016

Other specified/unspecified arthritis

1174

9032

1.33

17.64

1.2

135.11

145.90

u/ml

0.30

439

3464

Benign neoplasm: Colon

1812

13746

1.25

17.56

1.2

110.72

135.91

u/ml

2.48

659

5006

Schizophrenia or delusion

1411

11126

1.29

17.53

1.2

84.34

141.53

u/ml

9.32

478

4302

Corticotropin deficiency

213

3.64

17.50

1.4

1.2

98.27

170.32

u/ml

1.01

Congenital iodine-deficiency syndrome/hypothyroidism

111

461

2.56

17.50

1.3

1.1

220.78

63.22

u/ml

3.58

146

Mixed and other personality disorders

431

2808

1.61

17.40

1.3

1.2

95.13

151.37

u/ml

2.94

125

1082

Oxycodone

1392

9334

1.29

17.35

1.2

106.60

140.81

u/ml

2.57

411

3524

Other noninfective gastroenteritis and colitis

1070

8145

1.34

17.32

1.3

1.2

111.83

142.50

u/ml

1.84

352

3020

Symptoms and signs involving the urinary system

3064

19615

1.19

17.32

1.2

135.55

138.44

u/ml

0.12

1045

7376

Postmenopausal atrophic vaginitis

1126

4652

1.35

17.26

1.2

133.59

160.86

u/ml

1.42

449

1851

Malignant melanoma, including Hilmo

587

4053

1.48

17.23

1.3

1.2

120.64

125.81

u/ml

0.10

158

1540

Malignant melanoma

527

3565

1.52

17.20

1.3

1.2

124.44

122.64

u/ml

0.03

137

1371

Fibroblastic disorders

786

5711

1.40

17.18

1.2

118.00

138.22

u/ml

0.80

266

2157

Injuries to the neck

1125

8651

1.33

17.17

1.3

1.2

119.78

139.27

u/ml

0.87

427

3296

Certain disorders involving the immune mechanism

755

5466

1.42

17.15

1.3

1.2

105.72

140.61

u/ml

2.18

277

2072

Other arthritis (FG)

1342

10546

1.30

17.10

1.2

131.93

143.41

u/ml

0.38

506

4100

Disorders of refraction and accommodation

1484

11776

1.28

17.09

1.3

1.2

133.83

143.62

u/ml

0.48

582

4490

Malignant neoplasm of tonsil and base of tongue, including Hilmo

395

2.69

17.09

1.2

123.29

135.78

u/ml

0.10

163

Testicular dysfunction

133

603

2.31

17.03

1.2

62.41

139.90

u/ml

2.78

198

Falls/tendency to fall

5478

24241

1.14

16.92

1.2

134.86

142.60

u/ml

0.63

2010

9406

Malignant neoplasm of head and neck, including Hilmo

297

1764

1.73

16.86

1.1

1.2

102.63

129.53

u/ml

0.67

644

Malignant melanoma of skin, including Hilmo

486

3251

1.53

16.77

1.3

1.2

120.68

126.23

u/ml

0.10

128

1243

Malignant neoplasm of urinary organs

282

1655

1.75

16.74

1.3

1.2

138.60

122.00

u/ml

0.24

600

Herpesviral [herpes simplex] infections, including avohilmo

1406

11178

1.29

16.62

1.3

1.2

137.67

145.56

u/ml

0.22

527

4362

Papulosquamous disorders

1601

12884

1.26

16.62

1.2

113.69

140.14

u/ml

2.35

588

4890

Hyperparathyroidism

638

4455

1.45

16.59

1.2

119.64

140.21

u/ml

0.82

232

1632

Malignant neoplasm of urinary organs, including Hilmo

324

1979

1.68

16.52

1.2

135.69

117.25

u/ml

0.30

713

Psychotic depression

279

1649

1.77

16.48

1.2

141.56

151.05

u/ml

0.15

639

Disorders of sclera, cornea, iris and ciliary body

2432

20421

1.21

16.45

1.2

126.23

141.41

u/ml

1.14

902

7727

Congenital malformations, deformations and chromosomal abnormalities

3074

24950

1.18

16.42

1.3

1.2

119.73

143.76

u/ml

3.00

1185

9562

Conjunctivitis (acute, non atopic)

1379

10895

1.29

16.37

1.3

1.2

133.57

139.76

u/ml

0.23

466

4171

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

311

1299

1.72

16.29

1.2

1.1

139.15

151.58

u/ml

0.20

500

Diseases of external ear

1450

11567

1.27

16.28

1.3

1.2

141.54

137.48

u/ml

0.14

492

4352

Convulsions, not elsewhere classified

984

7379

1.34

16.20

1.3

1.2

113.34

147.50

u/ml

1.48

337

2737

Other disorders of glucose regulation and pancreatic internal secretion

348

2186

1.65

16.16

1.3

1.2

111.31

145.95

u/ml

1.20

125

793

Brachial plexus disorders

507

3471

1.52

16.15

1.3

1.2

107.47

155.21

u/ml

3.03

254

1379

Oral lichen planus and hypothyroidism or thyroxine medication

122

557

2.43

16.15

1.3

1.2

178.22

140.49

u/ml

0.55

219

Atypical facial pain

267

1583

1.78

15.90

1.3

1.2

89.63

146.24

u/ml

1.97

610

Disorders of choroid and retina

3083

18448

1.18

15.84

1.2

129.33

138.60

u/ml

0.58

1095

6908

Postprocedural disorders of nervous system

439

2941

1.57

15.82

1.3

100.63

152.86

u/ml

2.75

180

1170

Other external causes of accidental injury

4077

17778

1.16

15.80

1.2

141.46

142.61

u/ml

0.06

1490

7053

Speech therapy

987

7535

1.34

15.76

1.2

157.25

141.08

u/ml

0.48

278

2842

Dislocation, sprain and strain of joints and ligaments at neck level

831

6216

1.38

15.69

1.3

1.2

132.29

142.53

u/ml

0.27

322

2383

Diabetic retinopathy, strict definition

647

4108

1.44

15.68

1.3

1.2

167.21

127.30

u/ml

0.96

254

1445

Lichen planus, including avohilmo

751

5515

1.40

15.68

1.2

118.77

141.04

u/ml

1.07

268

2096

Wide developmental disorders, excluding more controls

199

1061

1.95

15.66

1.3

1.2

93.63

145.04

u/ml

0.98

390

Infections of the skin and subcutaneous tissue

2662

22247

1.19

15.66

1.3

1.2

117.91

138.45

u/ml

2.06

972

8350

Biological medicines for asthma

144

710

2.23

15.64

1.4

1.2

81.72

145.74

u/ml

2.20

292

Malignant neoplasm of endocrine gland, including Hilmo

389

2535

1.60

15.61

1.2

137.18

139.78

u/ml

0.04

146

1000

Primary hyperparathyroidism

443

2964

1.55

15.58

1.2

113.15

133.62

u/ml

0.68

166

1109

Accidents

4073

17778

1.16

15.57

1.2

136.93

142.61

u/ml

0.35

1504

7053

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

2803

20782

1.19

15.55

1.3

1.2

153.64

147.04

u/ml

0.34

1181

8212

Vitiligo

348

2.83

15.54

1.4

1.2

183.53

170.60

u/ml

0.10

146

Endometriosis ASRM stages 1,2

1083

8437

1.33

15.53

1.3

1.2

112.09

150.23

u/ml

3.03

429

3417

Viral infections characterized by skin and mucous membrane lesions

1826

15000

1.23

15.50

1.2

127.57

140.22

u/ml

0.55

660

5640

Infections with a predominantly sexual mode of transmission, including avohilmo

2433

18813

1.20

15.48

1.3

1.2

150.13

143.41

u/ml

0.31

843

7398

Ocular pain

458

3101

1.54

15.47

1.4

1.2

162.88

150.73

u/ml

0.23

155

1173

Malignant neoplasm of thyroid gland, including Hilmo

358

2298

1.63

15.42

1.2

143.47

139.06

u/ml

0.07

133

911

Benign intracranial hypertension

102

449

2.68

15.31

1.3

95.36

153.71

u/ml

0.92

187

Other problems related to primary support group, including family circumstances

686

4871

1.42

15.31

1.3

123.24

149.99

u/ml

1.08

234

1865

Mental disorders, not otherwise specified

465

3168

1.53

15.29

1.3

1.2

153.10

154.21

u/ml

0.02

140

1240

Oligomenorrhoea

237

1383

1.84

15.25

1.2

1.3

142.09

147.13

u/ml

0.05

568

Abrasion of teeth

1671

13665

1.24

15.14

1.2

118.51

144.38

u/ml

2.38

604

5353

Testicular hypofunction

116

523

2.32

15.11

1.2

65.54

123.74

u/ml

1.66

171

Diseases of male genital organs

1184

4606

1.31

15.07

1.2

89.24

123.02

u/ml

2.96

393

1549

Other and unspecified nonorganic psychotic disorders

944

7227

1.34

15.01

1.2

85.37

141.68

u/ml

5.86

305

2782

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

275

1659

1.72

14.96

1.2

104.88

142.60

u/ml

1.15

595

Plantar fascial fibromatosis

461

3139

1.52

14.94

1.2

135.62

143.87

u/ml

0.17

169

1266

Excessive vomiting in pregnancy

546

3868

1.48

14.90

1.3

1.2

113.91

148.52

u/ml

1.39

214

1556

Malignant melanoma of skin

405

2678

1.55

14.87

1.3

1.2

127.91

128.56

u/ml

0.01

1027

Candidiasis

687

5031

1.41

14.83

1.3

1.2

110.66

143.74

u/ml

1.47

257

1906

Other and unspecified nerve root and plexus disorders, also in other diseases

877

6649

1.35

14.83

1.2

117.96

148.55

u/ml

1.77

346

2536

Viral and other specified intestinal infections

1129

8643

1.30

14.80

1.3

114.14

139.27

u/ml

1.67

446

3197

False labour

2124

11030

1.22

14.78

1.3

150.25

145.09

u/ml

0.23

886

4421

Cholelithiasis

3721

22155

1.16

14.64

1.2

118.70

143.10

u/ml

3.90

1373

8525

Malignant neoplasm of kidney, except renal pelvis

255

1522

1.72

14.32

1.3

1.2

140.43

122.60

u/ml

0.24

551

Hypotension

472

3236

1.49

14.31

1.2

145.25

124.35

u/ml

0.47

152

1098

Benign neoplasm of colon, rectum, anus and anal canal

2172

15416

1.20

14.24

1.2

108.35

138.48

u/ml

4.02

785

5662

Abnormal weight loss

356

2317

1.59

14.22

1.2

120.26

136.45

u/ml

0.36

120

830

Malignant neoplasm of endocrine gland

344

2232

1.61

14.17

1.2

137.55

136.98

u/ml

0.01

132

875

Female genital prolapse

1320

5843

1.28

14.05

1.3

1.2

120.73

161.05

u/ml

3.24

522

2319

Inflammatory diseases of prostate (prostatitis)

274

1670

1.67

14.04

1.2

140.14

111.97

u/ml

0.44

546

Exposure to other specified factors

3922

29636

1.15

14.00

1.2

137.99

140.47

u/ml

0.13

1374

11331

Hypertension, Pulmonary Arterial

160

3.58

13.95

1.2

1.3

323.44

148.31

u/ml

—

Thyrotoxicosis factitia

5.15

13.93

1.3

264.73

137.89

u/ml

0.66

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2140

17834

1.20

13.90

1.3

1.2

144.72

142.72

u/ml

0.08

768

6900

Otitis externa

1011

7889

1.31

13.87

1.3

1.2

137.74

139.86

u/ml

0.05

340

3032

Pregnancy hypertension

2567

19679

1.19

13.84

1.3

1.2

155.40

147.13

u/ml

0.42

1086

7794

Diseases of tongue

256

1552

1.71

13.80

1.2

170.01

142.82

u/ml

0.41

581

Anankastic personality disorder

236

1415

1.78

13.74

1.3

1.2

81.39

141.39

u/ml

2.24

555

Anosmia

356

2.52

13.74

1.2

69.24

76.56

u/ml

0.12

129

Hypertensive diseases

3599

17719

1.16

13.72

1.2

144.82

145.02

u/ml

0.01

1344

7007

Implicit fungal Sepsis, including avohilmo

301

1906

1.64

13.67

1.2

102.03

137.22

u/ml

1.03

105

698

Hypertension

3595

17704

1.16

13.63

1.2

144.74

145.09

u/ml

0.01

1345

7001

Radiculopathy

547

3902

1.43

13.54

1.3

1.2

116.63

143.70

u/ml

1.11

232

1462

Hypo-osmolality and hyponatraemia

551

3902

1.43

13.51

1.2

118.16

128.57

u/ml

0.29

196

1397

Drug-induced adrenocortical insufficiency

109

511

2.34

13.50

1.3

1.2

77.96

145.10

u/ml

1.81

216

ILD medications: immunosuppressive drugs

2930

22969

1.17

13.46

1.2

119.52

148.23

u/ml

3.84

1048

8835

Ganglion

1023

8031

1.30

13.43

1.2

140.86

150.26

u/ml

0.31

397

3277

Atrophic disorders of skin

747

5631

1.36

13.38

1.2

158.17

146.01

u/ml

0.35

291

2118

Weight loss

394

2659

1.53

13.31

1.3

1.2

118.69

141.32

u/ml

0.63

133

959

Sequelae of external causes of morbidity and mortality

964

7511

1.31

13.27

1.2

103.16

140.69

u/ml

3.03

364

2781

Fissure and fistula of anal and rectal regions

958

7459

1.31

13.26

1.2

120.89

141.92

u/ml

1.02

363

2884

Early lumbar disc prolapse, operated

512

3642

1.45

13.25

1.2

140.57

148.45

u/ml

0.16

221

1464

Female infertility, tubal origin

295

1886

1.65

13.23

1.2

127.42

163.47

u/ml

0.89

115

788

Malignant neoplasm of thyroid gland

323

2101

1.60

13.22

1.2

141.50

139.77

u/ml

0.03

122

829

Other bacterial intestinal infections, including avohilmo

919

7123

1.31

13.18

1.2

125.52

133.18

u/ml

0.23

322

2694

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

278

1734

1.64

13.16

1.3

1.2

138.73

122.41

u/ml

0.24

634

Malignant neoplasm of base of tongue, including Hilmo

125

3.82

13.15

1.2

144.19

112.68

u/ml

0.14

Cholelithiasis, broad definition with cholecystitis

3830

22447

1.15

13.11

1.2

118.89

143.13

u/ml

3.93

1414

8634

Other inflammation of eyelid

600

4383

1.40

13.10

1.2

125.92

146.58

u/ml

0.53

195

1651

Cluster headache, wide,, including avohilmo

275

1730

1.67

13.10

1.3

1.2

94.32

142.00

u/ml

1.42

108

662

Cluster headache, strict, including avohilmo

267

1670

1.68

13.06

1.3

1.2

94.88

141.57

u/ml

1.33

106

641

Persons encountering health services for specific procedures, not carried out

403

2749

1.52

13.02

1.3

1.2

163.22

146.37

u/ml

0.26

111

1037

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

406

2776

1.51

12.98

1.3

1.2

123.30

146.63

u/ml

0.54

144

1018

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

4143

24774

1.14

12.90

1.2

114.69

144.57

u/ml

5.74

1446

9489

Other viral diseases, including avohilmo

2017

16899

1.20

12.80

1.3

1.2

126.79

144.11

u/ml

1.22

761

6528

Disorders of tooth development and eruption

773

4772

1.35

12.73

1.2

142.44

155.00

u/ml

0.36

305

1880

Diagnoses used for exclusion with ILD

804

6145

1.33

12.70

1.2

123.15

132.67

u/ml

0.30

293

2259

Benign neoplasm: Colon, unspecified

742

5608

1.34

12.70

1.2

131.11

130.55

u/ml

0.01

251

1996

Haemorrhage in early pregnancy

1659

13438

1.23

12.68

1.3

1.2

142.57

150.48

u/ml

0.33

621

5351

Chronic apical periodontitis

5399

27221

1.12

12.68

1.2

133.21

140.35

u/ml

0.63

1967

10413

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

200

1170

1.81

12.68

1.3

1.2

187.51

154.97

u/ml

0.65

501

Necrosis of pulp, including avohilmo

2817

24171

1.16

12.66

1.2

141.25

142.08

u/ml

0.04

1055

9327

Complications associated with artificial fertilization

140

744

2.07

12.55

1.4

1.3

104.69

147.37

u/ml

0.78

311

Agoraphobia

209

1246

1.79

12.50

1.3

1.2

76.55

160.86

u/ml

3.64

517

Other symptoms and signs involving the circulatory and respiratory systems

263

1646

1.65

12.49

1.3

1.2

107.04

139.70

u/ml

0.71

595

Other acute lower respiratory infections

2255

18337

1.18

12.47

1.3

1.2

126.56

137.74

u/ml

0.64

780

6854

Anorexia (incl.atypical)

374

2553

1.54

12.37

1.3

1.2

103.58

146.87

u/ml

1.59

112

960

Allergic urticaria

427

2983

1.49

12.36

1.3

1.2

105.08

154.25

u/ml

2.77

151

1134

Injuries to the wrist and hand

4912

29214

1.12

12.36

1.2

149.33

138.45

u/ml

0.87

1728

11184

Other disorders starting during childhood or adolecense, excluding more controls

277

1686

1.64

12.34

1.2

168.61

147.20

u/ml

0.24

632

Pulmonary heart disease, diseases of pulmonary circulation

996

7853

1.29

12.34

1.2

146.96

134.39

u/ml

0.36

297

2838

Ethmoidectomy

543

3946

1.41

12.33

1.2

117.67

148.64

u/ml

1.38

233

1488

Use of pramipexole

758

5780

1.34

12.32

1.3

1.2

97.12

137.77

u/ml

2.70

293

2144

Emotional disorders and disorders of social functioning with onset specific to childhood

351

2323

1.56

12.28

1.3

119.22

148.26

u/ml

0.67

117

832

Acute bronchitis

1625

13253

1.22

12.27

1.3

1.2

129.19

141.12

u/ml

0.52

538

4959

Blepharochalasis

995

7862

1.29

12.24

1.2

119.51

140.44

u/ml

1.15

352

2916

Abnormal findings on diagnostic imaging of other body structures

575

4219

1.40

12.24

1.3

1.2

138.80

141.43

u/ml

0.06

238

1606

Keratitis

1517

12556

1.23

12.20

1.2

136.32

140.64

u/ml

0.16

560

4792

Childhood asthma (age<16), excluding more controls

838

5062

1.33

12.19

1.3

144.51

153.80

u/ml

0.25

324

1956

Other and unspecified tonsillitis

1810

12641

1.21

12.17

1.3

1.2

131.90

143.06

u/ml

0.59

694

4896

Oter anti-inflammatory and antirheumatic agents, non-steroids

623

2496

1.39

12.16

1.2

113.45

142.09

u/ml

1.08

218

955

All influenza

972

7662

1.29

12.16

1.3

1.2

99.68

137.18

u/ml

2.62

358

2846

Disorders of gallbladder, biliary tract and pancreas

4333

24026

1.13

12.14

1.2

118.70

143.05

u/ml

4.40

1579

9215

Sarcoidosis

490

3506

1.43

12.13

1.2

125.87

138.72

u/ml

0.33

182

1301

Abnormal findings on diagnostic imaging of lung

1506

11781

1.22

12.06

1.2

118.93

135.00

u/ml

0.84

504

4251

Emotional disorders starting during childhood or adolescence

335

2234

1.57

12.03

1.3

124.78

146.24

u/ml

0.43

113

792

Benign neoplasm of other and ill-defined parts of digestive system

635

4741

1.37

12.01

1.2

110.66

137.42

u/ml

1.24

245

1746

Erosion of teeth , including avohilmo

1382

11374

1.24

12.00

1.3

1.2

113.62

142.51

u/ml

2.37

480

4385

Other noninflammatory disorders of vagina

399

2767

1.50

11.99

1.3

1.2

126.24

154.20

u/ml

0.72

137

1137

Ptosis of eyelid

385

2641

1.50

11.97

1.2

133.05

137.61

u/ml

0.08

131

956

Speech and linguistic disorders, excluding more controls

398

2579

1.49

11.96

1.3

1.2

81.13

146.07

u/ml

4.14

113

971

Childhood asthma (age<16)

838

5076

1.32

11.96

1.3

144.51

153.87

u/ml

0.25

324

1959

Internal derangement of knee

1554

12783

1.22

11.91

1.2

144.08

143.60

u/ml

0.01

575

4894

Other specified and unspecified personality disorders

449

3190

1.46

11.84

1.2

107.52

152.31

u/ml

1.53

116

1224

Epilepsy

1135

9111

1.26

11.80

1.2

93.61

144.31

u/ml

6.26

417

3375

Hypokalaemia

437

3077

1.45

11.80

1.2

88.28

134.11

u/ml

2.04

144

1151

External causes of morbidity and mortality

3357

14760

1.15

11.79

1.2

142.06

144.06

u/ml

0.09

1233

5818

Endometriosis of rectovaginal septum and vagina

368

2521

1.52

11.79

1.3

1.2

95.05

153.73

u/ml

2.56

157

1003

Appendectomy

3127

26159

1.15

11.74

1.2

140.59

142.77

u/ml

0.11

1173

10102

Otalgia

409

2861

1.48

11.73

1.4

1.2

84.21

144.28

u/ml

4.00

153

1055

Lateral epicondylitis

567

4183

1.39

11.70

1.2

112.75

149.69

u/ml

1.57

231

1696

Injuries to the abdomen, lower back, lumbar spine and pelvis

1611

13262

1.21

11.66

1.3

1.2

143.52

135.49

u/ml

0.25

563

4906

Other CVD (FINNGEN)

384

2000

1.50

11.65

1.2

155.01

130.93

u/ml

0.47

121

728

Bulimia nervosa (incl. atypical)

266

1725

1.66

11.64

1.4

1.3

80.64

148.67

u/ml

2.76

683

Other viral diseases, not elsewhere classified, including avohilmo

1352

11062

1.24

11.64

1.3

1.2

133.68

144.03

u/ml

0.42

538

4259

Autoimmune hepatitis, wide definition

166

937

1.84

11.63

1.3

1.1

152.66

82.23

u/ml

1.66

294

Intracranial injury

2506

20210

1.17

11.63

1.2

110.22

140.59

u/ml

3.50

881

7549

Other abnormal uterine and vaginal bleeding

1063

6099

1.28

11.63

1.2

113.82

157.45

u/ml

3.54

356

2407

Ehlers-Danlos syndrome, including avohilmo

109

550

2.25

11.62

1.4

1.3

131.47

156.52

u/ml

0.21

230

Maternal care for other known or suspected fetal problems

1768

9347

1.22

11.60

1.3

145.81

143.07

u/ml

0.10

721

3719

Vulvovaginal ulceration/inflammation in other diseases

467

3372

1.45

11.57

1.3

136.44

156.53

u/ml

0.43

185

1364

Acute pharyngitis

794

6101

1.32

11.54

1.3

1.2

139.15

143.97

u/ml

0.08

282

2316

Dissociative [conversion] disorders

234

1466

1.69

11.54

1.3

1.2

103.28

151.38

u/ml

1.18

583

Hypoglycaemia, other or unspecified

274

1768

1.60

11.53

1.3

1.2

100.09

144.97

u/ml

1.61

652

Intracranial trauma

2723

15978

1.16

11.53

1.2

120.96

156.22

u/ml

3.71

998

6093

170

986

1.87

11.49

1.3

1.2

87.27

157.57

u/ml

2.77

409

Impingement syndrome of shoulder

816

6346

1.31

11.45

1.2

123.82

141.26

u/ml

0.60

303

2441

Allergic contact dermatitis

680

5183

1.35

11.42

1.2

139.24

145.66

u/ml

0.14

248

2018

Sleep disorders, other/unspecified

211

1292

1.73

11.37

1.3

1.2

110.64

151.88

u/ml

1.11

487

Injuries to the knee and lower leg

5759

28244

1.11

11.35

1.2

139.53

139.96

u/ml

0.03

2145

10703

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

840

6589

1.31

11.34

1.2

116.66

145.97

u/ml

1.26

257

2567

Postmenopausal bleeding

1046

4350

1.28

11.27

1.2

134.71

162.56

u/ml

1.40

410

1725

Benign neoplasm: Stomach

341

2315

1.52

11.26

1.3

1.2

91.63

140.05

u/ml

2.90

131

826

Malignant neoplasm of oropharynx

279

2.61

11.25

1.2

77.61

135.10

u/ml

0.82

113

Diseases of middle ear and mastoid

2953

21166

1.15

11.20

1.3

1.2

146.06

140.59

u/ml

0.27

1136

8060

Malignant neoplasm of oropharynx, including Hilmo

341

2.43

11.18

1.1

1.2

78.13

140.14

u/ml

1.09

139

Chondrocostal junction syndrome [Tietze]

189

1129

1.77

11.13

1.3

1.2

118.62

137.97

u/ml

0.24

443

Thyrotoxicosis with toxic single thyroid nodule

237

2.87

11.12

1.2

146.00

149.87

u/ml

0.02

Other skin changes

717

5513

1.32

11.04

1.2

151.10

143.63

u/ml

0.18

258

2034

Benign neoplasm of other and unspecified endocrine glands

508

3721

1.40

11.00

1.2

146.92

142.73

u/ml

0.07

159

1384

FESS (DNB20)

524

3860

1.39

11.00

1.2

120.34

149.29

u/ml

1.20

225

1450

Percutaneous Coronary Intervention

2890

15360

1.15

10.99

1.2

117.17

143.90

u/ml

3.47

1111

5772

Postpartum care and examination

1020

5141

1.28

10.95

1.3

145.60

152.17

u/ml

0.15

443

2051

Autism spe, excluding more controls

146

813

1.91

10.94

1.3

1.2

79.21

144.52

u/ml

1.37

301

Other CVD

545

4025

1.37

10.92

1.2

139.04

125.94

u/ml

0.29

168

1375

Osteopathies and chondropathies

2303

18198

1.17

10.88

1.2

127.21

139.78

u/ml

0.80

850

6810

Assault by bodily force

371

2585

1.48

10.87

1.2

145.10

148.94

u/ml

0.05

120

971

Other specified/unspecified systemic involvement of connective tissue

271

1777

1.59

10.83

1.3

1.2

137.16

141.91

u/ml

0.07

681

Cluster headache, wide

190

1144

1.74

10.80

1.3

1.2

85.18

143.93

u/ml

1.66

432

Thyroid crisis or storm

6.24

10.66

1.5

1.2

328.76

49.43

u/ml

1.43

Hypocalcemia

113

586

2.06

10.62

1.3

1.2

219.11

145.85

u/ml

0.68

236

Lichen planus

478

3487

1.40

10.62

1.2

108.50

140.82

u/ml

1.42

176

1302

Trigger finger

595

4492

1.35

10.55

1.2

155.41

148.25

u/ml

0.15

247

1803

Osteoporosis

883

6428

1.28

10.55

1.2

113.51

138.60

u/ml

1.13

319

2306

Disorders of muscles

409

2910

1.44

10.54

1.3

1.2

114.67

142.96

u/ml

0.86

151

1119

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

3214

22123

1.14

10.53

1.3

1.2

150.53

144.78

u/ml

0.31

1240

8678

Cluster headache, strict

182

1093

1.75

10.49

1.3

1.2

85.80

140.05

u/ml

1.41

419

Polymyalgia rheumatica

372

2597

1.46

10.49

1.2

93.22

121.96

u/ml

0.84

123

897

Chromosomal abnormalities, not elsewhere classified

131

719

1.97

10.48

1.3

167.18

150.06

u/ml

0.13

280

Coronary revascularization (ANGIO or CABG)

2883

15364

1.15

10.38

1.2

117.20

143.91

u/ml

3.46

1110

5774

Cutaneous abscess, furuncle and carbuncle

1109

9055

1.24

10.36

1.3

1.2

128.11

136.43

u/ml

0.28

401

3466

Clear cell adenocarcinoma of kidney

144

807

1.85

10.35

1.3

1.2

161.02

122.07

u/ml

0.35

307

Anomalies of dental arch relationship, including avohilmo

1066

7846

1.25

10.33

1.3

119.08

140.47

u/ml

1.09

403

2986

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1205

9926

1.23

10.28

1.2

110.16

144.99

u/ml

2.72

442

3878

Glucagon-like peptide-1 (GLP-1) analogues

1205

9926

1.23

10.28

1.2

110.16

144.99

u/ml

2.72

442

3878

Malignant neoplasm of base of tongue

4.13

10.27

1.3

1.2

161.23

105.66

u/ml

0.22

Other and unspecified drugs and medicaments

365

2567

1.47

10.18

1.3

1.2

119.72

148.74

u/ml

0.70

123

955

Open wound of wrist and hand

1896

15702

1.18

10.18

1.2

124.98

135.60

u/ml

0.59

644

5957

Emergency coronary revascularization (for ACS)

3024

16090

1.14

10.14

1.2

117.06

143.36

u/ml

3.50

1154

6017

Noninfective enteritis and colitis

2006

17268

1.17

10.11

1.2

106.92

141.62

u/ml

4.06

680

6536

Hypercalcemia

163

959

1.77

10.03

1.2

168.97

129.53

u/ml

0.47

357

Endometriosis diagnosis and infertility diagnosis occurring together

662

5155

1.33

9.85

1.3

135.65

150.57

u/ml

0.45

259

2133

Zoster [herpes zoster], including avohilmo

2028

16904

1.17

9.84

1.2

113.82

141.83

u/ml

3.13

767

6286

DVT of lower extremities and pulmonary embolism

1334

11083

1.21

9.80

1.2

121.18

136.99

u/ml

0.76

434

4067

Diseases of appendix

3402

27167

1.13

9.77

1.2

140.08

141.21

u/ml

0.06

1322

10374

Assault

596

4560

1.34

9.73

1.2

135.58

143.42

u/ml

0.16

192

1731

Sequelae with surgical and medical care as external cause

717

5614

1.30

9.68

1.2

103.61

140.24

u/ml

2.20

276

2062

Injury, poisoning and certain other consequences of external causes

2767

12186

1.15

9.65

1.2

145.79

147.20

u/ml

0.05

1008

4773

Other complications of surgical and medical care, not elsewhere classified

419

3046

1.41

9.64

1.3

1.2

135.60

143.48

u/ml

0.15

156

1144

Disorders of psychological development

635

4549

1.33

9.64

1.3

80.12

140.80

u/ml

4.58

189

1660

Pulmonary embolism

899

7223

1.26

9.61

1.2

140.12

133.24

u/ml

0.18

277

2630

Alopecia universalis

4.61

9.61

1.4

1.2

91.45

119.14

u/ml

0.24

Implicit Sepsis

2987

19486

1.14

9.61

1.2

107.91

143.06

u/ml

5.74

974

7352

Reimbursement for rheumatic diseases

2427

21149

1.15

9.60

1.2

120.65

142.08

u/ml

2.12

908

8018

1341

0.44

9.58

1.1

1.2

63.98

127.22

u/ml

0.87

463

Abnormal blood-pressure reading, without diagnosis

200

1258

1.65

9.53

1.2

99.28

143.45

u/ml

1.02

466

Benign lipomatous neoplasm

1051

8608

1.24

9.52

1.2

147.32

141.69

u/ml

0.15

384

3254

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

127

718

1.93

9.48

1.4

1.3

120.68

152.02

u/ml

0.33

290

Pulmonary heart disease

899

7236

1.26

9.47

1.2

140.12

133.84

u/ml

0.16

277

2629

Appendicitis, broad definition

3373

27076

1.13

9.44

1.2

140.42

141.41

u/ml

0.05

1311

10341

Premenstrual syndrome

112

610

2.01

9.41

1.4

1.3

85.25

152.33

u/ml

1.20

248

Striking against or struck by other objects

1421

11969

1.20

9.41

1.3

1.2

132.81

136.96

u/ml

0.13

452

4487

Vitreous haemorrhage

335

2348

1.46

9.41

1.2

226.21

142.02

u/ml

0.87

102

828

Spondylolisthesis/Spondylolysis

675

5268

1.30

9.38

1.2

133.19

155.41

u/ml

0.72

265

2000

Substance use, excluding alcohol

843

6762

1.27

9.37

1.3

1.2

116.06

143.25

u/ml

1.20

255

2591

Lesion of ulnar nerve

498

3729

1.36

9.37

1.2

104.37

147.04

u/ml

2.11

194

1406

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2189

11992

1.16

9.33

1.2

122.57

147.56

u/ml

2.63

845

4829

Other diseases of intestine

498

3727

1.36

9.33

1.2

171.26

137.23

u/ml

0.82

148

1391

Flat foot [pes planus] (acquired)

412

3005

1.41

9.30

1.2

114.35

149.36

u/ml

1.06

159

1131

Malignant neoplasm of breast, HER2-negative

1572

11895

0.84

9.30

1.2

153.18

148.94

u/ml

0.16

612

4865

Autonomic disorders

119

657

1.92

9.28

1.3

1.2

104.98

142.41

u/ml

0.43

269

Other diseases of blood and blood-forming organs, wide

789

6284

1.28

9.28

1.2

106.26

139.13

u/ml

1.79

252

2315

Implicit Sepsis, including avohilmo

3446

22030

1.13

9.27

1.2

111.76

142.78

u/ml

5.26

1153

8354

Disorders of adrenal gland, other and/or unspecified

119

3.47

9.26

1.5

1.2

72.00

128.67

u/ml

—

Other disorders of patella

797

6367

1.28

9.26

1.3

1.2

128.89

149.33

u/ml

0.83

297

2563

Ischemic heart diseases

3101

16397

1.13

9.24

1.2

122.59

144.07

u/ml

2.40

1218

6191

Other diseases of the digestive system

926

7497

1.25

9.23

1.2

113.98

131.40

u/ml

0.67

291

2652

Raynaud syndrome

431

3180

1.40

9.20

1.3

1.2

150.91

155.68

u/ml

0.08

169

1208

Dermatophytosis, including avohilmo

2867

24959

1.13

9.16

1.2

121.81

141.07

u/ml

1.95

1054

9424

Malignant neoplasm of breast

1578

11918

0.84

9.15

1.2

155.19

148.67

u/ml

0.27

616

4876

Neuromuscular dysfunction of bladder

315

2197

1.47

9.12

1.3

1.2

153.82

142.94

u/ml

0.14

119

829

Malignant neoplasm of breast, HER2-negative, including Hilmo

1624

12142

0.85

9.01

1.2

152.33

149.25

u/ml

0.11

629

4980

Malignant neoplasm of tonsil

246

2.51

9.00

1.1

1.2

90.47

133.12

u/ml

0.45

Malignant neoplasm of breast, HER-positive

1107

9924

0.82

8.99

1.2

160.19

149.06

u/ml

0.41

432

4023

Mental and behavioural disorders due to sedatives or hypnotics

293

2028

1.49

8.98

1.3

1.2

69.81

143.12

u/ml

3.72

778

Any dementia

615

5482

0.77

8.96

1.1

1.2

89.81

121.20

u/ml

1.46

197

1765

Personal history of other diseases and conditions

665

5212

1.31

8.94

1.3

146.35

151.98

u/ml

0.13

216

1996

conjunctival haemorrhage

252

1691

1.53

8.91

1.2

141.07

138.82

u/ml

0.03

623

Other/unspecified synovitis and tenosynovitis

456

3400

1.37

8.90

1.2

132.14

142.91

u/ml

0.21

168

1353

Suicide or other Intentional self-harm

1117

9283

1.22

8.89

1.2

108.15

144.01

u/ml

2.32

338

3650

Other nonscarring hair loss

418

2.21

8.87

1.1

1.3

32.66

167.95

u/ml

9.34

182

Osteoporosis with pathological fracture (FG)

249

1669

1.53

8.86

1.2

81.71

143.11

u/ml

2.54

596

Malignant neoplasm of breast, including Hilmo

1626

12138

0.85

8.86

1.2

153.88

149.27

u/ml

0.18

631

4979

Arthrosis

2861

13888

1.14

8.83

1.2

127.37

145.13

u/ml

1.64

1096

5412

Other disorders of bone

846

6840

1.26

8.82

1.2

129.53

138.16

u/ml

0.25

323

2623

Hirsutism in women

151

918

1.79

8.81

1.2

1.3

119.15

173.62

u/ml

1.11

365

Neuralgia and neuritis, unspecified

224

1475

1.57

8.80

1.2

111.67

141.12

u/ml

0.56

580

Seborrhoeic dermatitis

351

2515

1.43

8.76

1.3

1.2

100.51

131.41

u/ml

1.10

120

898

Abnormalities of gait and mobility

363

2613

1.42

8.75

1.2

130.67

134.27

u/ml

0.05

118

903

Malignant neoplasm of breast, ER-positive, including Hilmo

1114

9937

0.82

8.71

1.2

160.41

149.20

u/ml

0.42

435

4028

Acne

662

5203

1.30

8.67

1.3

98.46

142.81

u/ml

2.73

263

1925

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

4055

23209

1.11

8.61

1.2

131.46

140.98

u/ml

0.82

1476

8896

Malignant neoplasm of oral cavity

111

610

1.89

8.60

1.1

1.2

109.65

125.01

u/ml

0.17

239

Viral warts, including avohilmo

1027

8496

1.23

8.60

1.2

135.39

138.33

u/ml

0.08

374

3228

Other and unspecified nonscarring hair loss

317

2.40

8.52

1.1

1.3

32.26

163.62

u/ml

7.37

141

Trigeminal neuralgia

256

1746

1.52

8.51

1.3

1.2

93.00

152.59

u/ml

2.63

668

Tongue abnormality

233

1558

1.55

8.51

1.2

172.42

144.03

u/ml

0.37

587

Strabismus

1159

9679

1.21

8.48

1.3

1.2

135.85

139.11

u/ml

0.10

445

3653

Presence of other functional implants

1955

11619

1.16

8.46

1.2

120.70

137.75

u/ml

1.33

654

4322

Malignant neoplasm of tongue

364

2.18

8.43

1.1

1.2

124.68

129.21

u/ml

0.03

156

Other bacterial intestinal infections

614

4802

1.30

8.41

1.2

112.40

127.65

u/ml

0.44

199

1783

Other abnormal immunological findings in serum

117

667

1.88

8.38

1.5

1.3

200.18

156.42

u/ml

0.38

275

Special screening examination for other diseases and disorders

474

3583

1.35

8.36

1.3

1.2

150.20

146.91

u/ml

0.06

176

1391

Other strabismus

1011

8343

1.23

8.36

1.3

1.2

134.17

141.25

u/ml

0.23

390

3159

Unknown and unspecified causes of morbidity

271

1871

1.49

8.36

1.2

84.21

148.69

u/ml

3.06

136

704

Supervision of high-risk pregnancy

1325

6739

1.21

8.36

1.3

1.2

129.54

154.22

u/ml

1.40

541

2734

Unspecified haematuria

1214

8282

1.20

8.35

1.2

110.84

129.54

u/ml

0.91

392

2965

Hypertrichosis

164

1032

1.71

8.33

1.2

1.3

116.18

165.03

u/ml

1.06

410

Melanocytic naevi

1437

12280

1.19

8.32

1.3

1.2

117.35

142.21

u/ml

1.96

566

4716

Artrosis, including avohilmo

3507

17275

1.12

8.31

1.2

129.49

145.32

u/ml

1.58

1352

6669

Other diseases of pericardium

148

893

1.71

8.30

1.2

135.93

127.41

u/ml

0.08

319

Superficial injury of wrist and hand

1000

8283

1.23

8.29

1.3

1.2

156.86

138.40

u/ml

0.67

364

3213

Malignant neoplasm of tongue, including Hilmo

469

2.01

8.28

1.1

1.2

124.48

131.56

u/ml

0.06

188

Complications of the puerperium, not elsewhere classified

294

2090

1.49

8.26

1.3

1.2

205.75

154.43

u/ml

0.56

127

850

Venous thromboembolism

1819

15207

1.16

8.26

1.2

123.19

136.89

u/ml

0.80

595

5678

Malignant neoplasm of tonsil, including Hilmo

288

2.32

8.24

1.1

1.2

85.50

136.10

u/ml

0.62

119

Otitis externa, unspecified

501

3839

1.34

8.21

1.3

1.2

113.33

147.96

u/ml

1.50

164

1423

Hard cardiovascular diseases

3222

17075

1.12

8.18

1.2

121.12

144.55

u/ml

2.87

1233

6501

Manic episode

146

887

1.73

8.17

1.3

1.2

78.63

138.25

u/ml

1.86

348

Other disorders of conjunctiva

459

3469

1.35

8.16

1.2

133.45

135.50

u/ml

0.04

167

1285

Dronedarone medication

471

1.99

8.15

1.2

203.32

113.96

u/ml

0.97

161

Coagulation defects, purpura and other haemorrhagic conditions

753

6063

1.26

8.14

1.3

1.2

153.22

138.36

u/ml

0.41

270

2285

Noninfectious colitis NAS

553

4294

1.31

8.14

1.3

1.2

121.11

144.41

u/ml

0.61

177

1575

Other disorders of veins

1705

14538

1.17

8.12

1.2

169.57

142.50

u/ml

1.65

573

5626

Unspecific neurodegenerative disorder

670

5780

0.79

8.12

1.1

1.2

83.98

122.04

u/ml

2.06

209

1847

Dementia

754

6409

0.80

8.11

1.1

1.2

97.05

123.17

u/ml

1.12

242

2074

Pacemaker

879

6663

1.24

8.11

1.2

88.80

124.91

u/ml

3.01

290

2257

Other specified/unspecified soft tissue disorders

182

1167

1.61

8.03

1.3

1.2

90.14

147.28

u/ml

1.59

445

Colonic or urogenital fistula

1007

8364

1.22

8.02

1.2

129.98

137.19

u/ml

0.17

382

3196

Disorder of lipoprotein metabolism, unspecified

340

2459

1.41

7.95

1.2

163.44

121.91

u/ml

0.72

864

Immunodeficiencies

204

1350

1.57

7.93

1.5

1.2

55.16

135.73

u/ml

7.35

525

Polyarthropathies

2894

16622

1.13

7.90

1.2

122.89

145.94

u/ml

2.07

1055

6378

Wide developmental disorders

199

1310

1.59

7.89

1.3

1.2

93.63

139.55

u/ml

0.85

464

Other disorders of nervous system

224

1508

1.53

7.87

1.2

126.82

155.42

u/ml

0.46

555

Radial styloid tenosynovitis [de Quervain]

285

2018

1.46

7.87

1.3

1.2

132.56

154.30

u/ml

0.42

124

801

Fall on same level

5591

27483

1.09

7.87

1.2

132.81

141.51

u/ml

0.75

1971

10613

Other (not insulin) diabetes medications

4304

23041

1.10

7.86

1.2

123.25

142.75

u/ml

2.53

1524

8874

Hypermetropia

321

2315

1.43

7.86

1.3

1.2

122.32

150.00

u/ml

0.71

126

827

Maltreatment syndromes

271

1904

1.48

7.84

1.3

1.2

104.32

153.24

u/ml

1.63

747

515

3697

1.31

7.84

1.1

1.2

94.18

117.78

u/ml

0.96

168

1211

Rash and other nonspecific skin eruption

382

2833

1.38

7.84

1.3

1.2

105.17

148.23

u/ml

1.80

143

1073

Maternal care for known or suspected abnormality of pelvic organs

1677

9825

1.17

7.84

1.3

158.31

146.64

u/ml

0.52

671

3910

Transport accidents

2255

16591

1.14

7.82

1.3

1.2

118.45

143.14

u/ml

2.78

847

6600

Pre-eclampsia or poor fetal growth

1884

16465

1.16

7.81

1.3

149.15

148.40

u/ml

0.03

799

6529

Benign neoplasm of mouth and pharynx

375

2772

1.38

7.81

1.2

143.60

140.97

u/ml

0.04

120

1007

Hallux valgus (acquired)

1372

8361

1.19

7.80

1.2

132.22

151.16

u/ml

0.99

511

3310

Superficial injury of abdomen, lower back and pelvis

669

5347

1.27

7.79

1.3

1.2

157.67

136.51

u/ml

0.37

236

2012

Perineal laceration during delivery

1242

8533

1.20

7.79

1.3

132.35

148.50

u/ml

0.81

484

3389

Pre-eclampsia or eclampsia

1213

10308

1.20

7.79

1.3

1.2

150.44

147.30

u/ml

0.10

513

4114

Other/unspecified enthesopathies of lower limb, excluding foot

313

2253

1.43

7.76

1.2

158.67

149.76

u/ml

0.12

110

875

Malignant neoplasm of oral cavity, including Hilmo

136

817

1.72

7.76

1.1

1.2

114.13

132.96

u/ml

0.24

315

Major coronary heart disease event

3005

16112

1.12

7.74

1.2

120.08

143.68

u/ml

2.81

1160

6050

Alzheimer disease, including avohilmo

555

4919

0.77

7.73

1.1

1.2

72.00

121.31

u/ml

3.56

175

1571

Fall on and from stairs and steps

1023

8544

1.21

7.71

1.2

119.64

140.67

u/ml

0.88

320

3241

Vitamin B12 deficiency anaemia

296

2105

1.43

7.69

1.2

210.13

131.39

u/ml

2.17

116

767

Disorders of breast

2740

21628

1.13

7.66

1.3

1.2

132.38

149.14

u/ml

1.41

1084

8471

Primary biliary cholangitis, wide definition

455

1.98

7.63

1.2

123.33

82.44

u/ml

0.56

147

GI-bleeding

901

7427

1.22

7.63

1.2

106.26

131.31

u/ml

1.26

297

2617

Other disorders of breast

727

5898

1.26

7.62

1.3

1.2

143.65

148.63

u/ml

0.13

300

2367

Gluteal tendinitis

198

1314

1.57

7.61

1.3

1.2

218.34

143.67

u/ml

1.17

506

Chronic kidney disease

802

6282

1.24

7.61

1.2

120.24

123.22

u/ml

0.04

241

2165

Non-small cell lung cancer

249

1696

1.47

7.61

1.2

131.19

115.39

u/ml

0.18

612

Psoriasis

1063

8920

1.21

7.60

1.2

113.02

141.45

u/ml

1.80

380

3405

Acute laryngitis and tracheitis

619

4848

1.28

7.57

1.3

1.2

147.80

148.72

u/ml

0.01

244

1831

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

315

2284

1.42

7.57

1.3

1.2

116.12

147.96

u/ml

0.59

107

862

Behavioural disorders, excluding more controls

107

609

1.85

7.56

1.3

1.2

132.19

152.08

u/ml

0.16

239

Type 2 diabetes, definitions combined, including avohilmo

4223

22295

1.10

7.55

1.2

124.96

143.65

u/ml

2.23

1483

8642

Postpartum haemorrhage

1662

11950

1.17

7.55

1.3

134.31

148.96

u/ml

0.83

635

4811

Hypertrophy of breast in women and men

983

8218

1.22

7.53

1.2

117.43

150.54

u/ml

2.08

389

3321

Ehlers-Danlos syndrome

439

2.09

7.51

1.5

1.3

124.26

164.86

u/ml

0.30

186

Lichen sclerosus et atrophicus

485

3754

1.32

7.43

1.2

163.89

142.99

u/ml

0.56

199

1426

Pediculosis, acariasis and other infestations, including avohilmo

845

6969

1.23

7.42

1.2

119.95

141.03

u/ml

0.84

284

2676

Viral warts

441

3372

1.34

7.42

1.2

114.14

145.89

u/ml

1.00

159

1239

Complications of labour and delivery

3524

17772

1.11

7.39

1.3

1.2

140.32

145.78

u/ml

0.34

1419

6915

Acute appendicitis

3141

26363

1.11

7.35

1.2

139.42

141.91

u/ml

0.13

1234

10115

Papilloedema, unspecified

121

723

1.77

7.35

1.3

136.50

141.27

u/ml

0.05

285

Other and unspecified disorders of autonomic nervous system

132

3.10

7.32

1.3

97.48

117.78

u/ml

0.15

Infections with a predominantly sexual mode of transmission

1700

14840

1.16

7.32

1.3

1.2

155.80

144.80

u/ml

0.50

580

5833

Benign neoplasm of thyroid gland

144

901

1.67

7.23

1.3

1.2

99.12

138.42

u/ml

0.67

359

Endometriosis ASRM stages 3,4

1180

10065

1.19

7.23

1.3

1.2

135.03

148.63

u/ml

0.54

475

3961

Any dementia, excluding more controls

581

5033

0.79

7.21

1.1

1.2

93.15

121.38

u/ml

1.15

183

1671

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

309

2210

1.42

7.19

1.2

1.3

171.12

149.61

u/ml

0.26

809

Cellulitis

807

6635

1.23

7.19

1.2

125.45

139.87

u/ml

0.46

297

2445

Acute appendicitis, no complications

2535

22583

1.13

7.17

1.2

142.84

143.39

u/ml

0.02

984

8714

Dementia, including avohilmo

832

6887

0.82

7.16

1.2

94.51

124.15

u/ml

1.51

270

2257

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

455

3501

1.32

7.14

1.2

94.07

124.31

u/ml

1.22

128

1331

Hyperfunction of pituitary gland

254

1799

1.47

7.12

1.3

1.2

110.25

147.41

u/ml

0.87

685

Oral lichen planus, including avohilmo , including avohilmo

292

2114

1.42

7.09

1.2

119.85

139.64

u/ml

0.52

125

796

Redundant prepuce, phimosis and paraphimosis

454

3434

1.31

7.04

1.2

88.26

123.26

u/ml

1.91

154

1155

Anogenital herpesviral [herpes simplex] infection, including avohilmo

672

5461

1.26

7.03

1.3

151.38

146.11

u/ml

0.11

228

2176

Other viral diseases

1366

11754

1.17

6.99

1.3

1.2

112.20

141.28

u/ml

2.53

492

4497

Meralgia paraesthetica

140

876

1.66

6.99

1.2

114.89

151.67

u/ml

0.55

357

SLE (Finngen)

132

813

1.69

6.98

1.4

1.2

94.93

80.56

u/ml

0.24

259

D07AA Corticosteroids, weak (group I)

735

6008

1.24

6.98

1.2

117.90

143.50

u/ml

1.11

267

2248

Benign neoplasm: Pituitary gland, craniopharyngeal duct

219

1511

1.50

6.98

1.2

146.31

146.11

u/ml

0.00

586

Heart failure and antihypertensive medication

717

3767

1.25

6.94

1.2

110.53

156.06

u/ml

2.78

247

1431

Other female pelvic inflammatory diseases

762

6272

1.24

6.94

1.2

136.41

148.50

u/ml

0.35

276

2478

Hyperkalaemia

149

943

1.61

6.89

1.1

1.2

78.31

124.68

u/ml

1.25

342

Lichen simplex chronicus and prurigo

233

1627

1.47

6.89

1.2

106.28

148.17

u/ml

1.08

591

Other superficial mycoses, including avohilmo

521

4116

1.30

6.87

1.3

1.2

135.81

144.35

u/ml

0.18

175

1562

Other cataract

1408

9027

1.17

6.85

1.2

111.15

139.13

u/ml

2.11

473

3372

Hypertrophy of breast

928

7799

1.21

6.83

1.2

120.10

150.59

u/ml

1.75

377

3188

Corneal ulcer

734

6017

1.24

6.81

1.3

1.2

154.97

138.87

u/ml

0.46

297

2300

Problems related to lifestyle

445

3446

1.32

6.80

1.3

1.2

120.18

142.00

u/ml

0.52

148

1392

Other peripheral vascular diseases

331

2460

1.38

6.80

1.2

121.76

144.26

u/ml

0.52

129

902

Acne vulgaris

504

3972

1.30

6.79

1.3

80.17

144.34

u/ml

5.90

213

1466

Atopic conjunctivitis

226

1580

1.49

6.79

1.2

129.26

137.76

u/ml

0.12

610

Malignant neoplasm of digestive organs, including Hilmo

914

8032

0.83

6.79

1.2

142.81

132.31

u/ml

0.29

276

3058

Volume depletion

258

1833

1.43

6.78

1.2

180.76

120.88

u/ml

0.37

646

Disorders of lens

2290

12643

1.13

6.77

1.2

122.13

143.42

u/ml

1.86

816

4850

Early lumbar disc prolapse operation

521

4126

1.29

6.76

1.2

141.56

151.45

u/ml

0.22

228

1632

Other noninflammatory disorders of uterus, except cervix

825

4544

1.23

6.75

1.2

107.00

159.44

u/ml

4.33

317

1777

Pregnancy with abortive outcome

3773

17976

1.10

6.72

1.2

143.21

144.05

u/ml

0.04

1446

7142

Meniscus derangement

2026

11898

1.14

6.70

1.2

128.74

144.06

u/ml

0.99

748

4598

Other disorders of white blood cells

195

1324

1.52

6.70

1.3

1.2

62.81

140.97

u/ml

3.88

504

Iridocyclitis

845

7033

1.22

6.70

1.2

118.91

138.76

u/ml

0.77

310

2665

Hallux rigidus

456

3545

1.31

6.69

1.2

145.63

142.07

u/ml

0.06

161

1325

Heterophoria

383

2920

1.35

6.68

1.3

1.2

141.66

145.99

u/ml

0.07

152

1075

Dermatitis due to substances taken internally

229

1606

1.47

6.68

1.3

1.2

117.82

149.79

u/ml

0.50

588

Degeneration of macula and posterior pole

1312

8709

1.17

6.64

1.2

118.28

128.21

u/ml

0.41

410

3060

Other otitis externa (chronic)

271

1960

1.42

6.62

1.3

1.2

131.68

149.32

u/ml

0.30

757

Follicular cysts of skin and subcutaneous tissue

662

5384

1.25

6.62

1.3

1.2

141.41

142.16

u/ml

0.01

249

2000

Androgenic alopecia

321

2.17

6.59

1.4

1.3

157.13

173.65

u/ml

0.10

137

Sacrococcygeal disorders, not elsewhere classified

155

1011

1.60

6.58

1.3

1.2

80.74

141.91

u/ml

2.12

392

Tic and related disorders

359

2.05

6.56

1.2

144.36

142.76

u/ml

0.01

120

Condition for Implicit Sepsis (Organ dysfunction codes)

3578

22644

1.10

6.55

1.2

111.09

143.85

u/ml

6.05

1212

8612

Complications predominantly related to the puerperium

1542

13532

1.16

6.54

1.3

1.2

137.00

147.78

u/ml

0.41

624

5359

Other disorders of optic [2nd] nerve and visual pathways

251

1798

1.44

6.51

1.3

1.2

143.30

146.44

u/ml

0.04

666

Type 2 diabetes, definitions combined

4150

22191

1.09

6.50

1.2

124.36

143.34

u/ml

2.23

1448

8592

Alzheimer disease

466

4258

0.78

6.50

1.1

66.96

122.95

u/ml

4.01

148

1370

Calculus of kidney and ureter

881

7373

1.21

6.50

1.2

128.89

133.70

u/ml

0.08

292

2691

Intestinal malabsorption

189

1286

1.52

6.48

1.4

1.2

84.99

146.10

u/ml

2.79

497

Other infectious diseases, including avohilmo

301

2218

1.39

6.47

1.3

1.2

114.02

138.79

u/ml

0.66

110

814

1097

8402

1.18

6.47

1.2

112.78

129.37

u/ml

0.77

365

2915

Type 2 diabetes, strict (exclude DM1)

4161

22264

1.09

6.44

1.2

124.54

143.32

u/ml

2.21

1455

8619

Injury of muscle and tendon at shoulder and upper arm level

1065

9069

1.19

6.43

1.2

125.68

134.33

u/ml

0.30

366

3337

Transient ischemic attack

1528

10619

1.15

6.42

1.2

109.53

132.47

u/ml

1.68

548

3824

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

302

2232

1.38

6.40

1.2

160.13

140.43

u/ml

0.34

107

812

Bacterial intestinal infections, IBD co-morbidities

605

4891

1.25

6.38

1.2

110.63

133.32

u/ml

0.74

198

1803

Schizoaffective disorder

331

2488

1.37

6.38

1.3

1.2

73.30

153.74

u/ml

4.75

106

959

Malignant neoplasm of digestive organs

791

7279

0.82

6.38

1.2

144.07

130.91

u/ml

0.35

243

2739

Viral hepatitis, IBD co-morbidity

184

1244

1.51

6.38

1.2

119.65

153.02

u/ml

0.46

484

Urolithiasis

935

7880

1.20

6.37

1.2

127.56

132.23

u/ml

0.09

310

2854

Selective deficiency of immunoglobulin G [IgG] subclasses

197

2.49

6.37

1.9

1.2

31.83

150.64

u/ml

3.68

Cramp and spasm

195

1341

1.50

6.36

1.3

1.2

173.90

147.79

u/ml

0.30

516

Spondyloarthritis

640

5209

1.25

6.34

1.2

108.17

129.39

u/ml

0.79

223

1929

Torsion of ovary, ovarian pedicle and fallopian tube

132

840

1.66

6.34

1.3

142.42

148.87

u/ml

0.07

330

Retinal detachments and breaks

1060

9034

1.18

6.33

1.2

122.23

136.08

u/ml

0.61

375

3296

Hyperplasia of prostate

646

2931

1.25

6.29

1.1

1.2

99.66

118.60

u/ml

0.63

211

959

Cholinergic urticaria

118

2.94

6.27

1.1

1.3

113.43

141.87

u/ml

—

Pre-eclampsia

1127

9703

1.18

6.26

1.3

1.2

155.44

147.71

u/ml

0.27

475

3885

Degenerative diseases of the nervous system

560

5014

0.80

6.25

1.1

1.2

80.55

122.43

u/ml

2.25

181

1621

Idiopathic hypoparathyroidism

3.82

6.24

1.1

1.2

45.08

209.36

u/ml

—

Superficial injury of lower leg

1164

10024

1.18

6.23

1.3

1.2

133.71

141.53

u/ml

0.28

440

3830

Excessive earwax

2329

18960

1.12

6.22

1.2

136.57

136.74

u/ml

0.01

948

6894

Allergic colitis

131

836

1.65

6.20

1.2

1.3

105.45

143.12

u/ml

0.67

276

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

692

5510

1.23

6.20

1.3

1.2

137.93

128.87

u/ml

0.18

154

2087

Other and unspecified follicular disorders

165

1103

1.55

6.19

1.3

1.2

97.37

151.28

u/ml

0.96

422

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

4.05

6.17

1.4

1.3

420.80

162.48

u/ml

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

469

3728

1.30

6.15

1.2

1.3

182.14

145.97

u/ml

0.63

208

1547

Spondylopathies (FG)

568

4589

1.26

6.14

1.2

99.21

139.80

u/ml

2.05

193

1791

Unspecified fall

1998

17497

1.13

6.14

1.2

138.07

137.95

u/ml

0.00

645

6495

Fracture of foot, except ankle

1097

9418

1.18

6.14

1.3

1.2

147.01

138.17

u/ml

0.29

390

3625

Diseases of the myoneural junction and muscle

366

2798

1.33

6.12

1.3

1.2

115.16

137.50

u/ml

0.48

111

996

Bacterial infection, other or unspecified, including avohilmo

2086

15266

1.13

6.11

1.2

108.39

138.43

u/ml

2.97

665

5710

Fall on same level involving ice and snow

2447

22082

1.12

6.11

1.2

127.33

141.73

u/ml

1.12

901

8313

Other and unspecified anaemias

1263

10264

1.16

6.07

1.2

132.83

131.02

u/ml

0.04

400

3680

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

164

1103

1.55

6.05

1.3

1.2

80.55

139.56

u/ml

2.16

441

Urethritis and urethral syndrome

591

1.76

6.03

1.5

1.3

94.56

135.88

u/ml

0.90

237

Malignant neoplasm of larynx, including Hilmo

223

2.23

6.03

1.1

1.2

113.45

131.58

u/ml

0.13

Other enthesopathy of foot (+metatarsalgia)

446

3515

1.29

6.02

1.2

124.47

147.28

u/ml

0.57

163

1393

Unspecified kidney failure

249

1798

1.41

6.00

1.2

141.88

127.15

u/ml

0.08

616

Defects in the complement system

209

2.39

6.00

1.7

1.3

47.33

161.68

u/ml

3.51

Superficial injury of forearm

450

3555

1.29

5.97

1.2

130.39

147.27

u/ml

0.36

145

1306

Oesophagitis

165

1108

1.53

5.97

1.2

103.55

147.92

u/ml

0.75

398

Impotence

113

694

1.66

5.95

1.2

49.21

109.60

u/ml

1.67

220

Convalescence

222

1584

1.44

5.95

1.2

152.18

148.06

u/ml

0.05

619

Abnormal serum enzyme levels

710

5662

1.22

5.94

1.2

102.66

127.05

u/ml

1.16

273

1919

Implicit bacterial Sepsis, including avohilmo

1380

10007

1.15

5.94

1.2

93.89

137.08

u/ml

5.36

414

3633

Gonarthrosis

2333

11834

1.12

5.93

1.2

128.40

143.03

u/ml

1.01

880

4608

Varicella [chickenpox], including avohilmo

204

1432

1.46

5.93

1.2

1.3

142.06

143.17

u/ml

0.01

520

Bicipital tendinitis

159

1063

1.54

5.91

1.2

101.16

146.45

u/ml

1.12

401

Ovarian hyperstimulation (induction)

131

854

1.65

5.91

1.4

1.3

106.57

162.28

u/ml

0.95

358

Eosinophilic disease (BM)

344

2.00

5.90

1.3

1.2

89.40

139.84

u/ml

0.65

139

Collagenous colitis

357

2743

1.33

5.88

1.3

1.2

118.00

144.40

u/ml

0.66

113

998

Other disorders of ear

3812

22677

1.09

5.87

1.2

129.89

142.50

u/ml

1.07

1466

8551

Scabies, including avohilmo

738

6159

1.22

5.86

1.2

113.40

143.51

u/ml

1.35

252

2356

Other/unspecified enthesopathies, not elsewhere classified

281

2084

1.38

5.84

1.3

1.2

165.05

133.70

u/ml

0.53

103

805

Disorders of optic nerve and visual pathways

406

3179

1.31

5.83

1.3

1.2

155.19

150.90

u/ml

0.07

148

1179

Car occupant injured in other and unspecified transport accidents

849

7176

1.20

5.81

1.3

1.2

122.22

143.14

u/ml

0.98

332

2708

Actinic keratosis

955

7387

1.18

5.78

1.2

117.61

126.55

u/ml

0.30

318

2525

Herpesviral [herpes simplex] infections

486

3890

1.27

5.77

1.3

1.2

130.87

143.16

u/ml

0.16

180

1473

Salpingitis and oophoritis

791

6657

1.21

5.76

1.2

128.06

151.62

u/ml

1.01

282

2674

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

1175

10211

1.17

5.75

1.3

1.2

154.21

140.32

u/ml

0.50

430

3985

All chronic kidney diseases

1879

13349

1.13

5.75

1.2

125.03

134.52

u/ml

0.35

642

4982

Gestational [pregnancy-induced] hypertension

1552

13723

1.15

5.73

1.3

162.34

148.65

u/ml

0.52

662

5429

Chronic thyroiditis

3.49

5.73

1.8

1.2

433.50

71.87

u/ml

0.75

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

541

4367

1.26

5.70

1.4

1.2

122.21

146.33

u/ml

0.73

205

1615

Spirochaetal infections, other/unspecified

318

2415

1.35

5.70

1.2

142.43

141.37

u/ml

0.02

107

887

Other peripheral vertigo

318

2414

1.35

5.70

1.3

1.2

107.72

141.69

u/ml

1.01

119

883

Metatarsalgia

406

3187

1.30

5.69

1.2

127.47

145.42

u/ml

0.38

149

1268

Misadventures to patients during surgical and medical care

521

4206

1.26

5.68

1.2

154.01

142.58

u/ml

0.24

188

1569

Other disorders of penis

196

1369

1.45

5.67

1.2

83.06

115.26

u/ml

0.89

431

Other superficial mycoses

109

680

1.68

5.66

1.3

1.2

95.23

148.63

u/ml

1.10

278

Diabetic maculopathy

418

3107

1.29

5.65

1.2

132.89

132.06

u/ml

0.01

159

1082

Injuries to the thorax

1536

13554

1.14

5.64

1.2

108.92

135.83

u/ml

2.06

526

5010

Other immunodeficiencies

332

2.01

5.59

1.6

1.3

50.20

161.56

u/ml

4.85

135

Skin changes due to chronic exposure to nonionizing radiation

997

7727

1.18

5.57

1.2

115.58

128.61

u/ml

0.50

330

2647

Sulfonylureas

512

5038

0.80

5.57

1.2

66.35

127.76

u/ml

6.57

150

1686

Hypersomnia

382

1.92

5.55

1.3

1.2

116.98

159.41

u/ml

0.40

160

Other anaemias

1269

10359

1.15

5.55

1.2

132.51

130.78

u/ml

0.04

401

3715

Vasomotor rhinitis (mode)

282

2116

1.37

5.54

1.3

1.2

149.89

141.34

u/ml

0.14

118

809

Sequelae of injuries, of poisoning and of other consequences of external causes

865

7347

1.19

5.54

1.2

149.49

142.27

u/ml

0.16

303

2820

Acute and transient psychotic disorders

452

3606

1.28

5.53

1.3

1.2

74.37

151.41

u/ml

7.40

145

1369

Nonsuppurative otitis media, including avohilmo

1684

12958

1.14

5.52

1.3

136.38

140.02

u/ml

0.14

631

4953

Chondropathies

613

5054

1.23

5.52

1.2

135.16

141.30

u/ml

0.14

234

1904

Other disorders of skin and subcutaneous tissue, not elsewhere classified

476

3816

1.27

5.51

1.2

113.25

133.25

u/ml

0.52

160

1422

Inguinal hernia

1454

10971

0.88

5.51

1.2

125.80

132.74

u/ml

0.28

530

3990

Calcific tendinitis of shoulder

224

1622

1.42

5.51

1.2

121.22

142.89

u/ml

0.37

102

652

Viral pneumonia

438

3479

1.28

5.49

1.2

102.51

138.89

u/ml

1.33

138

1264

Hyperprolactinaemia

191

1355

1.47

5.48

1.3

119.28

148.69

u/ml

0.52

531

Alzheimer’s disease, strict definition

340

3558

0.76

5.47

1.1

73.65

125.59

u/ml

2.32

107

1164

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

342

2639

1.32

5.46

1.2

147.84

143.69

u/ml

0.07

136

972

Female infertility, uterine origin

147

2.64

5.45

1.4

1.3

75.82

174.95

u/ml

1.10

Other follicular disorders

330

2541

1.33

5.43

1.2

114.81

156.32

u/ml

0.90

129

959

Deep endometriosis

479

3870

1.27

5.40

1.3

1.2

112.18

150.72

u/ml

1.12

197

1515

Nonalcoholic steatohepatitis

231

2.19

5.37

1.4

1.2

144.60

171.42

u/ml

0.28

Primary biliary cholangitis (PBC)

443

1.81

5.34

1.3

1.2

189.30

80.80

u/ml

1.56

144

Intentional self-harm by sharp object

145

981

1.55

5.34

1.3

29.28

140.93

u/ml

13.15

368

Other disorders of male genital organs

545

1.71

5.34

1.2

94.69

138.28

u/ml

0.59

171

Congenital malformations of the musculoskeletal system, not elsewhere classified

594

1.73

5.34

1.5

1.3

116.71

158.57

u/ml

0.38

244

Other diseases of stomach and duodenum

198

1409

1.44

5.33

1.2

92.38

157.07

u/ml

1.85

524

Cardiac murmurs and other cardiac sounds

416

3265

1.28

5.32

1.3

1.2

170.49

149.59

u/ml

0.38

160

1185

Malignant neoplasm of larynx

163

2.35

5.31

1.1

1.2

149.89

143.84

u/ml

0.03

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

389

3020

1.30

5.31

1.3

106.28

144.48

u/ml

1.36

149

1120

Myopia

651

5429

1.22

5.29

1.3

153.72

143.97

u/ml

0.25

258

2067

Cerebrovascular diseases (FINNGEN)

1208

7375

1.16

5.29

1.2

125.71

150.39

u/ml

1.20

433

2948

Single delivery by caesarean section

1232

6148

1.17

5.27

1.3

136.48

153.39

u/ml

0.79

524

2346

Other disorders of the musculoskeletal system and connective tissue

483

3901

1.26

5.27

1.2

103.48

135.63

u/ml

1.46

194

1450

Varicella [chickenpox]

166

1150

1.48

5.25

1.2

1.3

156.31

138.42

u/ml

0.27

426

Vertigo of central origin

315

1.96

5.23

1.4

1.2

183.84

147.05

u/ml

0.17

117

Other disorders starting during childhood or adolescence

278

2085

1.36

5.22

1.2

1.3

168.61

150.94

u/ml

0.19

739

Urticaria due to cold and heat

284

2.08

5.22

1.5

1.2

88.27

174.03

u/ml

1.06

122

Other and unspecified injuries of wrist and hand

179

1263

1.47

5.21

1.2

130.84

135.97

u/ml

0.07

495

Glaucoma suspect

1143

9956

1.16

5.20

1.2

124.36

136.58

u/ml

0.53

456

3655

Other coagulation defects

322

2488

1.33

5.19

1.3

1.2

187.91

144.40

u/ml

0.83

114

937

Other noninflammatory disorders of cervix uteri

187

1329

1.45

5.18

1.2

160.74

160.42

u/ml

0.00

531

Sacroiliitis, not elsewhere classified

237

1756

1.39

5.17

1.3

1.2

95.43

149.37

u/ml

1.72

674

Bacterial infection, other or unspecified

1804

13627

1.12

5.17

1.2

109.18

137.58

u/ml

2.33

557

5070

Polyglandular dysfunction

3.62

5.15

1.3

406.60

62.62

u/ml

—

Nasal polyp

563

4629

1.23

5.14

1.2

134.81

136.86

u/ml

0.04

214

1684

Cerebral palsy and other paralytic syndromes

391

3094

1.29

5.13

1.2

152.67

144.23

u/ml

0.12

130

1129

Effects of foreign body entering through natural orifice

823

7008

1.19

5.13

1.2

115.95

135.31

u/ml

0.85

307

2524

Down's syndrome

114

2.84

5.12

1.4

1.3

301.80

148.23

u/ml

0.62

Pre-eclampsia superimposed on chronic hypertension

247

2.21

5.12

1.2

1.3

93.65

157.49

u/ml

1.08

114

Implicit fungal Sepsis

139

935

1.53

5.11

1.3

1.2

86.68

143.01

u/ml

1.30

355

Superficial injury of thorax

523

4275

1.24

5.10

1.2

114.18

138.21

u/ml

0.75

179

1577

Maternal care related to the fetus and amniotic cavity and possible delivery problems

2682

14376

1.11

5.10

1.3

1.2

147.90

147.30

u/ml

0.03

1098

5748

Macular pucker

411

3269

1.27

5.10

1.2

113.83

128.49

u/ml

0.37

122

1123

Substance abuse, excluding more controls

2081

15704

1.11

5.09

1.2

115.19

145.34

u/ml

2.93

638

6241

Achilles tendinitis

355

2778

1.30

5.09

1.2

80.14

148.54

u/ml

5.02

119

1066

Senile cataract

1942

10598

1.12

5.09

1.2

124.82

140.44

u/ml

0.98

678

4014

Bursitis of shoulder

101

635

1.65

5.07

1.2

253.48

141.19

u/ml

0.79

242

Renal cell carcinoma of kidney

486

1.73

5.06

1.3

1.2

111.85

117.68

u/ml

0.06

196

Abnormal findings on antenatal screening of mother

579

4819

1.23

5.03

1.3

103.68

147.33

u/ml

2.74

278

1920

Gout, strict definition

367

2881

1.29

5.02

1.2

102.34

115.92

u/ml

0.22

945

Papillary adenocarcinoma of thyroid gland

219

1610

1.40

5.01

1.2

177.59

143.58

u/ml

0.49

643

Hypertrophy of (infrapatellar) fat pad

251

2.09

5.01

1.1

1.3

81.25

148.78

u/ml

1.06

108

Postmenopausal osteoporosis with pathological fracture

200

1444

1.42

5.01

1.2

94.77

126.70

u/ml

0.89

512

Faecal incontinence

330

2566

1.31

5.01

1.2

111.34

137.12

u/ml

0.59

117

975

Superficial injury of ankle and foot

590

4904

1.22

4.98

1.3

1.2

110.74

146.19

u/ml

1.90

216

1829

Myocarditis

160

1111

1.47

4.96

1.2

153.06

134.08

u/ml

0.21

424

Vitamin deficiency, wide

179

1272

1.45

4.96

1.3

1.2

273.96

137.92

u/ml

1.10

498

Vitamin deficiency

179

1272

1.45

4.96

1.3

1.2

273.96

137.92

u/ml

1.10

498

Localized skin eruption due to drugs and medicaments

331

1.94

4.95

1.5

1.3

118.30

155.34

u/ml

0.24

142

Use of anticholinesterases

538

5046

0.82

4.94

1.1

1.2

84.12

119.57

u/ml

1.43

170

1598

N06DA Anticholinesterases

538

5046

0.82

4.94

1.1

1.2

84.12

119.57

u/ml

1.43

170

1598

Specific development disorders of scholastic skills

230

1675

1.39

4.94

1.4

1.3

58.86

156.47

u/ml

5.46

606

Stenosis and insufficiency of lacrimal passages

333

2599

1.31

4.92

1.3

1.2

99.93

144.27

u/ml

1.62

128

964

Congenital malformations of the circulatory system

557

4471

1.23

4.91

1.3

1.2

110.61

147.96

u/ml

1.72

196

1617

Other specified/unspecified inflammatory spondylopathies

215

1582

1.40

4.90

1.3

1.2

68.52

139.65

u/ml

3.11

613

Non-small cell lung cancer, adenocarcinoma

158

1096

1.47

4.90

1.1

1.2

168.30

117.32

u/ml

0.46

397

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1327

11746

1.14

4.89

1.2

148.12

142.77

u/ml

0.17

465

4572

Renal failure

1251

9364

1.14

4.88

1.2

106.65

130.41

u/ml

0.80

369

3286

Other and unspecified coagulation defects

230

1714

1.38

4.86

1.3

1.2

203.62

145.72

u/ml

0.89

670

Acute nasopharyngitis (common cold)

378

2974

1.28

4.84

1.3

1.2

131.05

141.55

u/ml

0.22

144

1137

Embedded and impacted teeth

1607

11680

1.13

4.83

1.3

120.09

142.17

u/ml

1.52

629

4404

STROKE

2035

12379

1.11

4.83

1.2

124.16

146.21

u/ml

1.63

751

4712

Enterocolitis due to Clostridium difficile

309

2391

1.31

4.82

1.2

87.80

137.32

u/ml

2.22

121

879

Pericarditis

109

704

1.59

4.82

1.3

1.2

132.44

131.74

u/ml

0.01

268

Autoimmune polyglandular failure

5.12

4.81

1.4

1.3

406.60

62.87

u/ml

—

Open bite

298

2312

1.33

4.80

1.3

100.72

150.06

u/ml

1.55

124

861

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

285

2189

1.33

4.80

1.2

185.63

141.55

u/ml

0.62

820

Cardiomyopathy

434

3495

1.25

4.79

1.2

127.28

128.26

u/ml

0.02

131

1231

Other specified/unspecified dorsopathies

131

884

1.53

4.79

1.2

86.24

151.49

u/ml

1.44

333

Thoracic aortic aneurysm

319

2479

1.30

4.78

1.1

1.2

139.89

117.43

u/ml

0.40

104

811

Other diseases of blood and blood-forming organs

215

1584

1.39

4.77

1.3

1.2

143.95

136.05

u/ml

0.10

585

Fungal Sepsis

144

990

1.49

4.77

1.3

1.2

86.68

142.51

u/ml

1.29

380

Dermatitis due to ingested food

192

1335

1.43

4.76

1.3

135.71

126.40

u/ml

0.10

446

Melanocytic naevi of lower limb, including hip

194

1412

1.42

4.76

1.3

1.2

95.15

143.22

u/ml

1.76

546

Periodontal disease, other/unspecified

115

758

1.58

4.75

1.3

1.2

131.58

147.89

u/ml

0.19

291

Acute and subacute iridocyclitis

683

5771

1.20

4.74

1.2

125.99

143.69

u/ml

0.53

252

2195

Postpartum hemorraghe, parous women as controls

1662

12504

1.13

4.74

1.3

134.31

150.11

u/ml

0.93

635

5177

Autism

153

1072

1.49

4.74

1.3

1.2

77.85

145.00

u/ml

1.52

392

Benign neoplasm: Adrenal gland

250

1888

1.35

4.73

1.2

168.04

147.54

u/ml

0.26

697

Symptoms and signs involving emotional state

146

1013

1.50

4.72

1.3

1.2

115.11

141.88

u/ml

0.29

412

Mechanical strabismus

3.27

4.72

1.6

1.3

208.89

139.62

u/ml

—

Other bursopathies

401

3214

1.26

4.71

1.2

132.49

132.41

u/ml

0.00

150

1218

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

143

990

1.50

4.70

1.3

1.2

195.36

154.31

u/ml

0.19

393

Type 2 diabetes, wide definition

2883

16714

1.09

4.67

1.2

129.64

142.21

u/ml

0.85

966

6450

Varicose veins of other sites

189

1368

1.41

4.67

1.2

147.39

137.40

u/ml

0.10

492

Encephalitis

118

785

1.56

4.66

1.3

1.2

160.84

151.35

u/ml

0.08

318

Suppurative and unspecified otitis media

1872

14995

1.12

4.66

1.3

152.70

138.91

u/ml

0.61

718

5680

Retention of urine

865

6008

1.17

4.65

1.2

128.72

126.32

u/ml

0.05

304

2103

Otitis media, unspecified

562

4309

1.22

4.65

1.3

118.17

133.58

u/ml

0.44

212

1579

Palmar fascial fibromatosis [Dupuytren]

315

2452

1.30

4.64

1.1

1.2

85.77

115.66

u/ml

0.94

845

Periapical abscess

1818

16428

1.11

4.63

1.2

155.58

138.54

u/ml

0.99

682

6259

Liquid cancers, including Hilmo

1066

8212

1.15

4.61

1.2

108.99

133.41

u/ml

1.37

321

3076

Heart failure, not strict

2464

15137

1.10

4.60

1.2

105.56

141.80

u/ml

5.05

848

5657

Other disorders of pigmentation

169

1208

1.44

4.58

1.2

133.82

136.34

u/ml

0.03

465

Benign leiomyoma with endometriosis

613

5156

1.21

4.57

1.2

133.35

149.57

u/ml

0.45

219

1998

Anterior Iridocyclitis

721

6141

1.19

4.57

1.2

121.77

143.55

u/ml

0.76

268

2318

Unspecified acute lower respiratory infection

510

4209

1.23

4.56

1.2

124.95

141.82

u/ml

0.47

200

1558

Non-small cell lung cancer, adenocarcinoma, helper endpoint

158

1112

1.45

4.56

1.1

1.2

168.30

136.42

u/ml

0.25

385

680

4932

1.19

4.56

1.1

1.2

107.55

121.91

u/ml

0.43

221

1606

Abnormal findings on diagnostic imaging of central nervous system

209

1550

1.39

4.55

1.3

1.2

144.11

146.10

u/ml

0.02

602

Exophthalmic conditions

253

2.02

4.53

1.5

1.2

223.31

152.55

u/ml

0.36

106

Other viral diseases, not elsewhere classified

752

6413

1.18

4.53

1.3

1.2

117.69

143.59

u/ml

1.23

291

2390

Astigmatism

267

2050

1.33

4.52

1.3

1.2

114.89

145.23

u/ml

0.82

739

Cervical polyps

401

3239

1.26

4.52

1.2

136.05

160.33

u/ml

0.63

162

1301

Chronic pancreatitis

324

2545

1.29

4.52

1.2

120.13

133.10

u/ml

0.25

103

915

Pediculosis, acariasis and other infestations

224

1679

1.37

4.51

1.3

1.2

93.17

137.85

u/ml

1.61

628

Melanocytic naevi of other and unspecified parts of face

254

1942

1.34

4.51

1.4

1.2

108.51

143.45

u/ml

1.06

110

742

Benign neoplasm: Tonsil

282

1.95

4.50

1.3

74.95

149.95

u/ml

1.29

116

Phlebitis and thrombophlebitis (not including DVT)

780

6694

1.18

4.49

1.2

122.76

142.84

u/ml

0.83

265

2542

Speech and linguistic disorders

410

3184

1.26

4.48

1.4

1.3

82.13

145.85

u/ml

3.94

115

1141

Other predominantly sexually transmitted diseases, not elsewhere classified

910

7922

1.17

4.47

1.3

1.2

161.65

140.27

u/ml

0.78

316

3135

Procedures for purposes other than remedying health state

115

771

1.56

4.46

1.2

126.70

144.94

u/ml

0.16

309

Bruxism

108

718

1.59

4.45

1.2

1.3

110.26

147.02

u/ml

0.44

304

Fracture of rib(s), sternum and thoracic spine

878

7602

1.16

4.43

1.2

116.22

134.97

u/ml

0.68

289

2751

Ectopic pregnancy

885

7697

1.17

4.42

1.3

1.2

130.15

151.85

u/ml

0.98

341

3153

Disorder of the sleep-wake schedule

589

1.64

4.42

1.4

1.2

70.26

139.06

u/ml

1.80

220

Recurrent dislocation of patella

290

2268

1.32

4.42

1.3

1.2

135.50

145.66

u/ml

0.19

119

856

Budesonide

570

4777

1.21

4.40

1.2

98.89

149.05

u/ml

2.68

180

1816

Orchitis and epididymitis

168

1201

1.41

4.39

1.2

65.54

115.19

u/ml

2.20

379

Small fibre neuropathy

626

1.60

4.38

1.4

1.2

148.85

138.82

u/ml

0.10

242

Left bundle-branch block

205

1519

1.37

4.38

1.1

1.2

93.88

137.73

u/ml

1.31

520

Maternal care for known or suspected malpresentation of fetus

1287

8173

1.14

4.37

1.3

146.53

148.12

u/ml

0.05

493

3239

Malignant neoplasm of bladder, including Hilmo

209

1529

1.36

4.36

1.2

106.58

106.04

u/ml

0.01

544

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

4053

22127

1.08

4.36

1.2

125.86

145.38

u/ml

2.43

1417

8597

4053

22127

1.08

4.36

1.2

125.86

145.38

u/ml

2.43

1417

8597

Alcohol abuse, main dg, excluding more controls

485

4003

1.23

4.36

1.2

99.39

147.12

u/ml

2.45

154

1548

Autoimmune hepatitis

187

2.15

4.33

1.3

1.2

213.39

88.64

u/ml

0.80

Other diseases of peritoneum

164

1180

1.43

4.31

1.2

120.77

133.87

u/ml

0.15

452

Aplastic and other anaemias

1368

11165

1.13

4.31

1.2

134.18

131.39

u/ml

0.07

434

4037

Purpura and other haemorrhagic conditions

451

3702

1.24

4.31

1.3

1.2

132.54

141.04

u/ml

0.17

162

1330

Other neurotic disorders

151

1070

1.44

4.28

1.3

1.2

94.40

144.48

u/ml

1.06

400

Nail disorders

319

2526

1.29

4.28

1.2

115.57

148.94

u/ml

0.95

119

920

Gonarthrosis [arthrosis of knee](FG)

2750

14573

1.09

4.27

1.2

131.54

143.08

u/ml

0.80

1031

5709

Muscular dystrophy

182

2.18

4.26

1.4

1.2

97.08

163.21

u/ml

0.63

Necrobiosis lipoidica, not elsewhere classified

198

2.18

4.26

1.3

123.29

135.24

u/ml

0.12

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

192

1422

1.39

4.24

1.2

143.85

142.59

u/ml

0.01

562

Congenital malformations of genital organs

512

4252

1.22

4.23

1.3

121.13

149.92

u/ml

1.08

207

1672

Pure hyperglyceridaemia

420

1.72

4.23

1.2

42.66

133.02

u/ml

5.07

169

Malignant neoplasm of renal pelvis, including Hilmo

128

2.35

4.22

1.1

1.3

81.29

117.50

u/ml

—

Disorders of iron metabolism

369

1.78

4.22

1.2

201.67

148.92

u/ml

0.30

158

Gout

610

4412

1.19

4.21

1.2

105.78

127.94

u/ml

0.67

165

1479

Eosinophilia

385

1.77

4.21

1.3

1.2

89.40

155.90

u/ml

0.96

146

Implicit bacterial Sepsis

1185

8995

1.14

4.20

1.2

93.52

134.55

u/ml

4.36

341

3245

Psoriatic and enteropathic arthropathies

427

3498

1.24

4.20

1.2

99.13

137.88

u/ml

1.58

163

1364

Presence of other devices

685

5751

1.18

4.20

1.2

136.24

139.93

u/ml

0.07

256

2074

Spermatocele

127

871

1.48

4.19

1.1

1.2

72.27

106.55

u/ml

0.88

277

Erosion and ectropion of cervix uteri

113

764

1.53

4.19

1.2

149.68

143.08

u/ml

0.05

304

Melanoma in situ of trunk

266

1.92

4.19

1.3

1.2

77.40

150.78

u/ml

1.30

105

Scar conditions and fibrosis of skin

189

1402

1.39

4.18

1.2

141.59

144.75

u/ml

0.04

553

Pervasive developmental disorders excl. Autism + Asperger

412

1.75

4.18

1.4

1.3

135.80

134.22

u/ml

0.01

139

Other benign neoplasms of skin

1321

11805

1.13

4.17

1.2

139.87

139.12

u/ml

0.02

467

4471

Other endocrine disorders

219

1588

1.36

4.17

1.4

1.3

114.10

153.91

u/ml

0.71

572

Malignant neoplasm of oropharynx, including Hilmo

2.96

4.17

1.2

1.3

108.69

95.66

u/ml

—

Any event in hilmo or specialist outpatient

3.27

4.15

1.3

1.1

54.50

156.97

u/ml

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

2984

20383

1.09

4.15

1.3

1.2

155.12

147.51

u/ml

0.41

1165

8136

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

520

1.66

4.14

1.1

1.3

34.27

144.15

u/ml

6.78

200

Familial hypercholesterolemia

351

2814

1.26

4.13

1.2

112.75

116.44

u/ml

0.07

141

962

Other congenital malformations, including avohilmo

591

5004

1.20

4.13

1.3

1.2

148.70

141.31

u/ml

0.10

210

1884

Cardiomyopathy, other and unspecified

202

1509

1.36

4.12

1.1

1.2

181.71

132.88

u/ml

0.60

540

Nondiabetic hypoglycaemic coma

2.77

4.11

1.2

1.3

186.44

131.64

u/ml

0.24

Need for other prophylactic measures

192

1428

1.37

4.10

1.3

1.2

129.71

139.84

u/ml

0.14

536

Deep bite

516

3790

1.22

4.09

1.3

110.92

143.04

u/ml

1.47

187

1365

Retinal breaks without detachment

508

4242

1.21

4.08

1.2

136.22

140.16

u/ml

0.08

175

1625

Mental and behavioural disorders due to opioids

160

1159

1.42

4.08

1.2

78.68

129.71

u/ml

1.70

465

Other diseases of oesophagus

254

1962

1.31

4.08

1.3

1.2

86.97

145.29

u/ml

1.95

707

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

284

2233

1.30

4.08

1.3

1.2

85.81

143.87

u/ml

1.91

864

Exposure to other and unspecified inanimate mechanical forces

287

2259

1.29

4.07

1.2

124.52

138.51

u/ml

0.26

842

Outcome of delivery

1045

5658

1.15

4.07

1.2

1.3

211.40

152.84

u/ml

2.17

379

2280

Arthropathies in other diseases classified elsewhere

126

874

1.48

4.06

1.3

1.2

134.52

152.78

u/ml

0.25

324

Endometriosis of intestine

100

668

1.58

4.06

1.3

141.53

154.02

u/ml

0.10

275

Other encephalitis

109

737

1.53

4.04

1.3

1.2

169.27

148.53

u/ml

0.17

296

115

788

1.52

4.04

1.2

68.75

149.43

u/ml

3.05

320

Hyperkinetic disorders (excl. ADHD)

641

1.57

4.02

1.4

1.3

123.53

142.78

u/ml

0.13

232

Dermatophytosis

420

3449

1.23

4.02

1.2

123.61

131.56

u/ml

0.18

171

1254

Visual impairment including blindness (binocular or monocular)

203

1525

1.35

4.01

1.1

1.2

121.62

140.89

u/ml

0.27

563

Chalazion

428

3526

1.23

4.01

1.3

1.2

172.88

144.86

u/ml

0.56

152

1300

Other and unspecified disorders of skin and subcutaneous tissue

217

1650

1.34

4.00

1.3

1.2

97.30

145.40

u/ml

1.31

630

Other and unspecified trigeminal disorders

422

1.71

4.00

1.3

103.67

140.35

u/ml

0.51

178

Nail dystrophy

133

2.34

3.99

1.2

265.83

130.57

u/ml

0.77

Preterm labour and delivery

1282

11491

1.13

3.99

1.3

1.2

139.15

151.37

u/ml

0.60

536

4603

Giant cell arteritis

114

777

1.50

3.99

1.1

1.2

150.28

122.27

u/ml

0.27

281

Aortic aneurysm

457

3704

1.22

3.98

1.1

1.2

119.19

115.27

u/ml

0.07

145

1197

Psoriasis vulgaris

626

5338

1.19

3.97

1.2

109.80

142.95

u/ml

1.72

221

2005

Motor disorders, excluding more controls

359

1.75

3.97

1.7

1.3

137.80

148.76

u/ml

0.06

122

Other disorders of kidney and ureter

366

2968

1.25

3.95

1.3

1.2

110.06

133.58

u/ml

0.73

141

1066

Personal history of risk-factors, not elsewhere classified

440

1.70

3.94

1.3

61.53

143.89

u/ml

2.47

171

Abnormality of white blood cells, not elsewhere classified

216

2.02

3.93

1.2

1.3

191.52

172.28

u/ml

0.08

All influenza (not pneumonia)

498

4166

1.21

3.93

1.3

1.2

119.38

135.92

u/ml

0.42

199

1530

Autism spe

146

1053

1.44

3.93

1.3

79.21

144.62

u/ml

1.42

385

Granulomatous disorders of skin and subcutaneous tissue

120

834

1.49

3.93

1.3

1.2

122.11

140.59

u/ml

0.31

322

Labour and delivery complicated by fetal stress [distress]

1656

9779

1.12

3.92

1.3

151.26

150.01

u/ml

0.04

661

3926

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

118

812

1.48

3.91

1.2

56.06

127.23

u/ml

2.05

312

Mixed disorders of conduct and emotions, excluding more controls

114

785

1.51

3.91

1.3

1.2

142.31

147.55

u/ml

0.04

295

Alzheimer’s disease (Late onset)

308

3179

0.79

3.91

1.1

76.04

122.58

u/ml

1.61

1017

Non-small cell lung cancer, including Hilmo

343

2589

1.25

3.89

1.2

120.74

119.98

u/ml

0.01

930

Cicatricial alopecia [scarring hair loss]

210

2.03

3.89

1.2

123.88

153.26

u/ml

0.17

Other symptoms and signs involving general sensations and perceptions

144

1032

1.43

3.89

1.3

1.2

101.00

138.08

u/ml

0.51

401

Benign neoplasm: Transverse colon

286

2260

1.28

3.88

1.2

85.24

136.47

u/ml

2.52

112

776

Other noninfective disorders of lymphatic vessels and lymph nodes

137

975

1.45

3.88

1.3

1.2

102.62

149.66

u/ml

0.96

377

Oral lichen planus

106

720

1.53

3.88

1.2

85.69

134.38

u/ml

1.18

281

Fentanyl

255

1980

1.30

3.87

1.2

93.67

129.82

u/ml

0.87

730

Scleritis and episcleritis

258

2022

1.31

3.86

1.3

1.2

91.36

143.24

u/ml

1.76

771

Diastasis of muscle

291

1.87

3.86

1.3

120.49

182.60

u/ml

0.62

120

Zoster [herpes zoster]

579

4917

1.19

3.85

1.2

121.93

135.74

u/ml

0.40

197

1779

Maternal care for known or suspected fetal abnormality and damage

1058

7967

1.14

3.84

1.3

174.94

149.15

u/ml

0.92

353

3191

Speech disturbances, not elsewhere classified

257

2009

1.30

3.82

1.2

101.65

137.13

u/ml

0.78

737

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

387

1.71

3.81

1.1

1.2

91.13

143.67

u/ml

1.12

161

Hodgkin lymphoma, hilmo

105

714

1.52

3.80

1.2

85.30

133.36

u/ml

0.64

287

Hydronephrosis

346

2802

1.25

3.80

1.2

136.28

132.04

u/ml

0.06

120

1027

Other necrotizing vasculopathies

206

1567

1.34

3.78

1.2

138.10

141.48

u/ml

0.04

576

Inflammatory diseases of the central nervous system

289

2299

1.28

3.77

1.2

131.37

151.08

u/ml

0.34

104

848

Follow-up care involving plastic surgery

164

1211

1.39

3.77

1.2

161.37

148.26

u/ml

0.14

481

Follicular adenocarcinoma of thyroid gland

150

2.22

3.77

1.2

1.3

56.21

117.71

u/ml

0.90

Contracture of muscle

111

2.47

3.77

1.2

202.00

144.89

u/ml

—

Bronchiectasis

208

1585

1.33

3.75

1.2

78.31

128.08

u/ml

2.00

555

Diabetic retinopathy, excluding more controls

934

4586

1.15

3.73

1.2

131.83

131.87

u/ml

0.00

353

1628

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

4548

27099

1.06

3.73

1.2

129.35

142.62

u/ml

1.50

1635

10433

Other abnormal findings of blood chemistry

170

1262

1.38

3.73

1.4

1.2

101.39

148.57

u/ml

1.45

496

Scoliosis

380

3123

1.24

3.73

1.2

97.58

150.89

u/ml

2.61

122

1139

Squamous cell neoplasms and carcinomas of the skin

198

1495

1.34

3.73

1.1

1.2

152.66

99.57

u/ml

0.66

542

Medical abortion

3504

17753

1.08

3.71

1.2

154.96

144.83

u/ml

0.58

1289

7065

Viral meningitis

160

1181

1.40

3.71

1.3

1.2

77.63

145.82

u/ml

2.80

468

Psoriatic arthropathies

352

2867

1.25

3.71

1.2

112.93

144.58

u/ml

0.88

133

1084

Episcleritis

226

1752

1.32

3.71

1.3

1.2

95.29

142.78

u/ml

1.28

670

Rheumatoid arthritis

1156

9137

1.13

3.70

1.2

116.29

147.05

u/ml

2.14

447

3524

Angina pectoris

1577

9471

1.11

3.69

1.2

118.61

137.46

u/ml

1.09

580

3371

Other necrotizing vasculopathies (FG)

172

1279

1.37

3.69

1.3

1.2

137.07

130.05

u/ml

0.08

479

Spinal osteochondrosis

213

1.97

3.68

1.2

1.3

285.41

133.26

u/ml

0.87

Conduction disorders

831

5815

1.15

3.68

1.2

93.32

139.09

u/ml

4.00

276

2062

DVT of lower extremities

552

4689

1.19

3.67

1.2

95.79

135.06

u/ml

2.19

189

1732

Other and unspecified diseases of blood and blood-forming organs

597

1.56

3.67

1.3

1.2

195.42

143.46

u/ml

0.52

240

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

249

1924

1.29

3.67

1.1

1.2

145.16

106.21

u/ml

0.57

683

Other and unspecified injuries of ankle and foot

198

1511

1.35

3.66

1.3

1.2

83.96

138.65

u/ml

2.87

581

Scabies

182

1370

1.36

3.66

1.2

93.50

135.85

u/ml

1.23

519

Presbycusis

270

2104

1.28

3.65

1.1

104.78

126.43

u/ml

0.38

660

Gastric ulcer

426

3535

1.22

3.65

1.2

63.71

129.64

u/ml

7.31

144

1228

Gout, unspecified

416

3444

1.22

3.64

1.2

107.45

113.93

u/ml

0.10

100

1158

Impacted teeth

1210

9324

1.13

3.64

1.3

115.93

141.16

u/ml

1.53

477

3488

Other puerperal infections

513

4363

1.20

3.63

1.3

130.02

148.42

u/ml

0.57

197

1737

Superficial injury of head

876

7699

1.15

3.63

1.2

122.54

142.56

u/ml

0.80

293

2838

Chronic conjunctivitis

122

863

1.46

3.63

1.3

1.2

93.56

123.68

u/ml

0.55

343

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

301

1.78

3.63

1.3

1.2

318.04

128.09

u/ml

1.28

115

Non-rheumatic valve diseases

1403

9024

1.11

3.63

1.2

123.99

137.99

u/ml

0.71

485

3289

Dystonia

214

1652

1.33

3.62

1.4

1.2

91.88

145.41

u/ml

2.23

643

Other juvenile arthritis

203

1560

1.34

3.61

1.3

1.2

128.23

142.30

u/ml

0.18

575

Ménière disease

292

2339

1.27

3.60

1.2

124.88

144.59

u/ml

0.35

118

853

Other and unspecified injuries of shoulder and upper arm

125

889

1.45

3.59

1.2

180.21

134.42

u/ml

0.46

363

Valvular heart disease excluding rheumatic fever

1412

9098

1.11

3.58

1.2

123.07

138.21

u/ml

0.80

489

3305

L02BA Anti-estrogens

501

5901

0.84

3.58

1.2

150.38

144.30

u/ml

0.14

204

2354

Lactose intolerance

133

958

1.43

3.58

1.4

1.2

126.94

138.24

u/ml

0.14

379

Causalgia

475

1.63

3.58

1.1

1.3

60.23

145.20

u/ml

3.10

211

Unspecified urinary incontinence

314

2540

1.26

3.57

1.2

168.00

135.06

u/ml

0.43

963

Other protozoal intestinal diseases, including avohilmo

106

735

1.50

3.56

1.2

157.66

149.22

u/ml

0.07

306

Postinfectious hypothyroidism

2.50

3.55

1.4

1.2

106.10

78.94

u/ml

0.17

Iron deficiency anaemia secondary to blood loss (chronic)

479

4034

1.20

3.55

1.2

133.24

135.26

u/ml

0.04

161

1483

Lichen simplex chronicus

118

832

1.46

3.55

1.2

111.20

140.84

u/ml

0.44

312

Benign neoplasm: Ascending colon

376

3096

1.23

3.55

1.2

106.30

134.24

u/ml

0.78

139

1102

Seborrhoeic keratosis

771

6739

1.15

3.54

1.2

95.78

138.09

u/ml

3.55

318

2455

Other melanin hyperpigmentation

482

1.61

3.54

1.3

1.2

76.03

136.98

u/ml

1.40

191

Diabetic retinopathy

1074

5928

1.13

3.53

1.2

135.04

130.13

u/ml

0.11

399

2091

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1207

10850

1.12

3.53

1.2

140.47

136.51

u/ml

0.09

471

4050

Other infectious diseases

221

1715

1.31

3.52

1.3

1.2

116.52

133.26

u/ml

0.29

634

Event of undetermined intent

244

1922

1.29

3.51

1.2

104.85

144.66

u/ml

1.15

732

Fracture of skull and facial bones

739

6446

1.16

3.51

1.2

118.97

139.95

u/ml

0.90

273

2377

Acute renal failure

531

4512

1.19

3.51

1.1

1.2

82.61

120.59

u/ml

2.40

146

1546

Type of accident

1114

9974

1.13

3.51

1.2

143.55

137.21

u/ml

0.15

437

3741

Temporal arteritis

652

1.51

3.47

1.1

1.2

147.74

125.95

u/ml

0.18

226

Gout, FINNGEN

610

5208

1.17

3.47

1.2

105.78

116.95

u/ml

0.29

165

1766

Gout, idiopatic and unspecified

517

4387

1.19

3.46

1.2

104.61

116.19

u/ml

0.25

130

1448

Male infertility

106

733

1.47

3.46

1.2

121.07

139.02

u/ml

0.20

255

340

1.75

3.45

1.2

1.3

41.15

153.43

u/ml

3.86

126

Ulcer of vagina/vulva

148

1096

1.40

3.45

1.3

1.2

185.37

148.74

u/ml

0.38

428

Secondary parkinsonism, excluding more controls

389

1.66

3.45

1.2

117.32

138.16

u/ml

0.17

140

Spinal instabilities

106

738

1.48

3.44

1.3

1.2

111.97

138.48

u/ml

0.30

283

Somnolence

370

1.71

3.44

1.6

1.3

55.85

149.64

u/ml

2.35

150

Fracture of lumbar spine and pelvis

645

5564

1.17

3.43

1.2

152.75

127.30

u/ml

0.70

209

1972

Varicose veins

2157

15035

1.09

3.42

1.2

134.64

141.01

u/ml

0.32

852

5755

Hernia of abdominal wall

1509

13738

1.10

3.42

1.2

103.55

136.41

u/ml

3.54

531

5147

Monoarthritis, not elsewhere classified

155

1152

1.38

3.41

1.2

131.61

146.86

u/ml

0.20

421

Follow-up examination after treatment for malignant neoplasms

279

2235

1.26

3.41

1.2

147.60

142.54

u/ml

0.08

100

853

Paralytic ileus and intestinal obstruction

728

6347

1.15

3.41

1.2

136.64

135.35

u/ml

0.03

232

2359

Tic disorders

418

1.66

3.41

1.2

1.3

144.36

138.33

u/ml

0.04

137

Postpartum hemorraghe, all women as controls

1662

14865

1.10

3.40

1.3

134.31

149.07

u/ml

0.85

635

5975

Erythema nodosum

122

875

1.44

3.40

1.3

1.2

196.93

143.85

u/ml

0.65

351

Hemiplegia

167

1255

1.36

3.39

1.2

181.97

144.29

u/ml

0.35

485

Anogenital herpesviral [herpes simplex] infection

347

2863

1.24

3.39

1.3

179.62

149.07

u/ml

0.56

116

1156

Examination and encounter for administrative purposes

216

1679

1.30

3.39

1.2

122.82

132.56

u/ml

0.13

614

Complications of other internal prosthetic devices, implants and grafts

135

982

1.41

3.39

1.2

220.13

142.14

u/ml

1.12

374

Acute suppurative otitis media

1399

11844

1.11

3.38

1.3

157.34

139.76

u/ml

0.64

528

4482

Myositis

560

1.54

3.37

1.3

1.2

115.99

147.99

u/ml

0.23

210

Melanocytic naevi of trunk

474

4016

1.20

3.36

1.3

1.2

132.79

149.41

u/ml

0.40

167

1510

Other appendicitis

310

2523

1.25

3.36

1.2

132.00

146.49

u/ml

0.25

102

977

Problems related to social environment

112

791

1.46

3.36

1.2

120.39

135.82

u/ml

0.21

305

Other and unspecified disorders of white blood cells

132

959

1.41

3.36

1.3

1.2

44.44

146.60

u/ml

6.37

384

Conduct disorder

107

753

1.48

3.35

1.3

128.31

153.95

u/ml

0.23

271

Childhood allergy (age < 16)

920

6745

1.14

3.33

1.4

1.3

138.06

138.09

u/ml

0.00

330

2494

Testicular dysfunction, other/unspecified

2.58

3.32

1.3

1.2

33.02

134.57

u/ml

—

Additional codes for the location of defect, injury or illness

209

1628

1.31

3.31

1.3

1.2

252.03

146.19

u/ml

0.71

629

ILD, hospital admission 2, with pulmonary infections

231

1816

1.29

3.31

1.2

120.73

127.70

u/ml

0.10

656

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

460

3892

1.20

3.31

1.2

169.65

140.37

u/ml

0.66

166

1471

Cardiomyopathy in other diseases

2.71

3.30

1.2

1.1

72.95

132.50

u/ml

—

Other/unspecified disorders of vestibular function

134

979

1.40

3.29

1.2

104.24

133.06

u/ml

0.27

364

Injuries to the elbow and forearm

3201

25744

1.07

3.29

1.2

129.36

142.13

u/ml

1.08

1168

9741

Previous suicide attempt

368

1.70

3.28

1.3

57.35

154.29

u/ml

2.78

148

Congenital malformations and deformations of the musculoskeletal system

408

3405

1.21

3.28

1.4

1.2

115.58

150.39

u/ml

0.94

155

1241

Localized adiposity

160

2.12

3.28

1.2

116.41

177.40

u/ml

—

Other congenital malformations

389

3251

1.22

3.26

1.3

1.2

125.96

151.73

u/ml

0.67

136

1200

Sequelae of injuries of upper limb

337

2775

1.23

3.26

1.2

155.49

142.15

u/ml

0.18

123

1028

Sequelae of injuries of head

169

1281

1.35

3.26

1.2

113.46

148.97

u/ml

0.55

483

Other abnormalities of plasma proteins

312

1.73

3.25

1.3

1.2

38.57

126.76

u/ml

3.98

126

Immunodeficiency with predominantly antibody defects

110

782

1.46

3.25

1.7

1.2

59.35

149.63

u/ml

4.69

310

Viral meningitis, including avohilmo

165

1252

1.36

3.24

1.3

1.2

75.82

143.47

u/ml

2.93

493

Obstructed labour due to malposition and malpresentation of fetus

1360

11467

1.11

3.24

1.2

1.3

153.51

153.30

u/ml

0.01

552

4672

Arthropathic psoriasis

381

3177

1.22

3.23

1.2

103.44

142.07

u/ml

1.31

142

1202

Vitamin D deficiency

576

1.53

3.23

1.4

1.2

390.40

143.52

u/ml

0.72

243

Malignant neoplasm of hypopharynx, including Hilmo

2.52

3.22

1.1

1.2

72.97

96.18

u/ml

—

Mixed hyperlipidaemia

104

729

1.45

3.21

1.2

47.72

142.67

u/ml

5.21

258

Fracture at wrist and hand level

1312

11871

1.11

3.20

1.2

158.86

135.99

u/ml

0.80

454

4499

Sequelae of other external causes

196

1521

1.31

3.20

1.3

1.2

106.63

141.61

u/ml

0.85

579

Diffuse brain injury

109

772

1.44

3.19

1.2

88.54

148.30

u/ml

1.69

280

Foreign body in alimentary tract

179

1373

1.33

3.19

1.2

138.35

144.98

u/ml

0.07

517

Giant cell arteritis with polymyalgia rheumatica

665

1.48

3.18

1.1

1.2

147.74

127.64

u/ml

0.17

231

Other congenital malformations of nervous system

389

1.67

3.16

1.3

121.84

153.34

u/ml

0.38

155

Arnold-Chiari syndrome

358

1.70

3.15

1.3

121.84

147.36

u/ml

0.29

143

Acute inflammation of orbit

154

2.07

3.15

1.1

1.2

28.34

131.41

u/ml

—

Benign neoplasm: Central nervous system, other parts/unspecified

2.56

3.15

1.2

1.1

25.87

124.92

u/ml

—

Maxillary hypoplasia

101

2.42

3.15

1.3

1.5

54.16

122.93

u/ml

1.55

Retinal vascular occlusion

272

2195

1.25

3.14

1.2

85.10

123.83

u/ml

1.55

102

744

Other medical care

1629

12526

1.10

3.14

1.2

123.87

134.52

u/ml

0.50

502

4778

Myasthenia gravis

386

1.64

3.13

1.2

1.3

151.54

141.70

u/ml

0.05

150

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

127

929

1.40

3.13

1.2

118.24

134.88

u/ml

0.22

358

Phantom limb syndrome

3.02

3.13

1.3

1.0

18.12

186.13

u/ml

—

Acute gastritis

209

1638

1.29

3.13

1.2

107.98

149.83

u/ml

0.72

593

Other mental disorders due to brain damage and dysfunction and to physical disease

291

2368

1.24

3.12

1.1

1.2

80.41

125.53

u/ml

1.46

108

815

Pilonidal cyst

325

2681

1.23

3.12

1.3

1.2

133.93

146.74

u/ml

0.24

125

989

Antepartum haemorrhage, not elsewhere classified

527

4552

1.18

3.11

1.3

114.41

149.35

u/ml

1.60

201

1817

Disorders of puberty

550

1.54

3.11

1.4

1.3

136.48

143.88

u/ml

0.07

193

Hypoparathyroidism

128

940

1.40

3.10

1.3

1.2

126.43

144.08

u/ml

0.22

353

Other diseases of arteries and capillaries

271

2193

1.25

3.10

1.3

1.2

117.68

141.58

u/ml

0.46

812

Other benign neoplasms of connective and other soft tissue

339

2810

1.22

3.09

1.3

1.2

108.36

140.69

u/ml

1.11

123

1049

Umbilical hernia

866

7703

1.13

3.09

1.2

102.08

136.09

u/ml

2.30

306

2872

Failed induction of labour

405

3432

1.21

3.08

1.3

132.64

148.09

u/ml

0.34

149

1368

Defect, injury or illness of neck

163

2.04

3.08

1.4

1.2

110.67

110.64

u/ml

—

Follicular adenocarcinoma of thyroid gland, including Hilmo

258

1.79

3.06

1.3

73.80

116.86

u/ml

0.75

117

Presence of cardiac and vascular implants and grafts

1032

6801

1.12

3.05

1.2

96.88

127.54

u/ml

1.98

342

2357

Benign neoplasm: Small intestine

111

797

1.42

3.04

1.1

1.2

105.30

132.93

u/ml

0.38

291

Diabetic neuropathy

286

2320

1.24

3.04

1.3

1.2

163.08

125.42

u/ml

0.71

100

779

Benign neoplasm of bone and articular cartilage

318

2627

1.23

3.03

1.3

1.2

124.44

148.58

u/ml

0.50

120

997

Delirium, not induced by alcohol and other psychoactive substances

268

2163

1.25

3.02

1.1

1.2

76.75

127.12

u/ml

2.11

734

Other prurigo

251

1.79

3.02

1.1

1.3

172.44

155.11

u/ml

0.10

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

647

5499

1.15

3.01

1.3

1.2

105.67

143.32

u/ml

2.12

236

1971

Vertical strabismus

126

928

1.39

3.01

1.3

1.2

156.93

143.35

u/ml

0.16

372

Other respiratory diseases principally affecting the interstitium

420

3553

1.19

3.00

1.2

120.49

127.59

u/ml

0.15

134

1237

ILD-related respiratory insufficiency

484

1.54

3.00

1.2

75.51

150.50

u/ml

2.02

176

Benign neoplasm: Other and unspecified parts of mouth

107

767

1.43

2.99

1.2

165.02

145.69

u/ml

0.19

307

Carrier of infectious disease

108

778

1.43

2.99

1.4

1.2

52.73

136.58

u/ml

5.11

307

Urethral stricture

103

730

1.43

2.98

1.2

108.09

114.30

u/ml

0.08

249

Other local infections of skin and subcutaneous tissue

351

2930

1.21

2.98

1.2

73.18

138.28

u/ml

5.46

131

1079

Habit and impulse disorders

472

1.56

2.98

1.3

159.67

142.46

u/ml

0.12

179

Benign neoplasm: Sigmoid colon

501

4305

1.17

2.97

1.2

98.57

133.09

u/ml

1.55

194

1534

Algoneurodystrophy

147

1113

1.36

2.97

1.4

1.3

91.50

133.49

u/ml

0.90

452

Ulcer of lower limb, not elsewhere classified

341

2834

1.21

2.97

1.2

101.82

125.66

u/ml

0.64

107

991

Pleural plaque

142

1061

1.35

2.96

1.1

64.93

106.75

u/ml

1.33

314

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1601

11521

1.09

2.96

1.2

90.60

136.03

u/ml

6.11

540

4220

Benign neoplasm of eye and adnexa

335

2787

1.22

2.95

1.2

152.50

144.84

u/ml

0.11

120

1013

Presbyopia

288

2364

1.24

2.94

1.2

118.67

153.44

u/ml

1.21

121

936

Atlantoaxial subluxation

144

2.06

2.94

1.1

1.3

130.74

204.87

u/ml

0.35

Shoulder region

314

1.68

2.93

1.2

120.60

155.21

u/ml

0.24

128

Tic and related disorders

459

1.57

2.93

1.2

1.3

144.36

135.01

u/ml

0.07

150

Delayed puberty

255

1.79

2.92

1.2

1.3

179.45

152.90

u/ml

0.16

Benign lipomatous neoplasm of other sites/unspecified

239

1922

1.26

2.91

1.2

134.90

139.16

u/ml

0.06

692

Other surgical follow-up care

138

1037

1.36

2.91

1.3

1.2

113.21

149.03

u/ml

0.72

394

Other and unspecified mononeuropathies of lower limb

671

1.46

2.91

1.2

160.98

137.48

u/ml

0.16

267

Unspecified privation

352

2947

1.21

2.90

1.2

126.46

137.79

u/ml

0.22

1071

Benign neoplasm: Rectosigmoid junction

106

762

1.42

2.89

1.1

1.2

116.69

145.73

u/ml

0.30

278

Unspecified threat to breathing

318

1.70

2.88

1.4

1.3

77.76

160.95

u/ml

0.90

130

Pleural effusion

346

2889

1.21

2.88

1.2

88.33

128.14

u/ml

2.04

113

1000

Status epilepticus

106

763

1.42

2.88

1.3

1.2

147.49

160.26

u/ml

0.13

274

Other acquired deformities of musculoskeletal system and connective tissue

145

1098

1.35

2.87

1.2

92.97

140.47

u/ml

1.43

422

Thrombocytopenia, unspecified

213

1694

1.28

2.87

1.2

147.55

144.66

u/ml

0.04

615

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1054

9525

1.11

2.86

1.2

134.56

135.92

u/ml

0.04

372

3625

Organic, including symptomatic, mental disorders

1112

8641

0.90

2.86

1.2

94.80

126.47

u/ml

2.13

364

2911

Somnolence, stupor and coma

131

977

1.37

2.86

1.4

1.2

71.78

145.49

u/ml

2.40

376

Other spirochaetal diseases, including avohilmo

1283

11713

1.10

2.85

1.2

157.60

139.03

u/ml

0.79

442

4525

Other complications of labour and delivery, not elsewhere classified

840

6667

1.13

2.85

1.3

111.37

148.53

u/ml

2.38

295

2618

Ankylosing spondylitis

282

2316

1.23

2.84

1.2

108.42

143.25

u/ml

0.76

898

Liquid cancers

810

6822

1.13

2.84

1.2

111.35

131.11

u/ml

0.79

250

2535

Chronic iridocyclitis

177

1381

1.31

2.84

1.1

1.2

105.54

137.33

u/ml

0.50

522

Disturbances of smell and taste

149

1136

1.34

2.84

1.2

85.88

145.14

u/ml

2.21

454

Lactose intolerance, other/unspecified

114

836

1.40

2.84

1.4

1.2

129.93

137.22

u/ml

0.08

333

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

309

2564

1.22

2.83

1.2

123.94

144.45

u/ml

0.39

114

975

Pregnancy, childbirth and the puerperium

1403

6695

1.10

2.83

1.2

132.59

143.44

u/ml

0.48

545

2440

Retinal vascular disorders

272

2223

1.24

2.83

1.2

85.10

122.96

u/ml

1.50

102

752

Other and unspecified injuries of head

241

1949

1.25

2.82

1.2

138.59

143.12

u/ml

0.06

725

Other respiratory disorders and diseases

486

4185

1.17

2.81

1.2

98.47

124.98

u/ml

1.10

162

1453

Other diseases of the respiratory system

486

4185

1.17

2.81

1.2

98.47

124.98

u/ml

1.10

162

1453

Effects of other external causes

119

880

1.39

2.81

1.3

72.31

141.22

u/ml

2.10

338

Fracture of lower leg, including ankle

2171

19874

1.08

2.81

1.2

146.35

139.94

u/ml

0.29

769

7514

Malignant neoplasm of skin, including Hilmo

1726

10666

1.09

2.80

1.2

112.92

138.21

u/ml

2.14

552

4153

Adult-onset Still disease

106

2.25

2.79

1.2

41.11

154.29

u/ml

—

Striae atrophicae

401

1.60

2.78

1.2

139.97

157.04

u/ml

0.10

183

Glaucoma

1706

13380

1.09

2.78

1.2

136.86

135.13

u/ml

0.06

624

4869

Other and unspecified nail disorders

628

1.46

2.77

1.2

87.66

142.97

u/ml

1.11

251

Mandibular retrognathia

306

2542

1.22

2.76

1.2

82.58

149.63

u/ml

3.98

117

949

L04AX Other immunosuppressants

2317

21667

1.07

2.75

1.2

121.25

142.14

u/ml

1.89

835

8205

Supervision of normal pregnancy

1335

6969

1.10

2.75

1.3

1.2

155.62

152.08

u/ml

0.10

522

2816

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

397

3386

1.19

2.75

1.2

128.33

146.25

u/ml

0.47

157

1290

Phantom limb syndrome with pain

2.79

2.75

1.3

1.1

18.12

128.76

u/ml

—

Impacted cerumen

315

2623

1.21

2.75

1.3

1.2

180.79

132.58

u/ml

0.85

106

944

Second line medication for Crohn's disease

2408

22539

1.07

2.74

1.2

120.18

141.52

u/ml

2.04

862

8533

Spirochaetal infections, other/unspecified, including avohilmo

1259

11508

1.10

2.74

1.2

160.65

137.95

u/ml

1.02

429

4440

Other keratitis

435

3731

1.18

2.74

1.2

121.19

143.00

u/ml

0.55

161

1394

Ventral hernia

746

6632

1.13

2.74

1.2

102.00

142.20

u/ml

2.73

261

2474

Other erythematous conditions

124

926

1.37

2.74

1.2

107.41

146.62

u/ml

0.56

349

Other salmonella infections, including avohilmo

154

1186

1.33

2.73

1.2

164.99

141.89

u/ml

0.24

472

Other infective otitis externa

214

1717

1.27

2.73

1.2

173.69

153.71

u/ml

0.25

662

Injuries to unspecified part of trunk, limb or body region

346

2912

1.20

2.72

1.3

1.2

118.65

145.06

u/ml

0.76

116

1056

Malignant neoplasm of bladder

107

776

1.39

2.71

1.2

118.40

97.33

u/ml

0.14

274

Injury of blood vessels at wrist and hand level

134

2.04

2.71

1.3

129.00

93.50

u/ml

—

Other hammer toe(s) (acquired)

517

4079

1.16

2.71

1.1

1.2

92.91

143.73

u/ml

2.68

165

1502

Infections of genitourinary tract in pregnancy

491

4264

1.17

2.71

1.2

114.56

148.71

u/ml

1.68

221

1649

Other and unspecified intracranial injuries

671

1.43

2.71

1.3

1.2

58.13

145.11

u/ml

3.50

255

Crossbite

325

2508

1.21

2.70

1.3

132.38

144.41

u/ml

0.19

112

886

Use of memantine

400

3780

0.85

2.70

1.1

67.01

119.89

u/ml

4.05

143

1201

Use of other anti-dementia drugs

400

3780

0.85

2.70

1.1

67.01

119.89

u/ml

4.05

143

1201

Desensitization to allergens

274

2266

1.24

2.70

1.2

140.60

150.28

u/ml

0.13

869

Other bursitis of hip

540

1.49

2.69

1.4

1.2

138.08

139.01

u/ml

0.01

206

Anomalies of pupillary function

701

1.43

2.69

1.2

1.3

110.75

143.51

u/ml

0.44

290

Short stature, not elsewhere classified

106

720

1.41

2.68

1.4

1.3

134.19

153.49

u/ml

0.16

236

Bacterial Sepsis

1391

10546

1.09

2.68

1.2

92.73

135.69

u/ml

5.39

413

3838

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

480

1.54

2.67

1.3

1.2

95.68

150.63

u/ml

0.83

207

Biomechanical lesions, not elsewhere classified

164

1278

1.31

2.66

1.3

1.2

94.14

147.27

u/ml

1.34

483

Use of donepezil

285

3278

0.82

2.66

1.1

1.2

85.71

121.73

u/ml

0.98

1062

Bell's palsy

387

3295

1.19

2.66

1.2

183.13

149.62

u/ml

0.73

149

1223

Inflammatory disease of cervix uteri

243

1986

1.25

2.66

1.2

125.82

147.73

u/ml

0.39

101

779

Perioral dermatitis

121

909

1.38

2.65

1.3

1.2

77.61

151.34

u/ml

2.51

368

Infectious mononucleosis, including avohilmo

437

3767

1.18

2.65

1.2

1.3

77.77

148.43

u/ml

5.75

133

1435

Infectious mononucleosis

437

3767

1.18

2.65

1.2

1.3

77.77

148.43

u/ml

5.75

133

1435

Other specified and unspecified disorders of eye and adnexa

129

974

1.35

2.65

1.2

112.27

139.05

u/ml

0.22

385

Hypertensive Heart Disease

539

3554

1.16

2.65

1.2

102.40

124.48

u/ml

0.64

176

1234

Tracheo-bronchomalasia

129

2.08

2.65

1.3

1.2

16.86

128.24

u/ml

—

Premature rupture of membranes

1389

9092

1.10

2.65

1.3

140.24

144.71

u/ml

0.17

542

3608

ILD, hospital admissions

344

2897

1.20

2.64

1.2

130.83

131.46

u/ml

0.01

104

1012

Anisometropia and aniseikonia

119

889

1.37

2.64

1.3

1.2

140.72

148.29

u/ml

0.08

344

Muscle strain

127

958

1.36

2.64

1.3

1.2

157.35

141.44

u/ml

0.18

374

Hypertensive heart and/or renal disease

604

3866

1.15

2.63

1.2

104.99

127.46

u/ml

0.69

199

1353

Other or unspecified immunodeficiency

109

2.20

2.63

1.6

1.3

54.46

178.24

u/ml

—

Other spirochaetal diseases

1259

11534

1.10

2.63

1.2

161.23

138.71

u/ml

1.01

429

4453

Chorioretinal inflammation

105

770

1.40

2.63

1.2

181.02

129.40

u/ml

0.43

299

Benign neoplasm: Retina

115

2.12

2.63

1.3

49.37

166.37

u/ml

—

Other benign neoplasm of uterus: Other parts/unspecified

717

1.41

2.62

1.2

70.75

118.76

u/ml

1.35

252

Recurrent dislocation and subluxation of joint

272

2249

1.23

2.62

1.2

119.08

143.88

u/ml

0.47

845

Other injuries of upper limb, level unspecified

301

1.66

2.62

1.5

1.2

101.84

141.22

u/ml

0.38

105

Suggestive for eosinophilic asthma

274

2265

1.23

2.62

1.2

113.00

142.51

u/ml

0.80

828

Other and unspecified iridocyclitis

173

1362

1.30

2.62

1.2

130.99

137.57

u/ml

0.08

522

Other misadventures during surgical and medical care

568

1.47

2.61

1.3

1.2

136.90

144.51

u/ml

0.07

222

Malignant neoplasm of other and unspecified parts of tongue

277

1.68

2.61

1.1

1.2

99.55

129.39

u/ml

0.41

113

Benign neoplasm: Descending colon

179

1412

1.29

2.61

1.2

128.55

131.85

u/ml

0.04

496

Maxillary retrognathism

621

1.45

2.61

1.3

112.51

147.67

u/ml

0.57

234

Viral conjunctivitis, including avohilmo

171

1347

1.30

2.61

1.3

1.2

168.44

143.91

u/ml

0.42

550

Other and unspecified primary disorders of muscles

180

1.88

2.61

1.7

1.2

226.52

189.10

u/ml

—

Other and unspecified local infections of skin and subcutaneous tissue

331

2787

1.20

2.61

1.2

75.66

134.32

u/ml

4.25

123

1024

Follicular keratosis (Darier-White), including avohilmo

3.38

2.61

1.2

41.00

151.34

u/ml

—

Peritonsillar abscess

872

7853

1.12

2.61

1.2

163.29

144.04

u/ml

0.71

356

2989

Other or ill-defined heart diseases

149

1148

1.32

2.60

1.2

106.79

124.76

u/ml

0.24

419

Pneumonia due to other infectious organisms, not elsewhere classified

103

753

1.40

2.60

1.2

152.25

145.30

u/ml

0.05

301

Lyme disease

1245

11407

1.10

2.60

1.2

162.09

138.02

u/ml

1.09

423

4395

Lyme disease, including avohilmo

1245

11407

1.10

2.60

1.2

162.09

138.02

u/ml

1.09

423

4395

Prurigo nodularis

552

1.47

2.59

1.2

71.48

137.72

u/ml

0.97

206

Other hearing loss

728

6276

1.13

2.59

1.2

154.88

134.68

u/ml

0.36

244

2160

Viral infections of the central nervous system, including avohilmo

285

2371

1.22

2.59

1.3

1.2

94.61

147.72

u/ml

2.01

879

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

185

1468

1.28

2.59

1.2

153.13

149.07

u/ml

0.04

529

Seronegative rheumatoid arthritis

383

3267

1.19

2.59

1.2

95.40

135.33

u/ml

1.59

131

1248

Invasive ventilation

202

1619

1.26

2.59

1.2

144.61

142.96

u/ml

0.02

582

Hypertrophy of tongue papillae

358

1.60

2.58

1.2

191.13

151.06

u/ml

0.19

146

Ulcer of oesophagus

144

1105

1.32

2.58

1.1

1.2

103.42

135.83

u/ml

0.62

382

Dislocation, sprain and strain of joints and ligaments of knee

2852

24329

1.06

2.58

1.2

137.67

141.91

u/ml

0.22

1101

9377

Balanced rearrangements and structural markers, not elsewhere classified

139

2.06

2.57

1.2

1.3

57.55

112.79

u/ml

—

Sexual dysfunction

430

1.53

2.57

1.1

1.2

27.31

165.92

u/ml

8.10

162

Posteruptive colour changes of dental hard tissues

2.25

2.55

1.2

185.86

168.64

u/ml

—

Tubulo-interstitial nephritis, not specified as acute or chronic

221

1793

1.25

2.55

1.2

83.17

140.77

u/ml

2.30

681

Other diseases of pancreas

222

1801

1.25

2.55

1.2

143.98

145.90

u/ml

0.02

651

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

717

0.62

2.54

1.2

97.68

132.12

u/ml

0.45

276

Barrett oesophagus

121

909

1.35

2.54

1.3

1.2

220.22

140.13

u/ml

0.55

310

Gastroduodenal ulcer

607

5336

1.14

2.53

1.2

87.73

129.64

u/ml

2.41

205

1851

Ovarian dysfunction, other/unspecified

245

1.76

2.53

1.4

1.3

125.26

187.26

u/ml

0.52

110

Pustulosis palmaris et plantaris

160

1255

1.30

2.52

1.3

1.2

126.60

153.93

u/ml

0.38

499

In situ neoplasms

1496

13832

1.09

2.52

1.2

139.39

139.48

u/ml

0.00

532

5228

Prolapse and hernia of ovary and fallopian tube

556

1.45

2.51

1.2

269.60

126.64

u/ml

0.38

202

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

601

5146

1.14

2.51

1.3

1.2

107.57

145.80

u/ml

1.99

220

1844

Other interstitial pulmonary diseases

346

2931

1.19

2.51

1.2

129.59

131.61

u/ml

0.03

105

1022

Viral conjunctivitis

693

1.42

2.51

1.3

1.2

180.74

141.51

u/ml

0.57

292

Hypersplenism

2.26

2.50

1.2

26.89

138.63

u/ml

—

Other embolism and thrombosis

378

3230

1.18

2.50

1.2

132.94

136.43

u/ml

0.05

120

1219

Pyoderma gangrenosum

213

1.78

2.49

1.2

195.44

161.45

u/ml

0.17

Cushing syndrome

322

1.62

2.49

1.3

153.29

144.02

u/ml

0.05

137

Other papulosquamous disorders

274

1.67

2.49

1.2

1.3

121.37

145.71

u/ml

0.24

104

Isolated growth hormone deficiency

191

1.84

2.48

1.5

1.4

180.21

173.82

u/ml

—

Follicular keratosis (Darier-White)

3.52

2.48

1.2

41.00

124.74

u/ml

—

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

182

1.83

2.48

1.2

77.50

125.89

u/ml

—

113

852

1.38

2.48

1.3

48.20

147.27

u/ml

6.23

307

Other/unspecified soft tissue disorders related to use, overuse and pressure

113

847

1.37

2.48

1.3

1.2

202.79

136.61

u/ml

0.53

326

Other adrenocortical overactivity

215

1.80

2.48

1.3

325.03

112.80

u/ml

—

Oral leukoplakia, including avohilmo

599

1.44

2.48

1.2

307.49

135.60

u/ml

1.81

242

Behavioural disorders

107

798

1.39

2.48

1.3

132.19

144.57

u/ml

0.10

287

Heart failure and coronary heart disease

960

6078

1.11

2.47

1.2

103.12

129.31

u/ml

1.45

309

2031

Chronic Coagulation defects

111

833

1.38

2.47

1.3

160.28

147.99

u/ml

0.11

341

Cyst of kidney

183

1459

1.27

2.47

1.3

1.2

94.87

138.44

u/ml

1.43

520

Perichondritis of external ear

329

1.60

2.46

1.1

1.2

200.55

130.03

u/ml

0.48

122

Fasciculation

339

1.60

2.46

1.4

1.2

109.70

148.10

u/ml

0.39

139

Ischaemic heart disease, wide definition

2447

14141

1.07

2.46

1.2

133.01

139.11

u/ml

0.31

934

5233

Acute pancreatitis

536

4704

1.15

2.45

1.2

123.53

130.07

u/ml

0.17

172

1744

Nummular dermatitis

240

1973

1.23

2.45

1.2

129.97

137.28

u/ml

0.10

693

Interstitial lung disease

346

2938

1.19

2.45

1.2

129.59

131.63

u/ml

0.03

105

1024

Interstitial lung disease endpoints

346

2938

1.19

2.45

1.2

129.59

131.63

u/ml

0.03

105

1024

Other protozoal intestinal diseases

420

1.53

2.45

1.1

1.3

137.81

146.96

u/ml

0.04

187

COPD, hospital admissions 1, only main diagnosis

616

5975

0.88

2.44

1.2

104.65

124.99

u/ml

0.72

178

2035

Juvenile arthritis (FINNGEN)

222

1819

1.25

2.43

1.3

153.12

143.45

u/ml

0.12

680

Pigmented purpuric dermatosis

206

1.77

2.43

1.1

1.2

78.64

137.63

u/ml

—

Disorder of pancreatic internal secretion, other and/or unspecified

177

1.85

2.42

1.2

132.48

151.45

u/ml

—

Carcinoma in situ of skin of scalp and neck

329

1.58

2.42

1.1

141.40

115.72

u/ml

0.12

108

ILD, hospital admissions 1, main diag only

310

2612

1.20

2.41

1.2

124.76

133.92

u/ml

0.16

902

Hyperaldosteronism

628

1.42

2.41

1.2

127.36

136.13

u/ml

0.07

257

Abnormal findings in nipple discharge synovial fluid wound secretions

430

1.52

2.41

1.2

1.3

68.29

128.26

u/ml

1.44

178

Nonspecific lymphadenitis

230

1891

1.24

2.40

1.2

87.30

146.77

u/ml

2.28

746

Personal history of allergy to drugs, medicaments and biological substances

382

1.56

2.40

1.2

1.3

163.08

143.89

u/ml

0.14

158

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

150

1177

1.30

2.39

1.3

1.2

212.43

135.40

u/ml

0.92

475

Biguanides

4003

23026

1.05

2.39

1.2

123.98

143.58

u/ml

2.36

1406

8892

Panniculitis affecting regions of neck and back

124

947

1.34

2.39

1.2

117.91

142.42

u/ml

0.32

365

Other disorders of amniotic fluid and membranes

870

7621

1.12

2.38

1.3

150.57

148.64

u/ml

0.05

346

3028

Gonarthrosis,primary

3047

17381

1.06

2.38

1.2

133.61

140.20

u/ml

0.39

1127

6598

Primary_lymphoid and hematopoietic malignant neoplasms

614

5447

1.13

2.38

1.2

111.76

125.49

u/ml

0.40

188

1884

Other inflammatory liver diseases

211

1720

1.25

2.37

1.2

159.27

137.89

u/ml

0.34

650

Cardiomyopathies, Primary/intrinsic

257

2133

1.21

2.35

1.2

104.38

121.08

u/ml

0.29

713

Primary gonarthrosis, bilateral

1561

12121

1.08

2.35

1.2

131.02

141.33

u/ml

0.44

580

4446

Open wound of lower leg

509

4470

1.15

2.35

1.2

112.00

140.51

u/ml

1.07

183

1625

Congenital malformations of the nervous system

106

797

1.37

2.34

1.3

103.54

144.19

u/ml

0.85

323

Vascular disorders of the intestines

148

1156

1.29

2.34

1.2

94.17

126.13

u/ml

0.68

407

Intussusception

590

1.43

2.34

1.3

1.2

171.96

139.81

u/ml

0.23

231

Spasmodic torticollis

124

952

1.34

2.34

1.4

1.2

95.46

145.91

u/ml

1.36

375

Rhinophyma

2.46

2.34

1.2

55.60

98.85

u/ml

—

Disorders of puberty, all

644

1.42

2.33

1.4

1.3

131.62

145.69

u/ml

0.14

229

Benign neoplasm: Parotid gland

224

1840

1.23

2.33

1.2

132.51

140.78

u/ml

0.10

672

Diseases of peritoneum

293

2468

1.20

2.33

1.1

1.2

130.89

140.28

u/ml

0.14

101

908

Malignant neoplasm of gum, including Hilmo

156

1.86

2.33

1.1

1.2

112.49

115.42

u/ml

—

Contusion of other and unspecified parts of foot

233

1927

1.23

2.32

1.2

127.32

154.20

u/ml

0.54

751

Lung cancer and mesothelioma

443

3262

1.16

2.32

1.2

130.06

126.52

u/ml

0.06

1188

Adenocarcinoma of pancreas

508

0.58

2.32

1.1

1.2

248.86

117.90

u/ml

0.73

198

Congenital malformations of eye, ear, face and neck

278

2338

1.21

2.31

1.2

133.19

147.88

u/ml

0.28

117

856

Haemangioma and lymphangioma, any site

331

2823

1.19

2.31

1.2

104.81

143.05

u/ml

1.43

128

1048

Congenital malformations of heart and great arteries

458

3880

1.16

2.31

1.3

1.2

112.31

146.61

u/ml

1.31

174

1389

Drug-induced tremor

128

1.97

2.31

1.3

1.2

85.80

132.03

u/ml

—

Benign neoplasm: Skin of other and unspecified parts of face

314

2664

1.19

2.30

1.2

165.13

142.27

u/ml

0.40

115

984

Benign neoplasm: Skin of eyelid, including canthus

469

4103

1.15

2.30

1.2

137.46

137.23

u/ml

0.00

152

1527

Lung diseases due to external agents

297

2504

1.19

2.30

1.2

115.62

130.68

u/ml

0.26

102

863

Endocrine disorders, other/unspecified

534

1.45

2.29

1.3

1.2

104.21

140.47

u/ml

0.40

230

Discharge from other and unspecified firearms

0.00

2.29

0.0

1.2

—

93.37

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

599

5321

1.13

2.29

1.2

130.89

137.23

u/ml

0.14

216

1873

Foreign body in respiratory tract

184

1486

1.26

2.29

1.3

1.2

78.43

141.46

u/ml

3.84

574

Benign neoplasm of middle ear and respiratory system

207

1690

1.24

2.28

1.2

60.34

139.07

u/ml

6.12

610

Open wound of ankle and foot

341

2917

1.18

2.27

1.2

102.42

141.75

u/ml

1.53

1053

Coxarthrosis

1555

9308

1.08

2.27

1.2

127.39

142.95

u/ml

0.86

544

3552

Short Achilles tendon (acquired)

108

817

1.35

2.26

1.3

1.2

150.47

136.64

u/ml

0.14

328

Toxic effects of substances chiefly nonmedicinal as to source

413

3588

1.16

2.26

1.3

1.2

92.15

146.38

u/ml

2.76

155

1318

Medicines for HER+ breast cancer

1293

13018

0.92

2.26

1.2

153.70

144.42

u/ml

0.37

504

5073

Other congenital malformations of skin

159

1268

1.28

2.24

1.3

1.2

112.95

142.57

u/ml

0.54

493

Cholecystitis

366

3149

1.17

2.24

1.2

131.16

132.73

u/ml

0.02

120

1159

Entropion and trichiasis of eyelid

174

1396

1.26

2.23

1.1

1.2

140.91

129.02

u/ml

0.14

471

Other disorders of binocular vision

489

1.47

2.23

1.1

1.3

53.92

166.90

u/ml

5.63

204

Other and unspecified spinal muscular atrophies

122

1.95

2.22

1.0

1.2

57.43

124.65

u/ml

—

Adenocarcinoma and ductal carcinoma of pancreas

637

0.63

2.22

1.1

1.2

244.63

126.72

u/ml

0.76

246

Special screening examination for neoplasms

183

1479

1.25

2.22

1.2

209.13

150.79

u/ml

0.48

573

Rheumatoid arthritis, including avohilmo

1340

12413

1.09

2.21

1.2

110.19

139.95

u/ml

2.49

512

4697

Benign neoplasm: Rectum

461

4039

1.15

2.21

1.2

94.27

128.91

u/ml

1.70

172

1458

Secondary polycythaemia

461

1.46

2.21

1.3

1.2

147.25

133.68

u/ml

0.07

178

Injury of nerves and spinal cord at neck level

470

1.46

2.20

1.2

69.56

128.25

u/ml

2.06

192

Congenital cataract

124

1.99

2.20

1.2

1.3

167.56

150.36

u/ml

—

Other disorders of central nervous system

332

1.56

2.19

1.2

1.3

91.26

164.06

u/ml

0.86

145

Malignant neoplasm of skin

1579

9937

1.08

2.19

1.2

110.23

137.30

u/ml

2.23

499

3875

COPD, early/later onset

924

8505

0.91

2.19

1.2

132.17

123.42

u/ml

0.24

265

2977

Benign neoplasm: Duodenum

470

1.46

2.19

1.2

75.90

129.80

u/ml

1.33

178

Assault by hanging, strangulation and suffocation

104

2.14

2.18

1.4

1.3

52.80

121.39

u/ml

—

Melanoma in situ

117

898

1.32

2.18

1.3

1.2

83.53

136.80

u/ml

1.36

342

Effects of other deprivation

2.39

2.18

1.0

1.4

34.80

150.22

u/ml

—

Herpesviral keratitis and keratoconjunctivitis

137

1075

1.30

2.18

1.2

95.33

131.33

u/ml

0.75

421

Iliotibial band syndrome

333

1.56

2.17

1.3

125.82

144.53

u/ml

0.13

147

Other congenital malformations of skin, including avohilmo

337

2897

1.18

2.17

1.2

160.98

150.74

u/ml

0.09

125

1083

Benign neoplasm: Skin of ear and external auricular canal

106

803

1.34

2.17

1.2

148.43

131.27

u/ml

0.13

304

Nontraumatic intracranial haemmorrhage

359

4157

0.86

2.17

1.2

109.51

132.94

u/ml

0.44

128

1479

Specific development disorders of speech and language

229

1834

1.22

2.16

1.4

1.2

108.15

142.98

u/ml

0.81

656

Benign neoplasm of major salivary glands

269

2267

1.20

2.16

1.2

121.48

139.48

u/ml

0.31

836

Haemorrhage, not elsewhere classified

717

1.36

2.15

1.2

119.80

129.84

u/ml

0.07

256

Major anomalies of jaw size

108

825

1.34

2.15

1.3

1.2

116.98

136.66

u/ml

0.23

329

Other and unspecified vaccines and biological substances

232

1.70

2.15

1.3

160.21

131.94

u/ml

0.14

Peroneal tendinitis

533

1.43

2.15

1.2

153.99

140.22

u/ml

0.09

218

Other salmonella infections

116

893

1.32

2.14

1.1

1.2

139.37

137.94

u/ml

0.01

356

Other and unspecified erythematous conditions

109

833

1.34

2.13

1.2

116.13

141.73

u/ml

0.27

316

Benign neoplasm: salivary glands, exclude unknown (D119)

247

2069

1.21

2.13

1.2

131.19

139.97

u/ml

0.12

768

Localized scleroderma [morphea]

417

1.49

2.13

1.3

1.2

171.14

150.99

u/ml

0.12

167

Conductive hearing loss, unspecified

278

2355

1.20

2.12

1.3

1.2

151.08

140.19

u/ml

0.16

106

855

Injury of nerves at wrist and hand level

127

991

1.31

2.12

1.3

1.2

133.30

138.87

u/ml

0.05

393

Helminthiases, including avohilmo

188

1539

1.25

2.12

1.2

121.63

150.01

u/ml

0.51

598

Atherosclerosis, excluding cerebral and coronary sclerosis

731

6362

0.90

2.12

1.1

1.2

106.90

121.82

u/ml

0.51

231

2130

Other condition

511

4526

1.14

2.12

1.2

150.13

138.87

u/ml

0.14

199

1680

Other disorders of cornea

310

2650

1.18

2.12

1.2

153.25

133.97

u/ml

0.34

101

967

Glomerular diseases

497

4391

1.14

2.11

1.2

162.14

131.27

u/ml

0.42

171

1561

Other disorders of the genitourinary system

409

3571

1.16

2.11

1.2

127.46

140.44

u/ml

0.32

153

1337

COPD, hospital admissions 3, with asthma pneumonia sepsis

444

4337

0.87

2.11

1.2

119.14

118.97

u/ml

0.00

119

1474

Disorders of synovium and tendon in diseases classified elsewhere

466

1.45

2.11

1.3

1.2

111.29

130.43

u/ml

0.32

183

Septal defects

239

1960

1.21

2.10

1.3

132.87

145.49

u/ml

0.21

683

Medial epicondylitis

135

1064

1.29

2.10

1.2

85.87

146.11

u/ml

1.76

434

Benign neoplasm: Other parts of oropharynx

224

1.68

2.10

1.2

84.14

141.35

u/ml

—

Spontaneous rupture of synovium and tendon

235

1962

1.21

2.10

1.2

105.88

129.93

u/ml

0.50

750

Carcinoma in situ of skin of other and unspecified parts of face

168

1354

1.25

2.09

1.1

1.2

140.98

119.30

u/ml

0.26

460

Later onset COPD

413

3797

0.87

2.08

1.2

144.13

107.01

u/ml

0.75

114

1206

Congenital malformations of uterus and cervix

128

1010

1.31

2.08

1.3

114.66

143.90

u/ml

0.47

416

Interstitial cystitis (chronic), drug-induced

2.31

2.08

1.1

1.2

37.64

159.11

u/ml

—

Other and unspecified myopathies

210

1735

1.22

2.08

1.3

1.2

115.51

139.77

u/ml

0.35

607

Acute bronchiolitis

271

2073

1.20

2.07

1.3

96.80

128.93

u/ml

0.82

692

Contusion of toe(s) with damage to nail

337

1.54

2.07

1.4

1.3

40.80

137.38

u/ml

4.37

139

Contact with sharp glass

157

1263

1.27

2.07

1.3

1.2

102.23

136.93

u/ml

0.41

497

Viral infections of the central nervous system

256

2160

1.20

2.07

1.3

1.2

97.02

149.21

u/ml

1.67

814

Malignant neoplasm of other and unspecified female genital organs

426

0.57

2.07

1.1

1.2

93.67

124.84

u/ml

—

171

Fistulae involving female genital tract

444

1.46

2.07

1.1

1.2

105.74

145.23

u/ml

0.40

185

Deficiency of other B group vitamins

468

1.44

2.06

1.2

218.55

136.08

u/ml

1.27

200

Leisure time condition

633

5686

1.12

2.06

1.2

136.95

139.41

u/ml

0.05

247

2091

Unspecified misadventure during surgical and medical care

174

1414

1.25

2.06

1.2

152.10

141.29

u/ml

0.10

533

Contact with other sharp object(s)

267

2263

1.20

2.06

1.2

134.86

144.25

u/ml

0.13

854

Peptic ulcer

155

1.80

2.06

1.3

1.1

182.07

163.40

u/ml

0.06

Crystal arthropathies, rheuma endpoint

303

1.55

2.05

1.2

67.61

137.82

u/ml

1.37

110

Keratoconus

613

1.39

2.05

1.2

123.69

136.92

u/ml

0.12

247

Intestinal adhesions without obstruction

228

1902

1.21

2.05

1.2

118.67

133.93

u/ml

0.22

701

Primary Sclerosing Cholangitis, IBD and UDCA required

588

1.40

2.05

1.1

1.3

77.08

144.57

u/ml

1.20

226

Pustular psoriasis

168

1363

1.26

2.05

1.3

1.2

124.57

151.84

u/ml

0.39

544

Benign neoplasm: Appendix

217

1.67

2.05

1.1

1.2

151.97

125.38

u/ml

0.11

Other specified and unspecified retinal disorders

104

794

1.33

2.05

1.2

131.61

129.83

u/ml

0.02

306

Charcot foot

361

1.51

2.05

1.2

164.78

157.93

u/ml

0.05

143

Erectile dysfunction

111

852

1.31

2.04

1.2

57.18

108.99

u/ml

1.25

252

Generalized skin eruption due to drugs and medicaments

141

1122

1.28

2.04

1.3

1.2

118.25

133.79

u/ml

0.16

428

Lesion of plantar nerve

201

1661

1.23

2.04

1.2

175.07

142.16

u/ml

0.35

632

Increased muscle tone

195

1.73

2.04

1.3

177.30

131.25

u/ml

—

Superficial injury of shoulder and upper arm

423

3712

1.15

2.04

1.2

133.15

141.49

u/ml

0.15

135

1379

Sulfasalazine

1070

9864

1.09

2.03

1.2

110.33

146.12

u/ml

2.69

395

3843

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

134

1.87

2.03

1.2

1.3

85.75

127.22

u/ml

—

Cerebral aneurysm, nonruptured

276

2348

1.19

2.02

1.2

121.45

145.84

u/ml

0.49

880

227

1.67

2.02

1.2

56.11

151.14

u/ml

2.18

Right bundle-branch block

673

1.36

2.02

1.2

69.65

119.84

u/ml

1.02

245

Long labour

1439

11381

1.08

2.02

1.3

157.02

151.13

u/ml

0.21

596

4560

Benign neoplasm: Connective and other soft tissue of head, face and neck

421

1.47

2.02

1.2

1.3

119.10

152.59

u/ml

0.27

173

Blepharospasm

195

1.70

2.01

1.3

1.2

107.08

135.14

u/ml

—

Calcaneal spur

331

1.53

2.00

1.1

1.2

153.35

132.22

u/ml

0.15

127

Other contact dermatitis

300

2574

1.18

1.99

1.2

154.35

148.32

u/ml

0.09

118

956

Idiopathic hypercalciuria

143

1.85

1.99

1.4

1.2

32.03

122.51

u/ml

3.13

Other specified/unspecified disorders of bone/cartilage

616

1.38

1.99

1.2

113.63

138.14

u/ml

0.20

238

Other and unspecified psoriasis

200

1655

1.22

1.99

1.2

64.90

141.80

u/ml

4.63

613

Other disorders of Eustachian tube

115

896

1.31

1.99

1.2

131.08

134.57

u/ml

0.04

367

Congenital lens malformations

136

1.88

1.99

1.2

1.3

152.40

146.11

u/ml

—

Turner's syndrome

101

2.10

1.98

1.5

1.3

158.57

134.05

u/ml

—

Early onset COPD, excluding more controls

512

4546

1.13

1.98

1.2

123.13

141.08

u/ml

0.48

151

1756

Other and unspecified disorders of orbit

2.06

1.97

1.0

1.2

403.40

130.11

u/ml

—

Primary coxarthrosis, bilateral

724

6562

1.11

1.97

1.2

123.02

130.88

u/ml

0.20

244

2294

Acquired absence of organs, not elsewhere classified

219

1.65

1.97

1.1

1.3

72.58

105.03

u/ml

0.37

Traumatic subarachnoid haemorrhage

624

1.36

1.97

1.2

72.63

149.42

u/ml

1.45

215

Other and unspecified paralytic syndromes

357

1.50

1.97

1.2

1.3

201.34

151.74

u/ml

0.26

145

Eustachian salpingitis and obstruction

346

3008

1.17

1.96

1.2

151.31

136.95

u/ml

0.33

139

1197

Heart failure,strict

1341

8692

1.08

1.95

1.2

104.96

133.38

u/ml

2.21

433

3058

Achalasia of cardia

340

1.51

1.95

1.2

84.01

142.01

u/ml

0.53

140

AV-block

386

2875

1.15

1.95

1.2

87.79

134.96

u/ml

2.03

132

963

Acute pancreatitis (for exclusion)

536

4784

1.13

1.95

1.2

123.53

131.16

u/ml

0.20

172

1746

Simple and mucopurulent chronic bronchitis

720

1.34

1.95

1.3

1.2

118.73

145.19

u/ml

0.44

266

Mantle cell lymphoma

106

1.94

1.95

1.1

1.2

78.35

86.25

u/ml

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

189

1.70

1.95

1.1

1.3

124.81

152.82

u/ml

—

COPD, hospital admissions

918

8429

0.91

1.95

1.2

132.17

123.36

u/ml

0.24

265

2956

Focal epilepsy

682

6168

1.11

1.95

1.2

91.64

137.65

u/ml

3.27

253

2273

Drug-induced headache, not elsewhere classified

183

1.74

1.95

1.3

41.70

145.03

u/ml

—

Pleural plaque with presence of asbestos

719

1.33

1.95

1.1

69.39

99.19

u/ml

0.56

207

Other deformities of toe(s)

123

969

1.29

1.94

1.2

98.56

146.21

u/ml

0.70

359

Mental and behavioural disorders associated with the puerperium

513

1.43

1.94

1.3

1.2

95.68

158.91

u/ml

0.99

214

Nonsuppurative otitis media

1154

9274

1.09

1.94

1.2

1.3

144.40

136.98

u/ml

0.25

437

3400

Other infestations, including avohilmo

416

1.46

1.94

1.3

1.2

189.97

129.66

u/ml

0.33

168

Family history of certain disabilities and chronic diseases leading to disablement

240

2032

1.20

1.93

1.3

1.2

154.39

157.51

u/ml

0.03

791

Benign neoplasm: Short bones of upper limb

451

1.44

1.93

1.3

1.2

195.77

147.81

u/ml

0.32

189

Horner syndrome

285

1.56

1.93

1.3

1.2

156.42

140.57

u/ml

0.06

120

Dementia in Alzheimer disease

239

2369

0.84

1.93

1.1

63.25

117.11

u/ml

3.03

757

Intestinal stricture

852

7794

1.10

1.92

1.2

120.93

134.44

u/ml

0.44

278

2820

Drug-induced hypoglycaemia without coma

317

1.52

1.92

1.3

116.60

158.87

u/ml

0.43

116

Hyperosmolality and hypernatraemia

189

1.68

1.92

1.2

43.00

147.08

u/ml

—

Syndrome of inappropriate secretion of antidiuretic hormone

2.07

1.91

1.2

26.88

167.02

u/ml

—

Fibrosis and cirrhosis of liver

207

1726

1.21

1.91

1.2

127.88

145.28

u/ml

0.26

617

Other disorders of iris and ciliary body

586

1.37

1.91

1.2

124.40

143.98

u/ml

0.16

232

Other chondrocalcinosis

174

1.71

1.91

1.3

1.1

45.82

129.30

u/ml

1.76

Diseases of arteries, arterioles and capillaries (FINNGEN)

710

4433

1.11

1.90

1.2

131.02

146.44

u/ml

0.45

250

1706

Congenital malformations of the respiratory system, including avohilmo

494

1.41

1.89

1.3

112.00

148.64

u/ml

0.62

189

Unspecified abortion

224

1890

1.21

1.89

1.2

156.38

145.74

u/ml

0.12

805

Anaemia in chronic diseases classified elsewhere

417

1.44

1.89

1.1

1.2

213.32

128.11

u/ml

0.83

162

Non-small cell lung cancer, squamous

542

1.38

1.89

1.3

1.2

96.29

97.18

u/ml

0.01

205

Pulmonary oedema

213

1.62

1.88

1.2

77.03

146.26

u/ml

1.04

Galactorrhea

448

1.45

1.88

1.4

1.2

172.28

161.94

u/ml

0.07

184

Other congenital malformations of circulatory system

693

1.34

1.88

1.4

1.2

91.15

143.52

u/ml

0.89

284

Benign neoplasm: Rectum, anus and anal canal

511

4561

1.13

1.88

1.2

98.47

132.55

u/ml

1.70

191

1624

Cardiomyopathy (excluding other)

268

2287

1.18

1.87

1.2

102.68

121.83

u/ml

0.36

780

All dysplastic lesions of the cervix uteri, vagina or vulva

1737

15963

1.07

1.87

1.2

1.3

156.45

146.58

u/ml

0.40

660

6439

Crushed, pushed or stepped on by crowd or human stampede

298

2572

1.17

1.87

1.3

1.2

138.72

144.87

u/ml

0.09

955

Mental and behavioural disorders of puerperium, not classified elsewhere

517

1.42

1.87

1.3

1.2

95.68

151.85

u/ml

0.86

222

Amblyopia ex anopsia

160

1308

1.25

1.86

1.3

1.2

139.61

145.30

u/ml

0.05

480

Hordeolum and other deep inflammation of eyelid

227

1918

1.20

1.85

1.3

1.2

142.30

155.70

u/ml

0.18

712

Haemangioma, any site

302

2611

1.17

1.85

1.2

102.23

145.46

u/ml

1.60

118

974

All kidney diseases

4421

28479

1.04

1.85

1.2

130.56

143.11

u/ml

1.07

1550

10942

Schizophrenia

525

4702

1.13

1.85

1.2

82.94

145.82

u/ml

3.91

175

1780

Asthma mixed form (mode), excluding more controls

167

1369

1.24

1.84

1.3

1.2

135.96

132.96

u/ml

0.03

525

Alzheimer’s disease (Early onset)

693

0.69

1.84

1.2

55.33

133.33

u/ml

2.40

243

Superficial injury of neck

670

1.35

1.84

1.4

1.3

64.36

146.37

u/ml

2.94

278

Alcoholic liver disease

151

1855

0.81

1.84

1.1

1.2

100.53

129.06

u/ml

0.38

660

Other obstructive and reflux uropathy

156

1272

1.25

1.84

1.2

103.20

134.43

u/ml

0.66

499

COPD related to multimorbidity

743

6890

0.91

1.84

1.2

135.07

123.47

u/ml

0.27

211

2366

Hydrocele

175

1438

1.22

1.84

1.1

1.2

91.57

110.84

u/ml

0.39

442

Reactive arthropathies

283

2435

1.17

1.83

1.2

88.85

136.20

u/ml

2.27

103

882

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Thyroperoxidase Ab [Units/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS